Syndromic disease
MONDO:0002254A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.
Also known as: cluster, symptom, clusters, symptom, symptom cluster, symptom clusters, syndrome, syndrome associated with disease or disorder, syndromes, syndromic disease
7133 clinical trials for this condition and its sub-types, 25 tagged with Syndromic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Syndromic disease
-
Neoplastic syndrome 1 trial · 1,430 incl. sub-types
11 sub-types
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Myelodysplastic syndrome 653 trials · 671 incl. sub-types Sub-types →
- Ectopic ACTH secretion syndrome 15 trials
- Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types Sub-types →
- Ectopic hormone secretion syndrome associated with neoplasia 0 trials · 5 incl. sub-types Sub-types →
- Tumor lysis syndrome 3 trials
- Zollinger-Ellison syndrome 2 trials
- Pancoast syndrome 1 trial
- Carney triad 0 trials
- Meigs syndrome 0 trials
- Growing teratoma syndrome 0 trials
-
Obstructive sleep apnea syndrome 516 trials · 517 incl. sub-types
1 sub-type
- Complex sleep apnea 1 trial
-
Acute respiratory distress syndrome 298 trials · 417 incl. sub-types
2 sub-types
- Adult acute respiratory distress syndrome 246 trials
- Pediatric acute respiratory distress syndrome 14 trials · 123 incl. sub-types Sub-types →
-
Abdominal obesity-metabolic syndrome 301 trials · 357 incl. sub-types
5 sub-types
- Metabolic syndrome X 338 trials
- LIPE-related familial partial lipodystrophy 0 trials
- Abdominal obesity-metabolic syndrome 3 0 trials
- Abdominal obesity-metabolic syndrome 4 0 trials
- Abdominal obesity-metabolic syndrome quantitative trait locus 2 0 trials
-
Acute coronary syndrome 298 trials
-
Fibromyalgia 279 trials
-
Dry eye syndrome 253 trials · 254 incl. sub-types
1 sub-type
- Xerophthalmia 2 trials
-
Toxic shock syndrome 224 trials
2 sub-types
-
Irritable bowel syndrome 221 trials
-
Autoinflammatory syndrome 21 trials · 207 incl. sub-types
37 sub-types
- Sarcoidosis 61 trials · 84 incl. sub-types Sub-types →
- Periodic fever syndrome 2 trials · 25 incl. sub-types Sub-types →
- Systemic-onset juvenile idiopathic arthritis 25 trials
- Type 1 interferonopathy 4 trials · 21 incl. sub-types Sub-types →
- Autoinflammatory syndrome of childhood 0 trials · 19 incl. sub-types Sub-types →
- VEXAS syndrome 18 trials
- Adult-onset Still disease 12 trials
- Pyoderma gangrenosum 10 trials Sub-types →
- Idiopathic recurrent pericarditis 8 trials
- PFAPA syndrome 6 trials
- Chronic recurrent multifocal osteomyelitis 3 trials · 4 incl. sub-types Sub-types →
- SAPHO syndrome 3 trials
- Schnitzler syndrome 1 trial
- Cherubism 1 trial Sub-types →
- CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome 0 trials
- F12-associated cold autoinflammatory syndrome 0 trials
- PAPASH syndrome 0 trials
- Pelger-Huet-like anomaly and episodic fever with abdominal pain 0 trials
- SAMD9L-associated autoinflammatory syndrome 0 trials
- Sharpin-related autoinflammatory syndrome 0 trials
- Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation 0 trials
- Autoinflammatory disease, X-linked 0 trials
- Autoinflammatory disease, multisystem, with immune dysregulation, X-linked 0 trials Sub-types →
- Autoinflammatory disease, systemic, with vasculitis 0 trials
- Autoinflammatory syndrome with immunodeficiency 0 trials
- Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
- Autoinflammatory syndrome, familial, Behcet-like 0 trials Sub-types →
- Autoinflammatory syndrome due to TBK1 deficiency 0 trials
- Early-onset pulmonary and cutaneous vasculitis 0 trials
- Granulomatous autoinflammatory syndrome of childhood 0 trials
- Infantile onset panniculitis with uveitis and systemic granulomatosis 0 trials
- Magic syndrome 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Neonatal-onset severe multisystemic autoinflammatory disease with increased IL18 0 trials
- Psoriasis 14, pustular 0 trials
- Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome 0 trials
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials
-
Psoriatic arthritis 188 trials · 201 incl. sub-types
1 sub-type
-
Polycystic ovary syndrome 200 trials
-
Sjogren syndrome 166 trials
-
Progressive supranuclear palsy 73 trials · 77 incl. sub-types
4 sub-types
- Supranuclear palsy, progressive, 1 5 trials
- Atypical progressive supranuclear palsy syndrome 1 trial · 4 incl. sub-types Sub-types →
- Supranuclear palsy, progressive, 2 0 trials
- Supranuclear palsy, progressive, 3 0 trials
-
Syndromic dyslipidemia 0 trials · 73 incl. sub-types
29 sub-types
- CHILD syndrome 37 trials
- Smith-Lemli-Opitz syndrome 6 trials
- Cerebrotendinous xanthomatosis 6 trials
- Familial lipoprotein lipase deficiency 6 trials
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- GM1 gangliosidosis type 1 3 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Apparent mineralocorticoid excess 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Peroxisome biogenesis disorder due to PEX5 defect in the PEX7-binding domain 0 trials · 1 incl. sub-types Sub-types →
- Rhizomelic chondrodysplasia punctata type 1 1 trial
- CHIME syndrome 0 trials
- Krabbe disease due to saposin A deficiency 0 trials
- PHARC syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hyperlipoproteinemia, type 1D 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Lipoprotein glomerulopathy 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Sitosterolemia 0 trials Sub-types →
-
Nephrotic syndrome 47 trials · 71 incl. sub-types
4 sub-types
- Idiopathic nephrotic syndrome 13 trials · 24 incl. sub-types Sub-types →
- Familial nephrotic syndrome 0 trials · 22 incl. sub-types Sub-types →
- Steroid-resistant nephrotic syndrome 5 trials · 15 incl. sub-types Sub-types →
- Nephrotic syndrome ocular anomalies 0 trials
-
Cushing syndrome 42 trials · 66 incl. sub-types
2 sub-types
- Endogenous Cushing syndrome 3 trials · 38 incl. sub-types Sub-types →
- Exogenous Cushing syndrome 1 trial
-
Myotonic syndrome 11 trials · 61 incl. sub-types
5 sub-types
- Myotonic dystrophy 56 trials · 57 incl. sub-types Sub-types →
- Nondystrophic myotonia 4 trials
- Laryngospasm, severe neonatal episodic 1 trial
- Paramyotonia congenita of Von Eulenburg 1 trial
- Potassium-aggravated myotonia 0 trials Sub-types →
-
Antiphospholipid syndrome 58 trials · 59 incl. sub-types
4 sub-types
- Primary antiphospholipid syndrome 4 trials
- Catastrophic antiphospholipid syndrome 1 trial
- Familial antiphospholipid syndrome 0 trials
- Secondary antiphospholipid syndrome 0 trials Sub-types →
-
Substance withdrawal syndrome 30 trials · 59 incl. sub-types
3 sub-types
- Neonatal abstinence syndrome 18 trials
- Alcohol withdrawal 11 trials · 13 incl. sub-types Sub-types →
- Baclofen withdrawal syndrome 0 trials
-
Hemophagocytic syndrome 38 trials · 58 incl. sub-types
2 sub-types
- Secondary hemophagocytic lymphohistiocytosis 15 trials · 24 incl. sub-types Sub-types →
- Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
-
Multiple organ dysfunction syndrome 50 trials
-
Hypereosinophilic syndrome 19 trials · 49 incl. sub-types
8 sub-types
- Pulmonary eosinophilia 30 trials Sub-types →
- Idiopathic hypereosinophilic syndrome 1 trial Sub-types →
- Secondary hypereosinophilic syndrome 0 trials · 1 incl. sub-types Sub-types →
- Disseminated eosinophilic collagen disease 0 trials
- Eosinophilia-myalgia syndrome 0 trials
- Episodic angioedema with eosinophilia 0 trials
- Hypereosinophilia of undetermined significance 0 trials
- Primary hypereosinophilic syndrome 0 trials
-
Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types
25 sub-types
- Ehlers-Danlos syndrome, hypermobility type 15 trials
- Joint laxity, familial 14 trials
- Ehlers-Danlos syndrome, vascular type 6 trials Sub-types →
- Bethlem myopathy 2 0 trials
- COL1A1-related Ehlers-Danlos syndrome 0 trials Sub-types →
- COL1A2-related Ehlers-Danlos syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome due to tenascin-X deficiency 0 trials
- Ehlers-Danlos syndrome, Beasley-Cohen type 0 trials
- Ehlers-Danlos syndrome, arthrochalasia type 0 trials Sub-types →
- Ehlers-Danlos syndrome, autosomal dominant, type unspecified 0 trials
- Ehlers-Danlos syndrome, classic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, classic-like, 2 0 trials
- Ehlers-Danlos syndrome, classic-like, 3 0 trials
- Ehlers-Danlos syndrome, dermatosparaxis type 0 trials
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Ehlers-Danlos syndrome, periodontitis type 0 trials Sub-types →
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, vascular-like type 0 trials
- Ehlers-Danlos/osteogenesis imperfecta syndrome 0 trials Sub-types →
- X-linked Ehlers-Danlos syndrome 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types
120 sub-types
- Dyskeratosis congenita 12 trials Sub-types →
- CTSC-related disorder 0 trials · 11 incl. sub-types Sub-types →
- Cardiofaciocutaneous syndrome 7 trials Sub-types →
- Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome 4 trials
- Incontinentia pigmenti 3 trials
- Ectodermal dysplasia WNT10A related 0 trials · 2 incl. sub-types Sub-types →
- Trichothiodystrophy 2 trials Sub-types →
- Cronkhite-Canada syndrome 1 trial
- Ellis-van Creveld syndrome 1 trial Sub-types →
- Cartilage-hair hypoplasia 1 trial Sub-types →
- Hypohidrotic ectodermal dysplasia 1 trial Sub-types →
- Trichorhinophalangeal syndrome 0 trials · 1 incl. sub-types Sub-types →
- ADULT syndrome 0 trials
- AREDYLD syndrome 0 trials
- Ackerman syndrome 0 trials
- Barber-Say syndrome 0 trials
- Bartsocas-Papas syndrome 1 0 trials
- Brunoni syndrome 0 trials
- Böök syndrome 0 trials
- CHIME syndrome 0 trials
- Clouston syndrome 0 trials
- Curly hair - acral keratoderma - caries syndrome 0 trials
- Dahlberg-Borer-Newcomer syndrome 0 trials
- Dubowitz syndrome 0 trials
- EEM syndrome 0 trials
- Fontaine progeroid syndrome 0 trials
- Fried's tooth and nail syndrome 0 trials
- GAPO syndrome 0 trials
- Ito hypomelanosis 0 trials
- Johnson neuroectodermal syndrome 0 trials
- KID syndrome 0 trials Sub-types →
- Lelis syndrome 0 trials
- Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome 0 trials
- Marshall syndrome 0 trials
- Naegeli-Franceschetti-Jadassohn syndrome 0 trials
- Rapp-Hodgkin syndrome 0 trials
- Schinzel-Giedion syndrome 0 trials
- Stern-Lubinsky-Durrie syndrome 0 trials
- Teebi-Shaltout syndrome 0 trials
- Toriello-Lacassie-Droste syndrome 0 trials
- Acrofacial dysostosis, Weyers type 0 trials
- Alopecia - contractures - dwarfism - intellectual disability syndrome 0 trials
- Alves Castelo dos Santos syndrome 0 trials
- Amelocerebrohypohidrotic syndrome 0 trials
- Ameloonychohypohidrotic syndrome 0 trials
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome 0 trials Sub-types →
- Anonychia with flexural pigmentation 0 trials
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma 0 trials
- Arthrogryposis-ectodermal dysplasia-other anomalies syndrome 0 trials
- Autosomal dominant palmoplantar keratoderma and congenital alopecia 0 trials
- Autosomal dominant trichoodontoonychodysplasia-syndactyly 0 trials
- Autosomal recessive palmoplantar keratoderma and congenital alopecia 0 trials
- Blepharocheilodontic syndrome 0 trials Sub-types →
- Cataract-hypertrichosis-intellectual disability syndrome 0 trials
- Cerebellar ataxia-ectodermal dysplasia syndrome 0 trials
- Chondroectodermal dysplasia with night blindness 0 trials
- Choroidal atrophy-alopecia syndrome 0 trials
- Circumscribed palmoplantar hypokeratosis 0 trials
- Cleft lip/palate-ectodermal dysplasia syndrome 0 trials
- Conductive deafness-ptosis-skeletal anomalies syndrome 0 trials
- Congenital hypotrichosis with juvenile macular dystrophy 0 trials
- Contractures-ectodermal dysplasia-cleft lip/palate syndrome 0 trials
- Cranioectodermal dysplasia 0 trials Sub-types →
- Dermatoosteolysis, Kirghizian type 0 trials
- Dermatopathia pigmentosa reticularis 0 trials
- Dermo-odonto dysplasia 0 trials
- Dermotrichic syndrome 0 trials
- Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type 0 trials
- Ectodermal dysplasia 13, hair/tooth type 0 trials
- Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis 0 trials
- Ectodermal dysplasia 15, hypohidrotic/hair type 0 trials
- Ectodermal dysplasia 17 with or without limb malformations 0 trials
- Ectodermal dysplasia 5, hair/nail type 0 trials
- Ectodermal dysplasia Bartalos type 0 trials
- Ectodermal dysplasia alopecia preaxial polydactyly 0 trials
- Ectodermal dysplasia arthrogryposis diabetes mellitus 0 trials
- Ectodermal dysplasia blindness 0 trials
- Ectodermal dysplasia margarita type 0 trials
- Ectodermal dysplasia neurosensory deafness 0 trials
- Ectodermal dysplasia with natal teeth, Turnpenny type 0 trials
- Ectodermal dysplasia, trichoodontoonychial type 0 trials
- Ectodermal dysplasia-blindness syndrome 0 trials
- Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome 0 trials
- Ectodermal dysplasia-sensorineural deafness syndrome 0 trials
- Ectodermal dysplasia-syndactyly syndrome 0 trials Sub-types →
- Epidermolysis bullosa simplex due to plakophilin deficiency 0 trials
- Focal facial dermal dysplasia 0 trials Sub-types →
- Gingival fibromatosis-hypertrichosis syndrome 0 trials
- Hidrotic ectodermal dysplasia, Christianson-Fourie type 0 trials
- Hidrotic ectodermal dysplasia, Halal type 0 trials
- Hypertrichosis cubiti-short stature syndrome 0 trials
- Hypertrichosis lanuginosa congenita 0 trials Sub-types →
- Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome 0 trials
- Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome 0 trials
- Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome 0 trials
- Jones hersh yusk syndrome 0 trials
- Limb-mammary syndrome 0 trials
- Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies 0 trials
- Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome 0 trials
- Oculodentodigital dysplasia 0 trials Sub-types →
- Oculoosteocutaneous syndrome 0 trials
- Oculotrichodysplasia 0 trials
- Odonto-onycho dysplasia-alopecia syndrome 0 trials
- Odonto-tricho-ungual-digito-palmar syndrome 0 trials
- Odontomicronychial dysplasia 0 trials
- Odontotrichomelic syndrome 0 trials
- Pili torti-onychodysplasia syndrome 0 trials
- Pilodental dysplasia-refractive errors syndrome 0 trials
- Pure hair and nail ectodermal dysplasia 0 trials Sub-types →
- Scalp-ear-nipple syndrome 0 trials
- Taurodontia-absent teeth-sparse hair syndrome 0 trials
- Tooth and nail syndrome 0 trials
- Tricho-dento-osseous syndrome 0 trials
- Tricho-oculo-dermo-vertebral syndrome 0 trials
- Tricho-retino-dento-digital syndrome 0 trials
- Trichodental syndrome 0 trials
- Trichodermodysplasia-dental alterations syndrome 0 trials
- Trichodysplasia-amelogenesis imperfecta syndrome 0 trials
- Trichomegaly-retina pigmentary degeneration-dwarfism syndrome 0 trials
- Trichoodontoonychial dysplasia 0 trials
-
Alpha 1-antitrypsin deficiency 44 trials
-
Tourette syndrome 41 trials
-
Guillain-Barre syndrome 23 trials · 39 incl. sub-types
11 sub-types
- Polyneuropathy, inflammatory demyelinating, chronic 15 trials
- Guillain-Barre syndrome, familial 1 trial
- Acute inflammatory demyelinating polyradiculoneuropathy 1 trial
- Autoimmune autonomic ganglionopathy 1 trial
- Acute motor and sensory axonal neuropathy 0 trials
- Acute motor axonal neuropathy 0 trials
- Acute pure sensory neuropathy 0 trials
- Acute sensory ataxic neuropathy 0 trials
- Facial diplegia with paresthesias 0 trials
- Paraparetic variant of Guillain-Barre syndrome 0 trials
- Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome 0 trials
-
Type 2 collagenopathy 0 trials · 39 incl. sub-types
14 sub-types
- Dysplasia of the proximal femoral epiphyses 0 trials · 36 incl. sub-types Sub-types →
- Stickler syndrome type 1 3 trials Sub-types →
- Kniest dysplasia 0 trials
- Achondrogenesis type II 0 trials
- Hypochondrogenesis 0 trials
- Multiple epiphyseal dysplasia, Beighton type 0 trials
- Platyspondylic dysplasia, Torrance type 0 trials
- Spondyloepimetaphyseal dysplasia, Strudwick type 0 trials
- Spondyloepiphyseal dysplasia congenita 0 trials
- Spondyloepiphyseal dysplasia with metatarsal shortening 0 trials
- Spondyloepiphyseal dysplasia, Stanescu type 0 trials
- Spondylometaphyseal dysplasia, 'corner fracture' type 0 trials
- Spondylometaphyseal dysplasia, Schmidt type 0 trials
- Spondyloperipheral dysplasia 0 trials
-
Syndromic intellectual disability 2 trials · 38 incl. sub-types
17 sub-types
- Autosomal dominant syndromic intellectual disability 0 trials · 15 incl. sub-types Sub-types →
- X-linked syndromic intellectual disability 0 trials · 12 incl. sub-types Sub-types →
- Smith-Magenis syndrome 5 trials
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Autosomal recessive syndromic intellectual disability 0 trials · 1 incl. sub-types Sub-types →
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- 2p25.3 microduplication syndrome 0 trials
- 3q27.3 microdeletion syndrome 0 trials
- 7p22.1 microduplication syndrome 0 trials
- 9p13 microdeletion syndrome 0 trials
- 9q31.1q31.3 microdeletion syndrome 0 trials
- 9q33.3q34.11 microdeletion syndrome 0 trials
- AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0 trials
- CK syndrome 0 trials
- Aplasia cutis-enamel dysplasia syndrome 0 trials
- Intellectual disability, Buenos-Aires type 0 trials
- Intellectual disability, Wolff type 0 trials
-
Behcet disease 37 trials
-
Syndromic agammaglobulinemia 7 trials · 37 incl. sub-types
3 sub-types
- Common variable immunodeficiency 29 trials · 31 incl. sub-types Sub-types →
- Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome 0 trials
- Transient hypogammaglobulinemia 0 trials Sub-types →
-
X-linked ichthyosis syndrome 0 trials · 37 incl. sub-types
2 sub-types
- CHILD syndrome 37 trials
- Syndromic recessive X-linked ichthyosis 0 trials
-
Fragile X syndrome 34 trials
4 sub-types
- Fragile X syndrome type 1 0 trials
- Fragile X syndrome type 2 0 trials
- Fragile X syndrome type 3 0 trials
- Symptomatic form of fragile X syndrome in female carrier 0 trials
-
Primary ciliary dyskinesia 34 trials
59 sub-types
- Primary ciliary dyskinesia 1 6 trials
- CFAP46-related primary ciliary dyskinesia 0 trials
- Stromme syndrome 0 trials
- Ciliary discoordination due to random ciliary orientation 0 trials
- Ciliary dyskinesia with defective radial spokes 0 trials
- Ciliary dyskinesia with excessively long cilia 0 trials
- Ciliary dyskinesia with transposition of ciliary microtubules 0 trials
- Ciliary dyskinesia, primary, 36, X-linked 0 trials
- Ciliary dyskinesia, primary, 37 0 trials
- Ciliary dyskinesia, primary, 38 0 trials
- Ciliary dyskinesia, primary, 39 0 trials
- Ciliary dyskinesia, primary, 40 0 trials
- Ciliary dyskinesia, primary, 41 0 trials
- Ciliary dyskinesia, primary, 42 0 trials
- Ciliary dyskinesia, primary, 43 0 trials
- Ciliary dyskinesia, primary, 44 0 trials
- Ciliary dyskinesia, primary, 45 0 trials
- Ciliary dyskinesia, primary, 46 0 trials
- Ciliary dyskinesia, primary, 47, and lissencephaly 0 trials
- Ciliary dyskinesia, primary, 48, without situs inversus 0 trials
- Ciliary dyskinesia, primary, 49, without situs inversus 0 trials
- Ciliary dyskinesia, primary, 50 0 trials
- Ciliary dyskinesia, primary, 51 0 trials
- Ciliary dyskinesia, primary, 52 0 trials
- Ciliary dyskinesia, primary, 53 0 trials
- Ciliary dyskinesia, primary, 54 0 trials
- Primary ciliary dyskinesia 10 0 trials
- Primary ciliary dyskinesia 11 0 trials
- Primary ciliary dyskinesia 12 0 trials
- Primary ciliary dyskinesia 13 0 trials
- Primary ciliary dyskinesia 14 0 trials
- Primary ciliary dyskinesia 15 0 trials
- Primary ciliary dyskinesia 16 0 trials
- Primary ciliary dyskinesia 17 0 trials
- Primary ciliary dyskinesia 18 0 trials
- Primary ciliary dyskinesia 19 0 trials
- Primary ciliary dyskinesia 2 0 trials
- Primary ciliary dyskinesia 20 0 trials
- Primary ciliary dyskinesia 21 0 trials
- Primary ciliary dyskinesia 22 0 trials
- Primary ciliary dyskinesia 23 0 trials
- Primary ciliary dyskinesia 24 0 trials
- Primary ciliary dyskinesia 25 0 trials
- Primary ciliary dyskinesia 26 0 trials
- Primary ciliary dyskinesia 27 0 trials
- Primary ciliary dyskinesia 28 0 trials
- Primary ciliary dyskinesia 29 0 trials
- Primary ciliary dyskinesia 3 0 trials
- Primary ciliary dyskinesia 30 0 trials
- Primary ciliary dyskinesia 32 0 trials
- Primary ciliary dyskinesia 33 0 trials
- Primary ciliary dyskinesia 34 0 trials
- Primary ciliary dyskinesia 35 0 trials
- Primary ciliary dyskinesia 4 0 trials
- Primary ciliary dyskinesia 5 0 trials
- Primary ciliary dyskinesia 6 0 trials
- Primary ciliary dyskinesia 7 0 trials
- Primary ciliary dyskinesia 8 0 trials
- Primary ciliary dyskinesia 9 0 trials
-
Dialysis disequilibrium syndrome 33 trials
-
Exfoliation syndrome 32 trials
-
Prader-Willi syndrome 31 trials
5 sub-types
-
Rett syndrome 31 trials
-
Complex regional pain syndrome type 1 31 trials
-
Acute chest syndrome 30 trials
-
Polymyalgia rheumatica 30 trials
-
Syndromic congenital heart disease 0 trials · 30 incl. sub-types
8 sub-types
- NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types Sub-types →
- Hypoplastic left heart syndrome 9 trials Sub-types →
- Left ventricular noncompaction 3 trials · 4 incl. sub-types Sub-types →
- Dextrocardia 1 trial
- Char syndrome 0 trials
- Atrial septal defect, coronary sinus type 0 trials
- Congenital heart disease with heterotaxy syndrome 0 trials
- Scimitar syndrome 0 trials
-
Long QT syndrome 22 trials · 29 incl. sub-types
1 sub-type
- Familial long QT syndrome 1 trial · 11 incl. sub-types Sub-types →
-
Turner syndrome 28 trials
3 sub-types
- Turner syndrome due to structural X chromosome anomalies 0 trials
- Mixed gonadal dysgenesis 0 trials
- Monosomy X 0 trials Sub-types →
-
Corticobasal degeneration disorder 28 trials
-
Familial developmental dysphasia 28 trials
-
Takayasu arteritis 27 trials
-
Posterior leukoencephalopathy syndrome 27 trials
-
Lennox-Gastaut syndrome 26 trials · 27 incl. sub-types
3 sub-types
-
Piriformis syndrome 25 trials
-
Mucopolysaccharidosis type 2 24 trials
2 sub-types
-
Post-cardiac arrest syndrome 24 trials
-
Noonan syndrome 21 trials · 24 incl. sub-types
14 sub-types
- Noonan syndrome 3 2 trials
- Noonan syndrome 5 1 trial
- Noonan syndrome 1 0 trials
- Noonan syndrome 10 0 trials
- Noonan syndrome 11 0 trials
- Noonan syndrome 13 0 trials
- Noonan syndrome 14 0 trials
- Noonan syndrome 2 0 trials
- Noonan syndrome 4 0 trials
- Noonan syndrome 6 0 trials
- Noonan syndrome 7 0 trials
- Noonan syndrome 8 0 trials
- Noonan syndrome 9 0 trials
- Noonan syndrome 12 0 trials
-
Central sleep apnea syndrome 21 trials · 23 incl. sub-types
5 sub-types
- Central sleep apnea caused by high altitude 1 trial
- Central sleep apnea due to periodic breathing 1 trial
- Complex sleep apnea 1 trial
- Drug induced central sleep apnea 1 trial
- Primary central sleep apnea syndrome 0 trials
-
Sick sinus syndrome 22 trials
1 sub-type
- Familial sick sinus syndrome 0 trials Sub-types →
-
Syndromic craniosynostosis 1 trial · 22 incl. sub-types
40 sub-types
- Acrocephalosyndactyly 0 trials · 13 incl. sub-types Sub-types →
- Crouzon syndrome-acanthosis nigricans syndrome 4 trials
- Antley-Bixler syndrome 2 trials Sub-types →
- Muenke syndrome 2 trials
- Crouzon syndrome 1 trial Sub-types →
- Shprintzen-Goldberg syndrome 1 trial
- Pseudoaminopterin syndrome 1 trial
- Baller-Gerold syndrome 0 trials
- Beare-Stevenson cutis gyrata syndrome 0 trials
- C syndrome 0 trials
- Curry-Jones syndrome 0 trials
- Hunter-McAlpine craniosynostosis 0 trials
- Lowry-MacLean syndrome 0 trials
- Summitt syndrome 0 trials
- TCF12-related craniosynostosis 0 trials
- Weiss-Kruszka syndrome 0 trials
- X-linked intellectual disability-plagiocephaly syndrome 0 trials
- Acrocephalopolydactyly 0 trials
- Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0 trials
- Cardiocranial syndrome, Pfeiffer type 0 trials
- Cloverleaf skull-asphyxiating thoracic dysplasia syndrome 0 trials
- Cloverleaf skull-multiple congenital anomalies syndrome 0 trials
- Cranioectodermal dysplasia 0 trials Sub-types →
- Craniomicromelic syndrome 0 trials
- Craniosynostosis 2 0 trials
- Craniosynostosis 4 0 trials
- Craniosynostosis and dental anomalies 0 trials
- Craniosynostosis, Herrmann-Opitz type 0 trials
- Craniosynostosis, Philadelphia type 0 trials
- Craniosynostosis-anal anomalies-porokeratosis syndrome 0 trials
- Craniosynostosis-cataract syndrome 0 trials
- Craniosynostosis-fibular aplasia syndrome 0 trials
- Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome 0 trials
- Craniosynostosis-intracranial calcifications syndrome 0 trials
- Craniotelencephalic dysplasia 0 trials
- Familial scaphocephaly syndrome 0 trials Sub-types →
- Holoprosencephaly-craniosynostosis syndrome 0 trials
- Lethal occipital encephalocele-skeletal dysplasia syndrome 0 trials
- Osteosclerosis-developmental delay-craniosynostosis syndrome 0 trials
- Trigonocephaly-broad thumbs syndrome 0 trials
-
Marfan syndrome 21 trials
1 sub-type
- Neonatal Marfan syndrome 0 trials
-
Cardiovascular-kidney-metabolic syndrome 21 trials
-
Persian gulf syndrome 20 trials
-
Paraneoplastic syndrome 1 trial · 20 incl. sub-types
8 sub-types
- Paraneoplastic neurologic syndrome 1 trial · 15 incl. sub-types Sub-types →
- Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types Sub-types →
- Paraneoplastic hematological syndrome 0 trials · 9 incl. sub-types Sub-types →
- Paraneoplastic renal syndrome 0 trials · 3 incl. sub-types Sub-types →
- Bilateral diffuse uveal melanocytic proliferation disease 0 trials
- Paraneoplastic cutaneous syndrome 0 trials Sub-types →
- Paraneoplastic gastrointestinal syndrome 0 trials
- Paraneoplastic rheumatic syndrome 0 trials
-
Angelman syndrome 19 trials
-
Evans syndrome 19 trials
-
Atypical hemolytic-uremic syndrome 19 trials
4 sub-types
-
Dumping syndrome 19 trials
-
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types
3 sub-types
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 19 trials
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0 trials Sub-types →
- Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 0 trials
-
Infantile spasms 8 trials · 19 incl. sub-types
8 sub-types
- Developmental and epileptic encephalopathy, 2 10 trials
- Developmental and epileptic encephalopathy, 1 2 trials
- Developmental and epileptic encephalopathy, 12 0 trials
- Developmental and epileptic encephalopathy, 15 0 trials
- Developmental and epileptic encephalopathy, 27 0 trials
- Developmental and epileptic encephalopathy, 30 0 trials
- Developmental and epileptic encephalopathy, 40 0 trials
- Developmental and epileptic encephalopathy, 5 0 trials
-
Williams syndrome 18 trials
-
Cardio-renal syndrome 18 trials
-
Complex regional pain syndrome type 2 18 trials
-
Alport syndrome 17 trials · 18 incl. sub-types
5 sub-types
- X-linked Alport syndrome 3 trials
- Autosomal recessive Alport syndrome 2 trials
- Alport syndrome 3b, autosomal recessive 0 trials
- Autosomal dominant Alport syndrome 0 trials
- Digenic Alport syndrome 0 trials
-
Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types
4 sub-types
- Mucopolysaccharidosis type 3A 7 trials
- Mucopolysaccharidosis type 3B 6 trials
- Mucopolysaccharidosis type 3C 2 trials
- Mucopolysaccharidosis type 3D 0 trials
-
Fetal alcohol syndrome 17 trials
-
Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types
16 sub-types
- Progressive familial intrahepatic cholestasis type 1 4 trials
- Progressive familial intrahepatic cholestasis type 2 4 trials
- Cholestasis, progressive familial intrahepatic, 4 2 trials
- Progressive familial intrahepatic cholestasis type 3 2 trials
- Cholestasis, progressive familial intrahepatic, 5 1 trial
- Cholestasis, progressive familial intrahepatic, 6 1 trial
- Hereditary North American Indian childhood cirrhosis 1 trial
- MYO5B-related progressive familial intrahepatic cholestasis 0 trials
- Benign recurrent intrahepatic cholestasis type 1 0 trials
- Cholestasis, progressive familial intrahepatic, 10 0 trials
- Cholestasis, progressive familial intrahepatic, 11 0 trials
- Cholestasis, progressive familial intrahepatic, 12 0 trials
- Cholestasis, progressive familial intrahepatic, 13 0 trials
- Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss 0 trials
- Cholestasis, progressive familial intrahepatic, 8 0 trials
- Cholestasis, progressive familial intrahepatic, 9 0 trials
-
Usher syndrome 14 trials · 16 incl. sub-types
5 sub-types
- Usher syndrome type 1 0 trials · 3 incl. sub-types Sub-types →
- Usher syndrome type 2 2 trials · 3 incl. sub-types Sub-types →
- Usher syndrome type 3 0 trials Sub-types →
- Usher syndrome, type 4 0 trials
- Retinitis pigmentosa-deafness syndrome 0 trials
-
Alagille syndrome 15 trials
3 sub-types
-
Netherton syndrome 15 trials
-
Arts syndrome 14 trials
-
Erdheim-Chester disease 14 trials
-
Compartment syndrome 14 trials
2 sub-types
- Anterior compartment of tibia syndrome 1 trial
- Neonatal compartment syndrome 0 trials
-
Fetal cytomegalovirus syndrome 14 trials
-
MELAS syndrome 13 trials · 14 incl. sub-types
10 sub-types
- MELAS syndrome caused by mutation in MTTL1 1 trial
- MELAS syndrome caused by mutation in MTND1 0 trials
- MELAS syndrome caused by mutation in MTND5 0 trials
- MELAS syndrome caused by mutation in MTND6 0 trials
- MELAS syndrome caused by mutation in MTTC 0 trials
- MELAS syndrome caused by mutation in MTTH 0 trials
- MELAS syndrome caused by mutation in MTTK 0 trials
- MELAS syndrome caused by mutation in MTTQ 0 trials
- MELAS syndrome caused by mutation in MTTS1 0 trials
- MELAS syndrome caused by mutation in MTTS2 0 trials
-
HELLP syndrome 13 trials
-
Hepatorenal syndrome 13 trials
-
Familial chylomicronemia syndrome 11 trials · 13 incl. sub-types
5 sub-types
-
Stiff-person syndrome 12 trials
3 sub-types
- Classic stiff person syndrome 0 trials
- Focal stiff limb syndrome 0 trials
- Progressive encephalomyelitis with rigidity and myoclonus 0 trials
-
Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types
4 sub-types
- Chediak-Higashi syndrome 9 trials
- Hermansky-Pudlak syndrome 4 trials Sub-types →
- Griscelli syndrome 2 trials · 3 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome, Cross type 0 trials
-
Simpson-Golabi-Behmel syndrome 11 trials
2 sub-types
- Simpson-Golabi-Behmel syndrome type 1 0 trials
- Simpson-Golabi-Behmel syndrome type 2 0 trials
-
Thoracic outlet syndrome 11 trials
3 sub-types
- Arterial thoracic outlet syndrome 0 trials
- Neurogenic thoracic outlet syndrome 0 trials
- Venous thoracic outlet syndrome 0 trials
-
Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types
4 sub-types
- Autoimmune polyendocrine syndrome type 1 8 trials
- Autoimmune polyendocrinopathy type 2 1 trial
- Autoimmune polyendocrinopathy type 3 1 trial
- Autoimmune polyendocrinopathy type 4 0 trials
-
Syndromic microphthalmia 0 trials · 11 incl. sub-types
19 sub-types
- Matthew-Wood syndrome 5 trials
- Anophthalmia/microphthalmia-esophageal atresia syndrome 4 trials
- COFS syndrome 1 trial Sub-types →
- MMEP syndrome 1 trial
- Behrens Baumann dust syndrome 0 trials
- RAB18 deficiency 0 trials Sub-types →
- X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0 trials
- Colobomatous microphthalmia-rhizomelic dysplasia syndrome 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Microphthalmia microtia fetal akinesia 0 trials
- Microphthalmia with brain and digit anomalies 0 trials
- Microphthalmia, Lenz type 0 trials
- Microphthalmia, syndromic 1 0 trials
- Microphthalmia, syndromic 11 0 trials
- Microphthalmia, syndromic 12 0 trials
- Microphthalmia, syndromic 2 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Oculoauricular syndrome 0 trials
- Syndromic microphthalmia type 5 0 trials
-
Brugada syndrome 10 trials
9 sub-types
- Brugada syndrome 1 0 trials
- Brugada syndrome 2 0 trials
- Brugada syndrome 3 0 trials
- Brugada syndrome 4 0 trials
- Brugada syndrome 5 0 trials
- Brugada syndrome 6 0 trials
- Brugada syndrome 7 0 trials
- Brugada syndrome 8 0 trials
- Brugada syndrome 9 0 trials
-
Marinesco-Sjogren syndrome 10 trials
-
Phelan-McDermid syndrome 10 trials
2 sub-types
-
Post-infectious syndrome 5 trials · 10 incl. sub-types
3 sub-types
- KSHV inflammatory cytokine syndrome 4 trials
- Zika virus congenital syndrome 1 trial
- TORCH syndrome 0 trials
-
Mucopolysaccharidosis type 4 2 trials · 10 incl. sub-types
3 sub-types
- Mucopolysaccharidosis type 4A 8 trials
- Morquio syndrome C 0 trials
- Mucopolysaccharidosis type 4B 0 trials
-
Stevens-Johnson syndrome 9 trials
-
Burning mouth syndrome 9 trials
1 sub-type
- Burning mouth syndrome type 3 0 trials
-
Calciphylaxis 9 trials
2 sub-types
- Calciphylaxis cutis 0 trials
- Visceral calciphylaxis 0 trials
-
Hand-foot syndrome 9 trials
-
Mayer-Rokitansky-Kuster-Hauser syndrome 8 trials · 9 incl. sub-types
2 sub-types
-
Sickle cell-beta-thalassemia disease syndrome 5 trials · 9 incl. sub-types
2 sub-types
- Sickle cell-beta zero-thalassemia 6 trials
- Sickle cell-beta plus-thalassemia 5 trials
-
Leriche syndrome 8 trials
-
Breast implant illness 8 trials
-
Mucopolysaccharidosis type 6 8 trials
2 sub-types
-
Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types
2 sub-types
- Zellweger spectrum disorders 6 trials · 7 incl. sub-types Sub-types →
- Non-Zellweger spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
-
IRF6-related condition 0 trials · 8 incl. sub-types
2 sub-types
- Van der Woude syndrome 8 trials Sub-types →
- Popliteal pterygium syndrome 0 trials Sub-types →
-
Silver-Russell syndrome 7 trials
11 sub-types
- Russell-silver syndrome, X-linked 0 trials
- Silver-Russell syndrome 1 0 trials
- Silver-Russell syndrome 3 0 trials
- Silver-Russell syndrome 5 0 trials
- Silver-Russell syndrome due to 11p15 microduplication 0 trials
- Silver-Russell syndrome due to 7p11.2p13 microduplication 0 trials
- Silver-Russell syndrome due to an imprinting defect of 11p15 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7 0 trials
- Silver-russell syndrome 2 0 trials
- Silver-russell syndrome 4 0 trials
-
Wolfram syndrome 7 trials
3 sub-types
- Wolfram syndrome 1 1 trial
- Wolfram syndrome 2 0 trials
- Wolfram syndrome, mitochondrial form 0 trials
-
Cystinuria 7 trials
2 sub-types
- Cystinuria type A 0 trials
- Cystinuria type B 0 trials
-
Miliaria 7 trials
8 sub-types
- Infantile miliaria 0 trials
- Miliaria alba 0 trials
- Miliaria crystallina 0 trials
- Miliaria papulosa 0 trials
- Miliaria profunda 0 trials
- Miliaria pustulosa 0 trials
- Miliaria rubra 0 trials
- Miliaria vesiculosa 0 trials
-
Bardet-Biedl syndrome 6 trials · 7 incl. sub-types
22 sub-types
- Bardet-Biedl syndrome 1 1 trial
- Bardet-Biedl syndrome 10 0 trials
- Bardet-Biedl syndrome 11 0 trials
- Bardet-Biedl syndrome 12 0 trials
- Bardet-Biedl syndrome 13 0 trials
- Bardet-Biedl syndrome 14 0 trials
- Bardet-Biedl syndrome 15 0 trials
- Bardet-Biedl syndrome 16 0 trials
- Bardet-Biedl syndrome 17 0 trials
- Bardet-Biedl syndrome 18 0 trials
- Bardet-Biedl syndrome 19 0 trials
- Bardet-Biedl syndrome 2 0 trials
- Bardet-Biedl syndrome 20 0 trials
- Bardet-Biedl syndrome 22 0 trials
- Bardet-Biedl syndrome 3 0 trials
- Bardet-Biedl syndrome 4 0 trials
- Bardet-Biedl syndrome 5 0 trials
- Bardet-Biedl syndrome 6 0 trials
- Bardet-Biedl syndrome 7 0 trials
- Bardet-Biedl syndrome 8 0 trials
- Bardet-Biedl syndrome 9 0 trials
- Bardet-biedl syndrome 21 0 trials
-
Complex hereditary spastic paraplegia 1 trial · 7 incl. sub-types
50 sub-types
- Spastic paraplegia, optic atropy, and neuropathy 3 trials
- Hereditary spastic paraplegia 11 1 trial
- Hereditary spastic paraplegia 15 1 trial
- Hereditary spastic paraplegia 26 1 trial
- Hereditary spastic paraplegia 63 1 trial
- MASA syndrome 0 trials
- Troyer syndrome 0 trials
- Autosomal dominant complex spastic paraplegia 0 trials Sub-types →
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Autosomal recessive complex spastic paraplegia type 9B 0 trials
- Autosomal recessive spastic paraplegia type 59 0 trials
- Autosomal recessive spastic paraplegia type 60 0 trials
- Autosomal recessive spastic paraplegia type 66 0 trials
- Autosomal recessive spastic paraplegia type 67 0 trials
- Autosomal recessive spastic paraplegia type 68 0 trials
- Autosomal recessive spastic paraplegia type 69 0 trials
- Autosomal recessive spastic paraplegia type 70 0 trials
- Autosomal recessive spastic paraplegia type 76 0 trials
- Autosomal recessive spastic paraplegia type 78 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Glutamate pyruvate transaminase 2 deficiency 0 trials
- Hereditary sensory and autonomic neuropathy with spastic paraplegia 0 trials
- Hereditary spastic paraplegia 18 0 trials Sub-types →
- Hereditary spastic paraplegia 23 0 trials
- Hereditary spastic paraplegia 24 0 trials
- Hereditary spastic paraplegia 25 0 trials
- Hereditary spastic paraplegia 27 0 trials
- Hereditary spastic paraplegia 32 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hereditary spastic paraplegia 43 0 trials
- Hereditary spastic paraplegia 44 0 trials
- Hereditary spastic paraplegia 45 0 trials
- Hereditary spastic paraplegia 46 0 trials
- Hereditary spastic paraplegia 49 0 trials
- Hereditary spastic paraplegia 53 0 trials
- Hereditary spastic paraplegia 54 0 trials
- Hereditary spastic paraplegia 55 0 trials
- Hereditary spastic paraplegia 57 0 trials
- Hereditary spastic paraplegia 61 0 trials
- Hereditary spastic paraplegia 64 0 trials
- Hereditary spastic paraplegia 74 0 trials
- Hereditary spastic paraplegia 75 0 trials
- Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome 0 trials
- Maternally-inherited spastic paraplegia 0 trials
- Spastic ataxia 2 0 trials
- Spastic paraplegia 84, autosomal recessive 0 trials
- Spastic paraplegia 85, autosomal recessive 0 trials
- Spastic paraplegia 86, autosomal recessive 0 trials
- Spastic paraplegia-glaucoma-intellectual disability syndrome 0 trials
- Spastic paraplegia-severe developmental delay-epilepsy syndrome 0 trials
-
Duane retraction syndrome 6 trials
4 sub-types
- Duane retraction syndrome 2 0 trials
- Duane retraction syndrome 3 with or without deafness 0 trials
- Duane retraction syndrome with congenital deafness 0 trials
- Duane syndrome type 1 0 trials
-
Hurler syndrome 6 trials
-
Loeys-Dietz syndrome 6 trials
6 sub-types
- Loeys-Dietz syndrome 1 0 trials
- Loeys-Dietz syndrome 2 0 trials
- Loeys-Dietz syndrome 4 0 trials
- Loeys-Dietz syndrome 6 0 trials
- Rienhoff syndrome 0 trials
- Aneurysm-osteoarthritis syndrome 0 trials
-
Angioosteohypertrophic syndrome 6 trials
-
Carcinoid syndrome 6 trials
1 sub-type
- Carcinoid crisis 0 trials
-
Tethered spinal cord syndrome 6 trials
-
DICER1-related tumor predisposition 1 trial · 6 incl. sub-types
2 sub-types
-
Neonatal aspiration syndrome 1 trial · 6 incl. sub-types
2 sub-types
- Meconium aspiration syndrome 5 trials
- Massive neonatal aspiration syndrome 0 trials
-
Growth hormone insensitivity syndrome 0 trials · 6 incl. sub-types
6 sub-types
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Laron syndrome 0 trials
- Short stature due to partial GHR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
-
CLOVES syndrome 5 trials
-
Eisenmenger syndrome 5 trials
-
IMAGe syndrome 5 trials
-
Kearns-Sayre syndrome 5 trials
-
MERRF syndrome 5 trials
-
McCune-Albright syndrome 5 trials
-
Menkes disease 5 trials
-
Shwachman-Diamond syndrome 5 trials
3 sub-types
- DNAJC21-related Shwachman Diamond syndrome 0 trials
- Shwachman-Diamond syndrome 1 0 trials
- Shwachman-Diamond syndrome 2 0 trials
-
4 sub-types
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 0 trials
-
Congenital myasthenic syndrome 5 trials
8 sub-types
- Postsynaptic congenital myasthenic syndrome 0 trials · 2 incl. sub-types Sub-types →
- Presynaptic congenital myasthenic syndrome 0 trials · 1 incl. sub-types Sub-types →
- Congenital myasthenic syndrome 15 0 trials
- Congenital myasthenic syndrome 5 0 trials
- Congenital myasthenic syndrome with tubular aggregates 0 trials Sub-types →
- Myasthenia, congenital, refractory to acetylcholinesterase inhibitors 0 trials
- Myasthenic syndrome, congenital, 22 0 trials
- Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive 0 trials
-
Craniofacial microsomia 5 trials
2 sub-types
- Craniofacial microsomia 1 0 trials
- Craniofacial microsomia 2 0 trials
-
Pelvis syndrome 5 trials
-
Cornelia de Lange syndrome 4 trials · 5 incl. sub-types
6 sub-types
- Cornelia de Lange syndrome 1 1 trial
- Cornelia de Lange syndrome 2 0 trials
- Cornelia de Lange syndrome 3 0 trials
- Cornelia de Lange syndrome 4 0 trials
- Cornelia de Lange syndrome 5 0 trials
- Cornelia de Lange syndrome 6 0 trials
-
Boerhaave syndrome 4 trials
-
CHARGE syndrome 4 trials
1 sub-type
- CHD7-related CHARGE syndrome 0 trials
-
Fanconi renotubular syndrome 4 trials
4 sub-types
- Deal Barratt Dillon syndrome 0 trials
- Acquired Fanconi syndrome 0 trials Sub-types →
- Adult Fanconi syndrome 0 trials
- Inherited Fanconi renotubular syndrome 0 trials Sub-types →
-
SUNCT syndrome 4 trials
-
4 sub-types
-
Nephronophthisis 1 4 trials
-
Trisomy 13 4 trials
2 sub-types
- Complete trisomy 13 0 trials
- Mosaic trisomy 13 0 trials
-
Stickler syndrome 2 trials · 4 incl. sub-types
5 sub-types
- Stickler syndrome type 1 3 trials Sub-types →
- Stickler syndrome type 2 2 trials
- Stickler syndrome, type 4 0 trials
- Stickler syndrome, type 5 0 trials
- Stickler syndrome, type 6 0 trials
-
Kenny-Caffey syndrome 0 trials · 4 incl. sub-types
2 sub-types
-
Hypoplastic right heart syndrome 0 trials · 4 incl. sub-types
2 sub-types
-
Barre-Lieou syndrome 3 trials
-
Hutchinson-Gilford progeria syndrome 3 trials
-
Kallmann syndrome 3 trials
18 sub-types
- Hypogonadotropic hypogonadism 1 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 11 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 14 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 15 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 16 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 17 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 18 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 19 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 2 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 20 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 21 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 22 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 3 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 4 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 5 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 6 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 8 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 9 with or without anosmia 0 trials
-
3 sub-types
- LEOPARD syndrome 1 0 trials
- LEOPARD syndrome 2 0 trials
- LEOPARD syndrome 3 0 trials
-
Pearson syndrome 3 trials
-
Pitt-Hopkins syndrome 3 trials
-
Cannabinoid hyperemesis syndrome 3 trials
-
Facial hemiatrophy 3 trials
-
Oculocerebrorenal syndrome 3 trials
-
Ornithine translocase deficiency 3 trials
-
Triple-A syndrome 3 trials
-
Trisomy 18 3 trials
2 sub-types
- Complete trisomy 18 0 trials
- Mosaic trisomy 18 0 trials
-
Trisomy X 3 trials
-
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 1 trial · 3 incl. sub-types
4 sub-types
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 2 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 1 trial
- Inclusion body myopathy and brain white matter abnormalities 0 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 0 trials
-
Iridocorneal endothelial syndrome 1 trial · 3 incl. sub-types
3 sub-types
- Chandler syndrome 2 trials
- Cogan-Reese syndrome 0 trials
- Essential iris atrophy 0 trials
-
Aicardi syndrome 2 trials
-
Birt-Hogg-Dube syndrome 2 trials
2 sub-types
- Birt-Hogg-Dube syndrome 1 0 trials
- Birt-Hogg-Dube syndrome 2 0 trials
-
Charles bonnet syndrome 2 trials
-
Cri-du-chat syndrome 2 trials
-
Hurler-Scheie syndrome 2 trials
-
Joubert syndrome 2 trials
39 sub-types
- Joubert syndrome 1 0 trials
- Joubert syndrome 10 0 trials
- Joubert syndrome 11 0 trials
- Joubert syndrome 13 0 trials
- Joubert syndrome 14 0 trials
- Joubert syndrome 15 0 trials
- Joubert syndrome 16 0 trials
- Joubert syndrome 17 0 trials Sub-types →
- Joubert syndrome 18 0 trials
- Joubert syndrome 19 0 trials
- Joubert syndrome 2 0 trials
- Joubert syndrome 20 0 trials
- Joubert syndrome 21 0 trials
- Joubert syndrome 22 0 trials
- Joubert syndrome 23 0 trials
- Joubert syndrome 24 0 trials
- Joubert syndrome 25 0 trials
- Joubert syndrome 26 0 trials
- Joubert syndrome 27 0 trials
- Joubert syndrome 28 0 trials
- Joubert syndrome 29 0 trials
- Joubert syndrome 3 0 trials
- Joubert syndrome 30 0 trials
- Joubert syndrome 31 0 trials
- Joubert syndrome 32 0 trials
- Joubert syndrome 33 0 trials
- Joubert syndrome 34 0 trials
- Joubert syndrome 35 0 trials
- Joubert syndrome 36 0 trials
- Joubert syndrome 37 0 trials
- Joubert syndrome 38 0 trials
- Joubert syndrome 39 0 trials
- Joubert syndrome 40 0 trials
- Joubert syndrome 5 0 trials
- Joubert syndrome 6 0 trials
- Joubert syndrome 7 0 trials
- Joubert syndrome 8 0 trials
- Joubert syndrome 9 0 trials
- Joubert syndrome with renal defect 0 trials
-
Kabuki syndrome 2 trials
2 sub-types
- Kabuki syndrome 1 0 trials
- Kabuki syndrome 2 0 trials
-
Mobius syndrome 2 trials
1 sub-type
-
Poland syndrome 2 trials
-
Susac syndrome 2 trials
-
Werner syndrome 2 trials
-
Acrocallosal syndrome 2 trials
-
Cauda equina syndrome 2 trials
1 sub-type
-
Celiac trunk compression syndrome 2 trials
-
Congenital cardiovascular shunt 2 trials
-
Craniofacial and skeletal defects 2 trials
-
Dilated cardiomyopathy 1A 2 trials
-
Engraftment syndrome 2 trials
-
Gas bloat syndrome 2 trials
-
Hantavirus pulmonary syndrome 2 trials
-
Jaw-winking syndrome 2 trials
2 sub-types
- Marin-Amat syndrome 0 trials
- Inverse Marcus-Gunn phenomenon 0 trials
-
Nail-patella syndrome 2 trials
-
Polydactyly-myopia syndrome 2 trials
-
Superior mesenteric artery syndrome 2 trials
-
Superior vena cava syndrome 2 trials
-
Sweet syndrome 2 trials
-
Vertebral artery insufficiency 2 trials
-
Xeroderma pigmentosum-Cockayne syndrome complex 1 trial · 2 incl. sub-types
6 sub-types
- Xeroderma pigmentosum group F 1 trial
- Xeroderma pigmentosum group B 0 trials
- Xeroderma pigmentosum group D 0 trials
- Xeroderma pigmentosum group G 0 trials
- Xeroderma pigmentosum, type F/Cockayne syndrome 0 trials
- Xeroderma pigmentosum, type G/Cockayne syndrome 0 trials
-
Pallister-Hall syndrome 0 trials · 2 incl. sub-types
1 sub-type
-
Disappearing bone disease 0 trials · 2 incl. sub-types
2 sub-types
- Gorham-Stout disease 2 trials
- Acroosteolysis dominant type 0 trials
-
Short rib-polydactyly syndrome 0 trials · 2 incl. sub-types
4 sub-types
- Jeune syndrome 1 trial · 2 incl. sub-types Sub-types →
- Joubert syndrome with Jeune asphyxiating thoracic dystrophy 0 trials Sub-types →
- Cranioectodermal dysplasia 0 trials Sub-types →
- Short rib-polydactyly syndrome, Majewski type 0 trials Sub-types →
-
Aagenaes syndrome 1 trial
-
Adams-Stokes syndrome 1 trial
-
Alstrom syndrome 1 trial
-
Axenfeld-Rieger syndrome 1 trial
3 sub-types
- Axenfeld-Rieger syndrome type 3 1 trial
- Axenfeld-Rieger syndrome type 1 0 trials
- Axenfeld-Rieger syndrome type 2 0 trials
-
BNAR syndrome 1 trial
-
Capgras syndrome 1 trial
-
Caroli syndrome 1 trial
-
Coffin-Siris syndrome 1 trial
11 sub-types
- Coffin-Siris syndrome 1 0 trials
- Coffin-Siris syndrome 10 0 trials
- Coffin-Siris syndrome 11 0 trials
- Coffin-Siris syndrome 12 0 trials
- Coffin-Siris syndrome 5 0 trials
- Coffin-Siris syndrome 7 0 trials
- Coffin-Siris syndrome 8 0 trials
- Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
-
Currarino triad 1 trial
-
DNA ligase IV deficiency 1 trial
-
Denys-Drash syndrome 1 trial
-
Duane-radial ray syndrome 1 trial
2 sub-types
-
EEC syndrome 1 trial
-
Freeman-Sheldon syndrome 1 trial
1 sub-type
-
Fryns syndrome 1 trial
-
German syndrome 1 trial
-
Holmes-Adie syndrome 1 trial
-
5 sub-types
- Joubert syndrome 14 0 trials
- Joubert syndrome 16 0 trials
- Joubert syndrome 2 0 trials
- Joubert syndrome 5 0 trials
- Joubert syndrome 9 0 trials
-
Lesch-Nyhan syndrome 1 trial
1 sub-type
-
Liddle syndrome 1 trial
3 sub-types
- Liddle syndrome 1 0 trials
- Liddle syndrome 2 0 trials
- Liddle syndrome 3 0 trials
-
Meier-Gorlin syndrome 1 trial
9 sub-types
- Meier-Gorlin syndrome 1 0 trials
- Meier-Gorlin syndrome 2 0 trials
- Meier-Gorlin syndrome 3 0 trials
- Meier-Gorlin syndrome 4 0 trials
- Meier-Gorlin syndrome 5 0 trials
- Meier-Gorlin syndrome 6 0 trials
- Meier-Gorlin syndrome 7 0 trials
- Meier-Gorlin syndrome 8 0 trials
- Meier-Gorlin syndrome 9 0 trials
-
Potocki-Lupski syndrome 1 trial
-
Potter sequence 1 trial
-
RHYNS syndrome 1 trial
-
RNU4ATAC spectrum disorder 1 trial
3 sub-types
- Lowry-Wood syndrome 1 trial
- Roifman syndrome 1 trial
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
-
Reunion island Larsen syndrome 1 trial
-
Scheie syndrome 1 trial
-
Sotos syndrome 1 trial
-
Tolosa-Hunt syndrome 1 trial
-
Waardenburg syndrome 1 trial
5 sub-types
- Waardenburg syndrome type 1 1 trial
- Waardenburg syndrome type 2 1 trial Sub-types →
- Waardenburg syndrome type 3 0 trials
- Waardenburg syndrome, IIa 2F 0 trials
- Waardenburg-Shah syndrome 0 trials Sub-types →
-
Wernicke-Korsakoff syndrome 1 trial
1 sub-type
-
Acute radiation syndrome 1 trial
-
2 sub-types
-
Atlanto-axial fusion 1 trial
-
Bidirectional tachycardia 1 trial
-
Capillary leak syndrome 1 trial
-
Cleidocranial dysplasia 1 1 trial
-
Congenital amputation 1 trial
-
Craniofrontonasal syndrome 1 trial
-
Deafness-infertility syndrome 1 trial
-
Epidermal nevus syndrome 1 trial
-
Human HOXA1 syndromes 1 trial
1 sub-type
- Bosley-Salih-Alorainy syndrome 0 trials
-
Ichthyosis prematurity syndrome 1 trial
-
Levator syndrome 1 trial
-
Neuroleptic malignant syndrome 1 trial
-
Orofaciodigital syndrome I 1 trial
-
Palindromic rheumatism 1 trial
-
Postaxial acrofacial dysostosis 1 trial
-
Prune belly syndrome 1 trial
-
Septooptic dysplasia 1 trial
2 sub-types
- Congenital absence of septum pellucidum 0 trials
- Pagon stephan syndrome 0 trials
-
Subclavian steal syndrome 1 trial
-
Tarsal tunnel syndrome 1 trial
-
Thalidomide embryopathy 1 trial
-
Visceral heterotaxy 1 trial
19 sub-types
- Dextrocardia 1 trial
- Situs inversus 1 trial Sub-types →
- Heterotaxy, visceral, 1, X-linked 0 trials
- Heterotaxy, visceral, 10, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 11, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 12, autosomal 0 trials
- Heterotaxy, visceral, 13, autosomal 0 trials
- Heterotaxy, visceral, 14, autosomal 0 trials
- Heterotaxy, visceral, 2, autosomal 0 trials
- Heterotaxy, visceral, 3, autosomal 0 trials
- Heterotaxy, visceral, 4, autosomal 0 trials
- Heterotaxy, visceral, 5, autosomal 0 trials
- Heterotaxy, visceral, 6, autosomal 0 trials
- Heterotaxy, visceral, 7, autosomal 0 trials
- Heterotaxy, visceral, 8, autosomal 0 trials
- Heterotaxy, visceral, 9, autosomal, with male infertility 0 trials
- Laterality defects, autosomal dominant 0 trials
- Levocardia 0 trials
- Right atrial isomerism 0 trials
-
Meckel syndrome 0 trials · 1 incl. sub-types
14 sub-types
- Meckel syndrome, type 1 1 trial
- Meckel syndrome 13 0 trials
- Meckel syndrome, type 10 0 trials
- Meckel syndrome, type 11 0 trials
- Meckel syndrome, type 2 0 trials
- Meckel syndrome, type 3 0 trials
- Meckel syndrome, type 4 0 trials
- Meckel syndrome, type 5 0 trials
- Meckel syndrome, type 6 0 trials
- Meckel syndrome, type 8 0 trials
- Meckel syndrome, type 9 0 trials
- NPHP3-related Meckel-like syndrome 0 trials
- Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome 0 trials
- Meckel syndrome 14 0 trials
-
NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types
3 sub-types
- Thyroid cancer, nonmedullary, 1 1 trial
- Brain-lung-thyroid syndrome 0 trials
- Hereditary progressive chorea without dementia 0 trials
-
Seckel syndrome 0 trials · 1 incl. sub-types
12 sub-types
- Seckel syndrome 7 1 trial
- Seckel syndrome 1 0 trials
- Seckel syndrome 10 0 trials
- Seckel syndrome 11 0 trials
- Seckel syndrome 2 0 trials
- Seckel syndrome 4 0 trials
- Seckel syndrome 5 0 trials
- Seckel syndrome 6 0 trials
- Seckel syndrome 8 0 trials
- Seckel syndrome 9 0 trials
- Intrauterine growth retardation with increased mitomycin c sensitivity 0 trials
- Microcephaly 13, primary, autosomal recessive 0 trials
-
Microcephalic osteodysplastic primordial dwarfism types I and III 0 trials · 1 incl. sub-types
2 sub-types
-
3-M syndrome 0 trials
3 sub-types
- 3M syndrome 1 0 trials
- 3M syndrome 2 0 trials
- 3M syndrome 3 0 trials
-
48,XXXY syndrome 0 trials
-
48,XXYY syndrome 0 trials
-
48,XYYY syndrome 0 trials
-
49,XXXXY syndrome 0 trials
-
6q terminal deletion syndrome 0 trials
-
8p23.1 microdeletion syndrome 0 trials
-
AIDS dysmorphic syndrome 0 trials
-
ANE syndrome 0 trials
-
Abruzzo-Erickson syndrome 0 trials
-
Achard syndrome 0 trials
-
Achard-Thiers syndrome 0 trials
-
Achenbach syndrome 0 trials
-
Acrootoocular syndrome 0 trials
-
Ahumada Del Castillo syndrome 0 trials
-
Aksu von Stockhausen syndrome 0 trials
-
Al-Gazali syndrome 0 trials
-
Alfadhel syndrome 0 trials
-
Alice in Wonderland syndrome 0 trials
-
Alkuraya-Kucinskas syndrome 0 trials
-
Aloi Tomasini Isaia syndrome 0 trials
-
1 sub-type
-
Alsahan-Harris syndrome 0 trials
-
Apert-like polydactyly syndrome 0 trials
-
Armfield syndrome 0 trials
-
Arnold stickler bourne syndrome 0 trials
-
Atkin-Flaitz syndrome 0 trials
-
Ayme-Gripp syndrome 0 trials
-
BD syndrome 0 trials
-
BRESEK syndrome 0 trials
-
Bamforth-Lazarus syndrome 0 trials
-
2 sub-types
- Baraitser-Winter syndrome 1 0 trials
- Baraitser-winter syndrome 2 0 trials
-
Barnicoat Baraitser syndrome 0 trials
-
Bartter syndrome 0 trials
6 sub-types
- Bartter disease type 1 0 trials
- Bartter disease type 2 0 trials
- Bartter disease type 3 0 trials
- Bartter disease type 5 0 trials
- Bartter syndrome type 4 0 trials Sub-types →
- Bartter syndrome with hypocalcemia 0 trials
-
Basedow's coma 0 trials
-
Basilicata-Akhtar syndrome 0 trials
-
Beardwell syndrome 0 trials
-
Bencze syndrome 0 trials
-
Bernard-Soulier syndrome 0 trials
1 sub-type
-
Bloom syndrome 0 trials
-
Bonnemann-Meinecke-Reich syndrome 0 trials
-
Bonnevie-Ullrich syndrome 0 trials
-
Brown-Sequard syndrome 0 trials
-
Bruck syndrome 0 trials
2 sub-types
- Bruck syndrome 1 0 trials
- Bruck syndrome 2 0 trials
-
Brunsting-Perry syndrome 0 trials
-
Buschke-Ollendorff syndrome 0 trials
-
CADDS 0 trials
-
CEDNIK syndrome 0 trials
-
CODAS syndrome 0 trials
-
CREST syndrome 0 trials
-
3 sub-types
- Cataract 16 multiple types 0 trials Sub-types →
- Dilated cardiomyopathy 1II 0 trials
- Myofibrillar myopathy 2 0 trials
-
Camurati-Engelmann disease 0 trials
2 sub-types
- Camurati-Engelmann disease type 1 0 trials
- Camurati-Engelmann disease type 2 0 trials
-
Cartwright Nelson Fryns syndrome 0 trials
-
Cerebrorenodigital syndrome 0 trials
-
Christian Demyer Franken syndrome 0 trials
-
Christian Johnson angenieta syndrome 0 trials
-
Christianson syndrome 0 trials
-
Cohen Lockood Wyborney syndrome 0 trials
-
Cole-Carpenter syndrome 0 trials
2 sub-types
- Cole-Carpenter syndrome 1 0 trials
- Cole-Carpenter syndrome 2 0 trials
-
Collins-Sakati syndrome 0 trials
-
Colver Steer Godman syndrome 0 trials
-
Combarros Calleja Leno syndrome 0 trials
-
Cormier Rustin Munnich syndrome 0 trials
-
Cortes Lacassie syndrome 0 trials
-
Cramp-fasciculation syndrome 0 trials
-
Crandall syndrome 0 trials
-
Crigler-Najjar syndrome 0 trials
2 sub-types
- Crigler-Najjar syndrome type 1 0 trials
- Crigler-Najjar syndrome type 2 0 trials
-
Czeizel-Losonci syndrome 0 trials
-
DOORS syndrome 0 trials
-
Davenport-Donlan syndrome 0 trials
-
Davis Lafer syndrome 0 trials
-
Dennis-Fairhurst-Moore syndrome 0 trials
-
Diamond-Blackfan anemia 2 0 trials
-
Donohue syndrome 0 trials
-
Drachtman Weinblatt Sitarz syndrome 0 trials
-
Dubin-Johnson syndrome 0 trials
-
Duker-Weiss-Siber syndrome 0 trials
-
Dursun syndrome 0 trials
-
Dyggve-Melchior-Clausen disease 0 trials
1 sub-type
-
EDICT syndrome 0 trials
-
Eagle syndrome 0 trials
-
Elliott ludman Teebi syndrome 0 trials
-
Elsahy-Waters syndrome 0 trials
-
Engelhard Yatziv syndrome 0 trials
-
FG syndrome 0 trials
6 sub-types
- Aarskog-Scott syndrome, X-linked 0 trials
- FG syndrome 1 0 trials
- FG syndrome 2 0 trials
- FG syndrome 3 0 trials
- FG syndrome 4 0 trials
- FG syndrome 5 0 trials
-
FICUS syndrome 0 trials
-
FRAXF syndrome 0 trials
-
Fanconi-like syndrome 0 trials
1 sub-type
-
Faye-Petersen-Ward-Carey syndrome 0 trials
-
Feingold syndrome 0 trials
2 sub-types
- Feingold syndrome type 1 0 trials
- Feingold syndrome type 2 0 trials
-
Feingold trainer syndrome 0 trials
-
Felty syndrome 0 trials
-
Finnish type amyloidosis 0 trials
-
Fitz-Hugh-Curtis syndrome 0 trials
-
Fliedner-Zweier syndrome 0 trials
-
Frank-Ter Haar syndrome 0 trials
-
Fraser Jequier Chen syndrome 0 trials
-
Fraser syndrome 0 trials
3 sub-types
- Fraser syndrome 1 0 trials
- Fraser syndrome 2 0 trials
- Fraser syndrome 3 0 trials
-
Frasier syndrome 0 trials
-
Freiberg disease 0 trials
-
Friedman Goodman syndrome 0 trials
-
Froelich syndrome 0 trials
-
Fryns Fabry Remans syndrome 0 trials
-
Fryns Smeets Thiry syndrome 0 trials
-
Fuchs heterochromic iridocyclitis 0 trials
-
Fukuda-Miyanomae-Nakata syndrome 0 trials
-
Fuqua Berkovitz syndrome 0 trials
-
GMS syndrome 0 trials
-
Galloway-Mowat syndrome 0 trials
10 sub-types
- Galloway-Mowat syndrome 1 0 trials
- Galloway-Mowat syndrome 10 0 trials
- Galloway-Mowat syndrome 2, X-linked 0 trials
- Galloway-Mowat syndrome 3 0 trials
- Galloway-Mowat syndrome 4 0 trials
- Galloway-Mowat syndrome 5 0 trials
- Galloway-Mowat syndrome 6 0 trials
- Galloway-Mowat syndrome 7 0 trials
- Galloway-Mowat syndrome 8 0 trials
- Galloway-Mowat syndrome 9 0 trials
-
Gamstorp-Wohlfart syndrome 0 trials
-
Garret-Tripp syndrome 0 trials
-
Ghose-Sachdev-Kumar syndrome 0 trials
-
Gilbert syndrome 0 trials
-
Gitelman syndrome 0 trials
-
Goldberg-Shprintzen syndrome 0 trials
-
Greig cephalopolysyndactyly syndrome 0 trials
1 sub-type
-
Grisel syndrome 0 trials
-
Grubben-de Cock-Borghgraef syndrome 0 trials
-
Guillouet-Gordon syndrome 0 trials
-
Guttmacher syndrome 0 trials
-
HEC syndrome 0 trials
-
Hartsfield-Bixler-Demyer syndrome 0 trials
-
Hennekam syndrome 0 trials
3 sub-types
-
Hernández-Aguirre Negrete syndrome 0 trials
-
Ho-Kaufman-McAlister syndrome 0 trials
-
Holzgreve-Wagner-Rehder syndrome 0 trials
-
Houge-Janssens syndrome 0 trials
4 sub-types
- Houge-Janssens syndrome 1 0 trials
- Houge-Janssens syndrome 2 0 trials
- Houge-Janssens syndrome 3 0 trials
- Houge-Janssens syndrome 4 0 trials
-
Hoxha-Aliu syndrome 0 trials
-
Hughes-Stovin syndrome 0 trials
-
ICHAD syndrome 0 trials
-
IFAP syndrome 0 trials
2 sub-types
- IFAP syndrome 1, with or without BRESHECK syndrome 0 trials
- IFAP syndrome 2 0 trials
-
Imerslund-Grasbeck syndrome 0 trials
2 sub-types
- Imerslund-Grasbeck syndrome type 1 0 trials
- Imerslund-Grasbeck syndrome type 2 0 trials
-
Jaberi-Elahi syndrome 0 trials
-
Jacobsen syndrome 0 trials
-
Jaffer-Beighton syndrome 0 trials
-
Joubert syndrome with ocular defect 0 trials
5 sub-types
- Joubert syndrome 14 0 trials
- Joubert syndrome 15 0 trials
- Joubert syndrome 20 0 trials
- Joubert syndrome 28 0 trials
- Joubert syndrome 3 0 trials
-
Judge Misch wright syndrome 0 trials
-
KINSSHIP syndrome 0 trials
-
Kashani-Strom-Utley syndrome 0 trials
-
Kasznica-Carlson-Coppedge syndrome 0 trials
-
Kleine-Levin syndrome 0 trials
-
Kluver-Bucy syndrome 0 trials
-
Kocher-debre-Semelaigne syndrome 0 trials
-
Koone-Rizzo-Elias syndrome 0 trials
-
Kousseff syndrome 0 trials
-
Kozlowski Brown Hardwick syndrome 0 trials
-
Kozlowski Ouvrier syndrome 0 trials
-
Kozlowski Warren Fisher syndrome 0 trials
-
Krauss Herman Holmes syndrome 0 trials
-
Krieble Bixler syndrome 0 trials
-
Kuster Majewski Hammerstein syndrome 0 trials
-
Kuster syndrome 0 trials
-
Landau-Kleffner syndrome 0 trials
-
Landy-Donnai syndrome 0 trials
-
Laugier-Hunziker syndrome 0 trials
-
Laurence-Moon syndrome 0 trials
-
Laurence-Prosser-Rocker syndrome 0 trials
-
Leigh syndrome, mitochondrial 0 trials
-
Lenz-Majewski hyperostotic dwarfism 0 trials
-
Li-Takada-Miyake syndrome 0 trials
-
Liberfarb syndrome 0 trials
-
Long-Olsen-Distelmaier syndrome 0 trials
-
Lopes-Maciel-Rodan syndrome 0 trials
-
Lowe-Kohn-Cohen syndrome 0 trials
-
Lown-Ganong-Levine syndrome 0 trials
-
Lui-Jee-Baron syndrome 0 trials
-
Luscan-Lumish syndrome 0 trials
-
MEDNIK syndrome 0 trials
-
MIRAGE syndrome 0 trials
-
Mallory-Weiss syndrome 0 trials
-
Marinesco-Sjogren-like syndrome 0 trials
-
Marshall-Smith syndrome 0 trials
-
Mauriac syndrome 0 trials
-
Meacham syndrome 0 trials
-
Meester-Loeys syndrome 0 trials
-
Melhem-Fahl syndrome 0 trials
-
Melkersson-Rosenthal syndrome 0 trials
-
Mietens syndrome 0 trials
-
Mikati-Najjar-Sahli syndrome 0 trials
-
Miller Fisher syndrome 0 trials
-
Miller-Dieker lissencephaly syndrome 0 trials
-
Milner-Khallouf-Gibson syndrome 0 trials
-
NDUFB11-related disorders 0 trials
2 sub-types
-
Nager acrofacial dysostosis 0 trials
-
Nathalie syndrome 0 trials
-
Neu-Laxova syndrome 0 trials
3 sub-types
- Neu-Laxova syndrome 1 0 trials
- Neu-Laxova syndrome 2 0 trials
- Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency 0 trials
-
Norman-Roberts syndrome 0 trials
-
Opitz G/BBB syndrome 0 trials
1 sub-type
- X-linked Opitz G/BBB syndrome 0 trials
-
PAGOD syndrome 0 trials
-
PCWH syndrome 0 trials
-
PEHO syndrome 0 trials
-
Pallister-W syndrome 0 trials
-
Pan-Chung-Bellen syndrome 0 trials
-
Parana hard-skin syndrome 0 trials
-
Parinaud syndrome 0 trials
-
Pavone Fiumara Rizzo syndrome 0 trials
-
Pendred syndrome 0 trials
-
Perlman syndrome 0 trials
-
Perry syndrome 0 trials
-
Peters plus syndrome 0 trials
-
Pfeiffer Tietze Welte syndrome 0 trials
-
Plummer-Vinson syndrome 0 trials
-
Potocki-Shaffer syndrome 0 trials
-
Primrose syndrome 0 trials
-
Qazi Markouizos syndrome 0 trials
-
Rabson-Mendenhall syndrome 0 trials
-
Rahman syndrome 0 trials
-
Reye syndrome 0 trials
-
Roberts-SC phocomelia syndrome 0 trials
-
Robinow syndrome 0 trials
3 sub-types
-
Roussy-Levy syndrome 0 trials
-
Rubinstein Taybi like syndrome 0 trials
-
Ruvalcaba syndrome 0 trials
-
Ruzicka-Goerz-Anton syndrome 0 trials
-
SCARF syndrome 0 trials
-
SHORT syndrome 0 trials
-
STAD syndrome 0 trials
-
Saal-Bulas syndrome 0 trials
-
Sackey-Sakati-Aur syndrome 0 trials
-
Sammartino-Decreccio syndrome 0 trials
-
Samson-Gardner syndrome 0 trials
-
Samson-Viljoen syndrome 0 trials
-
Sanderson-Fraser syndrome 0 trials
-
Sandhaus-Ben-Ami syndrome 0 trials
-
Sandifer syndrome 0 trials
-
Saul-Wilkes-Stevenson syndrome 0 trials
-
Say-Barber-Miller syndrome 0 trials
-
Schilbach-Rott syndrome 0 trials
-
Schlegelberger-Grote syndrome 0 trials
-
Schmid metaphyseal chondrodysplasia 0 trials
-
Schwartz-Jampel syndrome 0 trials
2 sub-types
- Schwartz-Jampel syndrome type 1 0 trials
- Stüve-Wiedemann syndrome 1 0 trials
-
Sheehan syndrome 0 trials
-
Sillence syndrome 0 trials
-
Skraban-Deardorff syndrome 0 trials
-
Slti-Salem syndrome 0 trials
-
Stankiewicz-Isidor syndrome 0 trials
-
Sweeney-Cox syndrome 0 trials
-
Tan-Almurshedi syndrome 0 trials
-
Tayoun-Maawali syndrome 0 trials
-
Tietze syndrome 0 trials
-
Townes-Brocks syndrome 0 trials
2 sub-types
- Townes-Brocks syndrome 1 0 trials
- Townes-Brocks syndrome 2 0 trials
-
Treacher-Collins syndrome 0 trials
4 sub-types
- Treacher Collins syndrome 1 0 trials
- Treacher Collins syndrome 2 0 trials
- Treacher Collins syndrome 3 0 trials
- Treacher Collins syndrome 4 0 trials
-
VACTERL with hydrocephalus 0 trials
1 sub-type
-
VACTERL/vater association 0 trials
1 sub-type
-
Ververi-Brady syndrome 0 trials
2 sub-types
- Ververi-Brady syndrome 1 0 trials
- Ververi-Brady syndrome 2 0 trials
-
Vici syndrome 0 trials
-
Waterhouse-Friderichsen syndrome 0 trials
-
Weaver syndrome 0 trials
-
Weill-Marchesani syndrome 0 trials
4 sub-types
- Weill-Marchesani 4 syndrome, recessive 0 trials
- Weill-Marchesani syndrome 1 0 trials
- Weill-Marchesani syndrome 2, dominant 0 trials
- Weill-Marchesani syndrome 3 0 trials
-
Wiedemann-Rautenstrauch syndrome 0 trials
-
Wildervanck syndrome 0 trials
-
Wissler syndrome 0 trials
-
Wolcott-Rallison syndrome 0 trials
-
Wolf-Hirschhorn syndrome 0 trials
-
X-linked corneal dermoid 0 trials
-
X-linked mandibulofacial dysostosis 0 trials
-
XFE progeroid syndrome 0 trials
-
Yuksel-Vogel-Bauer syndrome 0 trials
-
Yunis-Varon syndrome 0 trials
-
Zadik-Barak-Levin syndrome 0 trials
-
Zazam Sheriff Phillips syndrome 0 trials
-
Zerres Rietschel Majewski syndrome 0 trials
-
Zinner syndrome 0 trials
-
Ablepharon macrostomia syndrome 0 trials
-
Achalasia-alacrima syndrome 0 trials
-
Acrofrontofacionasal dysostosis 2 0 trials
-
Aglossia and situs inversus 0 trials
-
Agnathia-microstomia-synotia 0 trials
-
Agyria pachygyria polymicrogyria 0 trials
-
Agyria-pachygyria type 1 0 trials
-
4 sub-types
-
Alpha-mannosidosis type 1 0 trials
-
Aluminosis 0 trials
-
Angioosteohypotrophic syndrome 0 trials
-
Aniridia-absent patella syndrome 0 trials
-
Ankle defects short stature 0 trials
-
Annular constricting bands 0 trials
-
Anophthalmia plus syndrome 0 trials
-
Anotia facial palsy cardiac defect 0 trials
-
Anterior spinal artery syndrome 0 trials
-
Aortic dissection lentiginosis 0 trials
-
Arakawa syndrome 2 0 trials
-
Arena syndrome 0 trials
-
Asternia 0 trials
-
Ataxia - telangiectasia variant 0 trials
-
Atrophoderma of Pierini and Pasini 0 trials
-
Auroneurodental syndrome 0 trials
-
Autosomal dominant cataract 0 trials
1 sub-type
-
2 sub-types
-
1 sub-type
-
Axial mesodermal dysplasia spectrum 0 trials
-
Baetz-greenwalt syndrome 0 trials
-
Bagatelle Cassidy syndrome 0 trials
-
Baker Vinters syndrome 0 trials
-
Basilar artery insufficiency 0 trials
-
Benign exophthalmos syndrome 0 trials
-
Bhaskar jagannathan syndrome 0 trials
-
Bobble-head doll syndrome 0 trials
-
Brachydactyly anonychia 0 trials
-
Brachydactyly tibial hypoplasia 0 trials
-
Brachydactyly type A2 0 trials
-
Brain malformation renal syndrome 0 trials
-
Branchio-oto-renal syndrome 0 trials
2 sub-types
- Branchiootorenal syndrome 1 0 trials
- Branchiootorenal syndrome 2 0 trials
-
Branchiootic syndrome 0 trials
3 sub-types
- Branchiootic syndrome 1 0 trials
- Branchiootic syndrome 2 0 trials
- Branchiootic syndrome 3 0 trials
-
Brittle bone syndrome lethal type 0 trials
-
Bronchiectasis oligospermia 0 trials
-
Bruyn scheltens syndrome 0 trials
-
Burn goodship syndrome 0 trials
-
Campomelia, Cumming type 0 trials
-
Camptodactyly vertebral fusion 0 trials
-
Camptomelic syndrome, long-limb type 0 trials
-
Carbon baby syndrome 0 trials
-
Cardiocutaneous syndrome 0 trials
-
Cardioectodermal syndrome 0 trials
2 sub-types
- Naxos disease 0 trials
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma 0 trials
-
Cardioencephalomyopathy 0 trials
-
Cardiofacial syndrome short limbs 0 trials
-
Cardiomyopathy diabetes deafness 0 trials
-
Cardiomyopathy spherocytosis 0 trials
-
Carpo tarsal osteolysis recessive 0 trials
-
Cat-eye syndrome 0 trials
-
Cataract - microcornea syndrome 0 trials
-
Cataract skeletal anomalies 0 trials
-
Cataract-glaucoma syndrome 0 trials
-
Caudal duplication 0 trials
-
1 sub-type
- Familial caudal dysgenesis 0 trials Sub-types →
-
Cennamo gangemi syndrome 0 trials
-
Cerebellar agenesis 0 trials
-
Cerebello-olivary atrophy 0 trials
-
Cerebrocostomandibular syndrome 0 trials
-
Childhood aortic valve stenosis 0 trials
-
Chondrodysplasia 0 trials
3 sub-types
-
Choreoacanthocytosis amyotrophic 0 trials
-
Chromosome 13q14 deletion syndrome 0 trials
-
Chromosome 18p deletion syndrome 0 trials
-
Chromosome 18q deletion syndrome 0 trials
2 sub-types
-
Chromosome 3 duplication syndrome 0 trials
-
Ciliary dyskinesia-bronchiectasis 0 trials
-
Cleft lip palate-tetraphocomelia 0 trials
-
Cleft lip-retinopathy syndrome 0 trials
-
Cleft tongue 0 trials
-
Cleidorhizomelic syndrome 0 trials
-
Cloacal exstrophy 0 trials
-
Coarse face hypotonia constipation 0 trials
-
Coloboma porencephaly hydronephrosis 0 trials
-
Colonic malakoplakia 0 trials
-
Complement receptor deficiency 0 trials
-
Congenital acardia 0 trials
1 sub-type
- Holoacardius amorphus 0 trials
-
Congenital articular rigidity 0 trials
-
Congenital contractures 0 trials
-
Congenital cystic eye 0 trials
1 sub-type
-
2 sub-types
-
Congenital laryngeal web 0 trials
-
Congenital mumps 0 trials
-
Congenital vagal hyperreflexivity 0 trials
-
Congenital varicella syndrome 0 trials
-
Corneal crystals myopathy neuropathy 0 trials
-
Corneal-cerebellar syndrome 0 trials
-
Cortada Koussef Matsumoto syndrome 0 trials
-
Craniofaciocardiohepatic syndrome 0 trials
-
Craniosynostosis-scoliosis syndrome 0 trials
-
Crawfurd syndrome 0 trials
-
Cutis laxa osteoporosis 0 trials
-
De Sanctis-Cacchione syndrome 0 trials
-
Deafness goiter stippled epiphyses 0 trials
-
Deafness-hypogonadism syndrome 0 trials
-
Dermochondrocorneal dystrophy 0 trials
-
Dextrocardia with situs inversus 0 trials
-
Diabetes persistent mullerian ducts 0 trials
-
Die Smulders droog van dijk syndrome 0 trials
-
Diencephalic syndrome 0 trials
-
Dilated cardiomyopathy 1E 0 trials
-
Diomedi bernardi placidi syndrome 0 trials
-
Distal monosomy 13q 0 trials
-
Distal trisomy 14q 0 trials
-
Double discordia 0 trials
-
Duodenal atresia tetralogy of fallot 0 trials
-
Duplication of leg mirror foot 0 trials
-
Dupont sellier chochillon syndrome 0 trials
-
Dwarfism bluish sclerae 0 trials
-
Dyschondrosteosis-nephritis syndrome 0 trials
-
Dysmorphism cleft palate loose skin 0 trials
-
Dystonia-aphonia syndrome 0 trials
-
Ectrodactyly cardiopathy dysmorphism 0 trials
-
Ectrodactyly-polydactyly syndrome 0 trials
-
Empty sella syndrome 0 trials
-
Encephalocele anencephaly 0 trials
-
Enchondromatosis dwarfism deafness 0 trials
-
Epimetaphyseal dysplasia cataract 0 trials
-
Ermine phenotype 0 trials
-
Esophageal atresia coloboma talipes 0 trials
-
Estrogen resistance syndrome 0 trials
-
Euthyroid sick syndrome 0 trials
-
Even-plus syndrome 0 trials
-
Faciodigitogenital syndrome 0 trials
3 sub-types
- Aarskog-Scott syndrome, X-linked 0 trials
- Autosomal dominant Aarskog syndrome 0 trials
- Autosomal recessive faciodigitogenital syndrome 0 trials
-
1 sub-type
-
Feigenbaum Bergeron syndrome 0 trials
-
Ferro-cerebro-cutaneous syndrome 0 trials
-
Fetal akinesia deformation sequence 0 trials
5 sub-types
- Fetal akinesia deformation sequence 1 0 trials
- Fetal akinesia deformation sequence 2 0 trials
- Fetal akinesia deformation sequence 3 0 trials
- Fetal akinesia deformation sequence 4 0 trials
- Fetal akinesia syndrome, X-linked 0 trials
-
Fetal brain disruption sequence 0 trials
-
Fetal enterovirus syndrome 0 trials
-
Fetal hydantoin syndrome 0 trials
-
Fetal phenothiazine syndrome 0 trials
-
Fetal valproate syndrome 0 trials
-
Fibrogenesis imperfecta ossium 0 trials
-
Fibromatosis multiple non ossifying 0 trials
-
Fibula aplasia complex brachydactyly 0 trials
-
Foix chavany Marie syndrome 0 trials
-
Frontofacionasal dysplasia 0 trials
-
Genitopatellar syndrome 0 trials
-
Gershinibaruch Leibo syndrome 0 trials
-
Glaucoma-sleep apnea syndrome 0 trials
-
Goldstein hutt syndrome 0 trials
-
Gray platelet syndrome 0 trials
-
Green sandford davison syndrome 0 trials
-
Grix Blankenship Peterson syndrome 0 trials
-
Hand-foot-genital syndrome 0 trials
-
Heart-hand syndrome 0 trials
6 sub-types
- Carney complex - trismus - pseudocamptodactyly syndrome 0 trials
- Holt-Oram syndrome 0 trials Sub-types →
- Brachydactyly-long thumb syndrome 0 trials
- Heart-hand syndrome type 2 0 trials
- Heart-hand syndrome, Slovenian type 0 trials
- Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome 0 trials
-
Holoprosencephaly 0 trials
17 sub-types
- Alobar holoprosencephaly 0 trials Sub-types →
- Chromosome 1q41-q42 deletion syndrome 0 trials
- Holoprosencephaly 1 0 trials
- Holoprosencephaly 10 0 trials
- Holoprosencephaly 11 0 trials
- Holoprosencephaly 12 with or without pancreatic agenesis 0 trials
- Holoprosencephaly 13, X-linked 0 trials
- Holoprosencephaly 14 0 trials
- Holoprosencephaly 2 0 trials
- Holoprosencephaly 3 0 trials Sub-types →
- Holoprosencephaly 4 0 trials
- Holoprosencephaly 6 0 trials
- Holoprosencephaly 7 0 trials
- Holoprosencephaly 8 0 trials
- Lobar holoprosencephaly 0 trials Sub-types →
- Microform holoprosencephaly 0 trials Sub-types →
- Semilobar holoprosencephaly 0 trials
-
Hypotonia-cystinuria syndrome 0 trials
1 sub-type
-
Hypotrichosis-deafness syndrome 0 trials
-
2 sub-types
-
Ichthyosis linearis circumflexa 0 trials
-
Ichthyosis-cheek-eyebrow syndrome 0 trials
-
Ischio-vertebral syndrome 0 trials
-
Isotretinoin syndrome 0 trials
-
Laryngo-onycho-cutaneous syndrome 0 trials
-
Lateral medullary syndrome 0 trials
-
Le Marec-Bracq-Picaud syndrome 0 trials
-
Lethal multiple pterygium syndrome 0 trials
1 sub-type
-
Limb body wall complex 0 trials
-
Linkeropathy 0 trials
3 sub-types
- Desbuquois dysplasia 2 0 trials
- Spondylo-ocular syndrome 0 trials
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Loin pain hematuria syndrome 0 trials
-
Lymphedema-distichiasis syndrome 0 trials
-
5 sub-types
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 0 trials
-
Megalencephaly-polydactyly syndrome 0 trials
-
Merlob grunebaum reisner syndrome 0 trials
-
Methimazole embryofetopathy 0 trials
-
1 sub-type
- Bilateral generalized polymicrogyria 0 trials
-
Microcephaly and chorioretinopathy 1 0 trials
-
Monosomy 13q34 0 trials
-
3 sub-types
-
Mulibrey nanism 0 trials
-
Multicentric reticulohistiocytosis 0 trials
-
Multiple synostoses syndrome 0 trials
4 sub-types
- Multiple synostoses syndrome 1 0 trials
- Multiple synostoses syndrome 2 0 trials
- Multiple synostoses syndrome 3 0 trials
- Multiple synostoses syndrome 4 0 trials
-
Nodular neuronal heterotopia 0 trials
3 sub-types
- Periventricular nodular heterotopia 0 trials Sub-types →
- Sub-cortical nodular heterotopia 0 trials
- Subependymal nodular heterotopia 0 trials
-
Oculo digital syndrome 0 trials
-
Oculo-skeletal-renal syndrome 0 trials
-
Oculocerebrodental syndrome 0 trials
-
Oculomaxillofacial dysostosis 0 trials
1 sub-type
- Tessier number 4 facial cleft 0 trials
-
Oculovertebral syndrome 0 trials
-
2 sub-types
-
Osteoporosis-pseudoglioma syndrome 0 trials
-
Otopalatodigital syndrome type 1 0 trials
-
1 sub-type
-
Parkinsonism-dystonia, infantile 0 trials
3 sub-types
-
Pentasomy X 0 trials
-
Pfeiffer rockelein syndrome 0 trials
-
Piepkorn karp hickok syndrome 0 trials
-
Podder-tolmie syndrome 0 trials
-
Pointer syndrome 0 trials
-
Polydactyly-macrocephaly syndrome 0 trials
-
Ptosis-vocal cord paralysis syndrome 0 trials
-
Radio-digito-facial dysplasia 0 trials
-
Ragopathy 0 trials
-
Renal coloboma syndrome 0 trials
-
Renal cysts and diabetes syndrome 0 trials
-
Ring chromosome 10 0 trials
-
Ring chromosome 13 0 trials
-
Ruvalcaba churesigaew myhre syndrome 0 trials
-
Schisis association 0 trials
-
Shone complex 0 trials
-
Short stature contractures hypotonia 0 trials
-
Spina bifida-hypospadias syndrome 0 trials
-
Subcortical band heterotopia 0 trials
2 sub-types
-
Syndromic congenital sodium diarrhea 0 trials
-
Syndromic microspherophakia 0 trials
-
Syndromic orbital border hypoplasia 0 trials
-
Syngnathia multiple anomalies 0 trials
-
Tempi syndrome 0 trials
-
Tetrasomy 12p 0 trials
-
Thyrocerebrorenal syndrome 0 trials
-
Trigeminal trophic syndrome 0 trials
-
Ulnar hypoplasia-split foot syndrome 0 trials
-
Ulnar-mammary syndrome 0 trials
-
Van den Bosch syndrome 0 trials
-
Vitamin K-antagonist embryofetopathy 0 trials
-
Weinstein kliman scully syndrome 0 trials
-
Yellow nail syndrome 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 2755 trials in this tab.
-
Can adding venetoclax make donor stem cell transplants safer for High-Risk blood cancers?
Cure Recruiting nowResearchers test whether adding venetoclax to a standard conditioning regimen called FLAMSA-treosulfan is safe for people with high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or secondary acute myeloid leukemia who are receiving a donor blood stem cell trans…
Phase 1/2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Off-the-Shelf immune cells target solid tumors
Cure Recruiting nowResearchers are testing a new cell therapy called CAR001 in adults with solid tumors that have come back or stopped responding to standard treatment. CAR001 uses donor gamma-delta T cells engineered with a chimeric antigen receptor to recognize and attack cancer cells. The trial …
Phase 1/2 • Sponsor: Ever Supreme Bio Technology Co., Ltd. • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
New combo therapy aims to tame rare bleeding disorder
Disease control Recruiting nowThis study tests a new biologic drug called ianalumab combined with a standard platelet-boosting drug (TPO-RA) in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The trial includes 164 adults who have tried at l…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost remission in rare blood cancer
Disease control Recruiting nowThis study tests whether adding enasidenib to standard treatment (ASTX727) improves outcomes for people with a high-risk form of myelodysplastic syndrome (MDS) that has a specific gene mutation (IDH2). About 54 adults who have not had prior cancer therapy will be randomly assigne…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tests if asthma drug can stop symptoms Long-Term
Disease control Recruiting nowThis study follows 335 adults with severe eosinophilic asthma who are taking benralizumab. Researchers want to see if the drug helps patients achieve partial or complete clinical remission—meaning fewer symptoms, no need for steroid pills, and better lung function—over 12 to 24 m…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a weekly shot fix hormone chaos in teens with PCOS?
Disease control Recruiting nowThis study tests whether a weekly injection of semaglutide (a GLP-1 drug used for obesity) can improve the brain's reproductive hormone signals in obese adolescent girls with polycystic ovary syndrome (PCOS). Twenty girls aged 12–18 will receive the drug plus lifestyle advice for…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo shows promise in AML fight
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy can better treat acute myeloid leukemia (AML) that is newly diagnosed or has come back. About 116 adults with AML or high-risk MDS will receive the combination. The goal is to see if the combo improves r…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tame kidney disease
Disease control Recruiting nowThis Phase 2 trial tests whether adding belimumab to standard rituximab treatment helps more people with primary membranous nephropathy achieve remission. The study enrolls 58 adults with confirmed disease. Belimumab targets new immune cells, while rituximab depletes existing one…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Boosting transplants with donor immune cells to fight blood cancer relapse
Disease control Recruiting nowThis study tests whether giving donor white blood cells (lymphocytes) soon after a stem cell transplant can lower the chance of cancer returning in people with high-risk blood cancers like leukemia or lymphoma. Participants receive chemotherapy, a stem cell transplant, and then a…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail of 5 drugs targets tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for kids with rare blood disorders: benralizumab trial launches
Disease control Recruiting nowThis Phase 3 trial tests the drug benralizumab (Fasenra) in children aged 6 to 17 with two rare eosinophilic diseases: EGPA and HES. The study aims to see if the drug is safe, how it works in the body, and whether it can help control the disease. Fourteen children will receive in…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can donated immune cells calm the cytokine storm?
Disease control Recruiting nowResearchers are testing whether regulatory T cells taken from donated thymus tissue can control the dangerous immune overreaction that occurs in severe COVID-19 and acute respiratory distress syndrome (ARDS). The trial enrolls adults aged 18 to 65 who are hospitalized with acute …
Phase 1/2 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for MDS patients
Disease control Recruiting nowThis Phase 3 trial compares elritercept to epoetin alfa in 300 adults with low- to intermediate-risk myelodysplastic syndromes (MDS) who need red blood cell transfusions. The main goal is to see if elritercept can help patients go without transfusions for at least 12 weeks while …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowThis study tests an oral drug called pacritinib in people aged 12 and older with myelodysplastic syndromes (MDS) or related blood cancers (MDS/MPN). The goal is to find the best dose and see if it can shrink or control the disease. Participants take capsules twice daily for up to…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a donor stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can help people with severe primary immunodeficiencies. Participants aged 4 to 75 receive chemotherapy before the transplant to prepare their body. The goal is to see if the procedure is safe and can improve imm…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could cutting back on IV fluids save lives in septic shock?
Disease control Recruiting nowThis study is testing whether giving fewer non-essential fluids to adults with septic shock can improve outcomes. The trial will enroll 1,850 patients in intensive care, comparing a restrictive fluid strategy to usual care. The main goal is to see if this approach reduces deaths …
Sponsor: Region Skane • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could detoxing metals boost chemo for leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether two drugs that lower metal levels in the body can help people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) respond better to chemotherapy. The study will enroll 58 adults and aims to find the safest dose and check f…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker trial aims to tame Parkinson's symptoms
Disease control Recruiting nowThis study follows 300 adults with Parkinson's disease, essential tremor, or dystonia who receive deep brain stimulation (DBS). DBS uses a device implanted in the chest to send electrical pulses to brain areas controlling movement. Researchers will track symptom severity, medicat…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug could replace standard infusions for nerve disorder
Disease control Recruiting nowThis study tests a new medicine called empasiprubart against the standard treatment (IVIg) for people with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disease that causes weakness and numbness. About 218 adults who have used IVIg before will receive either t…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowThis study tests whether adding a patient's own concentrated bone marrow cells to a standard hip surgery (core decompression) can prevent the hip ball from collapsing and delay or avoid the need for a hip replacement. It includes 192 adults with early-stage osteonecrosis (before …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Recruiting nowThis trial tests an experimental drug called DDY391 in about 220 adults with moderate to severe psoriatic arthritis, a condition that causes joint pain, swelling, and skin patches. Researchers want to see whether DDY391 can reduce joint symptoms better than a placebo and at what …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug ease rett syndrome? early trial launches
Disease control Recruiting nowThis early-stage trial is testing the drug vorinostat in 15 girls and young women with Rett syndrome, a rare genetic disorder that affects brain development. Each participant will receive placebo and two different doses of vorinostat, acting as their own control. The study aims t…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowThis Phase 3 study tests whether the oral drug zasocitinib (TAK-279) can improve symptoms of active psoriatic arthritis in people who have never used biologic treatments. About 1,088 adults will receive either zasocitinib, an active comparator, or a placebo for up to 60 weeks. Th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowThis study tests a daily injection called elamipretide in 48 people with genetically confirmed Barth syndrome, a rare condition that causes muscle weakness and heart problems. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see if the drug…
Phase 4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody tested to tame childhood arthritis and cut steroid use
Disease control Recruiting nowResearchers are testing an experimental drug called GenaKumab in children and teens with active systemic juvenile idiopathic arthritis, a condition that causes joint inflammation and recurring fevers. The trial enrolls about 290 participants aged 2 to under 18 who have had sympto…
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could an arthritis pill ease Sjogren's? new trial seeks answers
Disease control Recruiting nowThis study tests whether tofacitinib, a drug already used for rheumatoid arthritis, is safe and helpful for people with Sjogren's disease. About 60 adults with mild-to-moderate Sjogren's will take the pill twice daily for 28 weeks. Researchers will track side effects and measure …
Phase 2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Triple-Drug cholesterol attack aims to strike within 72 hours of a heart attack
Disease control Recruiting nowResearchers are testing whether adding bempedoic acid to high-intensity statin and ezetimibe therapy within 72 hours after a heart procedure helps adults with acute coronary syndrome reach very low LDL cholesterol. Participants receive either the three-drug combination or the sta…
Phase 4 • Sponsor: Taipei Medical University Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Breathing machine settings put to the test in severe lung injury
Disease control Recruiting nowAcute respiratory distress syndrome (ARDS) is a life-threatening lung injury that often requires a breathing machine. This trial compares two ways of using that machine: airway pressure release ventilation (APRV), which holds the lungs open longer with brief releases, and convent…
Sponsor: Hospital Civil de Guadalajara • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New CIDP drug empasiprubart enters final phase of testing
Disease control Recruiting nowThis phase 3 trial tests whether empasiprubart, given by IV infusion, can help adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness and disability. The study will enroll 160 participants. For the first 6 months, some get the …
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo attack on stubborn leukemia: chemo then transplant
Disease control Recruiting nowThis early-phase trial tests a two-step approach for people with acute myeloid leukemia or related blood cancers that have returned or not responded to treatment. First, patients receive intensive chemotherapy (CLAG-M or FLAG-Ida) followed immediately by a reduced-intensity stem …
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for kids with leukemia: new drug combo aims to boost remission
Disease control Recruiting nowThis phase 2 trial tests whether adding the targeted drug venetoclax to standard chemotherapy is safe and effective for children and young adults (up to age 22) with newly diagnosed acute myeloid leukemia (AML). The study aims to see if this combination can reduce the amount of c…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowThis study tests if hydroxychloroquine, a drug used for malaria and autoimmune diseases, can help people with sarcoidosis reduce or stop taking steroids. Sarcoidosis causes inflammation, often in the lungs, but this trial focuses on cases affecting the skin, eyes, or bones. 140 a…
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug help kids with rare brain disorder?
Disease control Recruiting nowThis study is testing whether a drug called vorinostat is safe and helpful for people with Pitt Hopkins syndrome, a rare genetic condition that affects development. Five participants will each receive a placebo and two different doses of the drug in a special 'N-of-1' design, mea…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody HT31-1 enters human trials for ARDS
Disease control Recruiting nowThis early-stage trial tests a new antibody called HT31-1 in 24 healthy volunteers to see if it is safe and how the body processes it. The antibody targets a protein linked to inflammation in acute respiratory distress syndrome (ARDS), a severe lung condition often caused by infe…
Phase 1 • Sponsor: HTIC, Inc • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for advanced cancers? first human trial launches
Disease control Recruiting nowThis early-stage study is testing a new drug called BGB-B2033, alone or with other drugs, in people with advanced liver, stomach, or lung cancers. The goal is to see if it is safe and how well it works. About 392 participants will take part.
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New device aims to help ventilator patients breathe easier by scrubbing CO2 from blood
Disease control Recruiting nowThis study tests a device called PrismaLung+ that removes carbon dioxide from the blood of critically ill patients who are on breathing machines. The trial will include 99 adults with acute respiratory distress syndrome or kidney injury. Half will receive standard care plus the d…
Sponsor: Vantive Health LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could removing tonsils supercharge a sleep apnea implant?
Disease control Recruiting nowThis trial tests whether removing the tonsils at the same time as implanting a hypoglossal nerve stimulator improves treatment for obstructive sleep apnea in adults whose airway collapses from the side during sleep. Participants are randomly assigned to receive the nerve stimulat…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for glioblastoma? drug combo trial targets aggressive brain tumors
Disease control Recruiting nowThis Phase 2 trial tests whether adding the experimental drug silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of newly diagnosed glioblastoma live longer without their cancer worsening. The study includes 162 participants whose tumors have c…
Phase 2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New shot may slash cholesterol right after a heart attack
Disease control Recruiting nowThis study tests whether starting inclisiran early during a hospital stay for a heart attack can lower bad cholesterol more than a placebo, when both are added to standard care. About 300 adults hospitalized for a heart attack will receive either inclisiran or a placebo shot at t…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New kidney drug shows promise in reducing protein leakage
Disease control Recruiting nowThis study tests an experimental tablet, BI 764198, in adults and some teens with four types of kidney disease that cause protein in the urine. Participants take the drug or a placebo daily for 20 weeks while continuing their usual care. The main goal is to see if the drug lowers…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a stem cell transplant fix a rare genetic immune disorder?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can treat GATA2 deficiency, a rare genetic condition that weakens the immune system and raises the risk of leukemia. Participants aged 6 to 70 with GATA2 mutations will receive chemotherapy or radiation before t…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could tailoring chemo by age make stem cell transplants safer for MDS patients?
Disease control Recruiting nowThis study looks at two different chemotherapy combinations given before a half-matched stem cell transplant in adults with myelodysplastic syndrome (MDS). One regimen is designed for people aged 55 and older to reduce side effects, while the other is a standard stronger regimen …
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to halt lung damage in autoimmune patients
Disease control Recruiting nowThis study tests whether the drug nerandomilast can slow lung scarring in people with autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults whose lung function hasn't improved with standard treatment will take either nerandomilast or a placebo twice daily…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill targets tough cancers with genetic flaw
Disease control Recruiting nowThis study tests an experimental oral drug, GSK5460025, alone or with other cancer drugs, in adults whose solid tumors have specific genetic changes (dMMR or MSI-H). The goal is to see if the drug can shrink tumors and to check its safety. About 47 people with advanced cancers th…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New stem cell method aims to cut transplant risks
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with severe aplastic anemia or other bone marrow failure diseases. Doctors give a smaller number of donor white blood cells along with the stem cells to try to reduce serious side effects. Up to 120 patients aged 4…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo therapy aims to stop kidney damage in membranous nephropathy
Disease control Recruiting nowThis study tests whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely reduce protein leakage in the urine of people with membranous nephropathy, a kidney disease where the immune system attacks the kidneys. About 30 adults with persistent high pr…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowThis study tests the drug abemaciclib, typically used for cancer, in people with neurofibromatosis type 1 (NF1) who have atypical neurofibromas that cannot be surgically removed. The goal is to find a safe dose and see if it can shrink or stabilize these tumors. Participants take…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a cancer drug tame rare clotting disorder?
Disease control Recruiting nowThis study tests whether daratumumab, a drug used for certain cancers, is safe for people with antiphospholipid syndrome (APS), an autoimmune disorder that raises blood clot risk. Up to 22 adults will receive weekly infusions for 8 weeks at different doses. The main goal is to ch…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for rare brain disease: platform trial targets PSP
Disease control Recruiting nowThis study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will receive one of the treatments or a placebo. The goal is to see if any of the treatments c…
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
Disease control Recruiting nowAfter a liver transplant, patients take tacrolimus to stop their immune system from rejecting the new organ, but the drug can cause kidney problems, high blood pressure, diabetes, and other side effects. Researchers at the University of Alberta are comparing a once-daily extended…
Phase 4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a pill replace the CPAP machine for sleep apnea?
Disease control Recruiting nowThis Phase 2 trial tests IHL-42X, a combination of two drugs (dronabinol and acetazolamide), in people with obstructive sleep apnea. The study aims to see if the drug can reduce the number of breathing pauses during sleep and improve daytime symptoms. Participants will receive di…
Phase 2 • Sponsor: Incannex Healthcare Ltd • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and an advanced cancer that has spread or cannot be removed by surgery. It tests the safety and effectiveness of the immunotherapy drug nivolumab, given alone or…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
A reversible gut sleeve could offer a new way to treat obesity
Disease control Recruiting nowThis pilot study tests a temporary, flexible tube called a duodenal-jejunal bypass sleeve. It is placed in the upper intestine using an endoscope and left for 3 months to help with weight loss and improve metabolic syndrome. The study involves 20 adults with obesity or excess wei…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug shows promise for rare, severe childhood epilepsy
Disease control Recruiting nowThis study tests whether clemizole HCl (EPX-100) can safely reduce seizures when added to current treatments for Lennox-Gastaut syndrome, a severe form of epilepsy. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo. The main goal is to measure c…
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for duchenne: new drug targets rare gene mutation in phase 3 trial
Disease control Recruiting nowThis study tests an experimental drug called AOC 1044 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change (exon 44 skipping). About 70 boys aged 7 to 16 who can still walk will receive either the drug or a placebo. The main goal is to see if the dru…
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in earl…
Phase 1/2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Recruiting nowThis study tests a procedure called pulsENDO that uses mild electric pulses to regenerate the lining of the duodenum (the first part of the small intestine). The goal is to improve blood sugar control and reduce fat buildup in the liver for people with type 2 diabetes and fatty l…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a new oral drug take on hard-to-treat leukaemia?
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called AMX-883, taken by mouth, for people with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. The study will first test AMX-883 alone, th…
Phase 1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a Low-Dose arthritis drug ease a dangerous sickle cell complication?
Disease control Recruiting nowThis phase 2 trial is testing whether a single low dose of tocilizumab, a drug that blocks inflammation, can help people with sickle cell disease who develop acute chest syndrome—a serious lung complication. Researchers will enroll 200 patients aged 12 and older and track their o…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill could ease severe childhood arthritis
Disease control Recruiting nowThis study tests a new oral medication, upadacitinib, in children aged 1 to 17 with active systemic juvenile idiopathic arthritis (sJIA), a rare and serious form of arthritis that can affect the whole body. About 90 participants will receive either upadacitinib or the standard in…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThis study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival without cancer returning. It is for people with certain high-risk blood cancers like leukemia or myelodysplastic syndromes. The approach aims to control the…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Real-World study tracks Ravulizumab's impact on rare kidney disease
Disease control Recruiting nowThis study will follow about 80 Polish patients with atypical hemolytic uremic syndrome (aHUS) who are receiving ravulizumab (Ultomiris) as part of routine care. Researchers will collect data from medical records and follow patients over time to see how well the drug controls the…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a simple antibody infusion shield myeloma patients from infections?
Disease control Recruiting nowThis study tests whether IgPro20 (HIZENTRA), a concentrated antibody solution given under the skin, can prevent infections in people with multiple myeloma who have low antibody levels due to bispecific antibody therapy. About 100 participants will either receive IgPro20 plus stan…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control Recruiting nowThis phase 2 trial tests whether the drug TPST-1495 can reduce the number and size of polyps in the small bowel and colon of people with familial adenomatous polyposis (FAP), an inherited condition that greatly raises colon cancer risk. About 38 participants will take the drug by…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New pill takes on tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study tests an oral drug called AUTX-703 in 34 adults with relapsed or hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goal is to check safety and find the right dose. It's an open-label trial, meaning everyone knows they'r…
Phase 1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo aims to free MDS patients from frequent blood transfusions
Disease control Recruiting nowThis Phase II trial tests whether combining luspatercept and darbepoetin alfa can help people with a certain type of lower-risk myelodysplastic syndrome (MDS) need fewer red blood cell transfusions. The study enrolls 60 adults who currently rely on transfusions. Participants rece…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug tulisokibart aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new medicine called tulisokibart for people with active psoriatic arthritis, a condition causing joint pain and skin plaques. Researchers will compare different doses of the drug to a placebo in 140 adults to see if it improves symptoms like joint tenderness an…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New breathing machine approach aims to shield heart in lung failure patients
Disease control Recruiting nowThis study tests a breathing machine strategy that adjusts pressure based on lung measurements to protect the right side of the heart in 180 adults with moderate to severe lung failure from pneumonia. The goal is to see if this method reduces heart strain and complications compar…
Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new drug called BGB-11417 (sonrotoclax) in people with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or related blood cancers. The drug works by blocking a protein that helps cancer cells survive. The trial will give the drug alone or toge…
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New ventilator aims to help patients breathe easier in the ICU
Disease control Recruiting nowThis trial is testing a new ventilator called INBENTUS VERSATILE in 81 adults who need help breathing. The study checks if the device is safe and works well for conditions like ARDS, pneumonia, and COPD. Participants will use the ventilator for 3 to 48 hours and be monitored unti…
Sponsor: Iconic Solutions By Murcia SL • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New immune cell therapy aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis early-phase trial tests whether giving patients a special infusion of donor immune cells (with certain T and B cells removed) after a stem cell transplant is safe and can help prevent their blood cancer from coming back. The study enrolls high-risk patients with hard-to-trea…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo targets tough leukemia in phase II trial
Disease control Recruiting nowThis phase II study is testing a combination of two drugs, enasidenib and azacitidine, in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The trial enrolls 50 adults with a specific IDH2 gene mutation. The goal is to see if the combinati…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail targets tough blood cancers
Disease control Recruiting nowThis study tests a combination of three drugs—ivosidenib, venetoclax, and azacitidine—in people with blood cancers like acute myeloid leukemia (AML) that have a specific IDH1 mutation. The goal is to see if the combo is safe and works better than current treatments. About 96 adul…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for young leukemia patients: experimental drug combo targets resistant cancer
Disease control Recruiting nowThis study tests a new drug called asciminib, given with chemotherapy and later with another drug (blinatumomab), in children, teens, and young adults up to age 30 who have a type of leukemia (Ph+ or Ph-like ALL) that has come back or not responded to treatment. The goal is to fi…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of debio 1562M begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called Debio 1562M in about 134 people with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The study first checks safety and finds the right dose, then looks at whether the drug can shrink the can…
Phase 1/2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combo targets tough blood cancers
Disease control Recruiting nowThis phase 2 trial tests a drug called olutasidenib combined with other targeted therapies for people with relapsed or hard-to-treat blood cancers that have a specific IDH1 mutation plus other signaling mutations. The study aims to see how safe and tolerable these drug combinatio…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a pill replace CPAP for sleep apnea? large study tests three treatments Head-to-Head
Disease control Recruiting nowThis study compares three treatments for obstructive sleep apnea: positive airway pressure (CPAP), a dental device that moves the jaw forward, and a combination of two medications (atomoxetine and oxybutynin). About 2,400 adults with sleep apnea will be randomly assigned to one o…
Phase 4 • Sponsor: Sairam Parthasarathy • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is testing whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent graft-versus-host disease (a common complication where donor cells attack the patient's body) while still being effective. The trial involves 260 adults with b…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug duo targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called rezatapopt combined with the standard drug azacitidine in 24 adults with a specific type of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has a TP53Y220C mutation. The main goal is to check safety and find the b…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New cord blood transplant recipe aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a standardized, optimized approach to cord blood transplantation for adults with high-risk blood cancers like leukemia and lymphoma. The method includes specific chemotherapy, radiation, and stem cell dosing, followed by careful monitoring. Researchers hope to im…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a biologic drug tame a rare vasculitis and cut steroid use?
Disease control Recruiting nowResearchers are studying how well benralizumab works in adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare disease that inflames blood vessels and can affect the lungs, nerves, and sinuses. The study follows about 100 patients at European referral centers wh…
Sponsor: European EGPA Study Group • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Experimental gene therapy offers hope for fatal nerve disease
Disease control Recruiting nowThis study tests a gene therapy for GM1 gangliosidosis, a fatal disorder that destroys nerve cells. The therapy uses a harmless virus to deliver a working gene, helping the body produce a missing enzyme. Up to 54 children with Type I (ages 6-12 months) or Type II (ages 1-12 years…
Phase 1/2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase
Disease control Recruiting nowThis study tests a new drug called sonelokimab for adults with active psoriatic arthritis who have not improved with or cannot take standard TNF-blocker medications. About 600 participants will receive either sonelokimab, a placebo, or an existing drug (risankizumab) for comparis…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill aims to keep blood cancer away after transplant
Disease control Recruiting nowThis study tests a daily pill called olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. The goal is to see if the drug is safe and tolerable as maintenance therapy. About 31 participants will take the…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New surgery approach may help kids with down syndrome breathe better at night
Disease control Recruiting nowThis study compares personalized surgery guided by a special camera during sleep (DISE) to standard tonsil and adenoid removal for treating obstructive sleep apnea in 303 children with Down syndrome, ages 2 to 17. Sleep apnea is very common in these children and standard surgery …
Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New combo pill aims to cut heart deaths in patients with failing kidneys
Disease control Recruiting nowThis Phase 3 trial is testing whether a combination of two drugs, balcinrenone and dapagliflozin, works better than dapagliflozin alone to prevent heart failure events and cardiovascular death. About 4,800 adults with heart failure and moderate-to-severe kidney impairment who rec…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New weekly shot could help sleep apnea without CPAP
Disease control Recruiting nowThis study tests a once-weekly injection called NNC0487-0111 in 300 adults with overweight or obesity and moderate-to-severe obstructive sleep apnea who do not use a CPAP machine. The goal is to see if the drug helps with weight loss and reduces breathing pauses during sleep. Par…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combination targets Hard-to-Treat blood cancers
Disease control Recruiting nowResearchers are testing an experimental drug called LP-108, a BCL-2 inhibitor, combined with azacitidine in adults with acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. The trial aims to find the highest dose people can tolerate and the best …
Phase 1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug aimed at genetic weakness in blood disorders
Disease control Recruiting nowThis study tests a drug called olutasidenib in people with certain early blood conditions (CCUS, lower-risk MDS, or CMML) that have a specific IDH1 gene change. The goal is to see if the drug can control the disease and is safe. About 15 participants will take the drug and be mon…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New cord blood treatment could transform transplants for bone marrow diseases
Disease control Recruiting nowThis study tests whether a new cord blood stem cell product, Omidubicel, can improve transplant outcomes for people with severe aplastic anemia or a related bone marrow disorder. Participants receive a combination of stem cells from a family member and specially processed cord bl…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New triple therapy targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—olutasidenib, decitabine, and venetoclax—in people with acute myeloid leukemia (AML) that has a specific IDH1 gene mutation. The goal is to find a safe and effective dose for those whose cancer has returned or not responded to treatme…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Combining GLP-1 drugs with Weight-Loss surgery: better results or just more pills?
Disease control Recruiting nowThis study looks at whether people who take GLP-1 receptor agonists (like Ozempic or Wegovy) should continue them after having bariatric surgery. Researchers will compare weight loss, blood sugar control, gut health, and hunger in 150 adults who either keep taking the drug or sto…
Phase 4 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a low-dose drug boost blood health in rare platelet disorder?
Disease control Recruiting nowThis study tests whether low-dose sirolimus can safely improve blood cell function in adults with RUNX1 familial platelet disorder, a genetic condition that raises bleeding and leukemia risks. Six participants receive the drug and are monitored for side effects and changes in blo…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug aims to reduce deaths from severe lung failure
Disease control Recruiting nowThis study tests an experimental drug called recombinant human plasma gelsolin (rhu-pGSN) added to standard care for people with moderate-to-severe acute respiratory distress syndrome (ARDS) caused by pneumonia or other infections. About 600 hospitalized adults will receive eithe…
Phase 2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for angelman syndrome: drug trial targets brain function
Disease control Recruiting nowThis study tests a drug called rugonersen, given via spinal injection, to see if it can improve thinking and communication skills in people with Angelman syndrome. The trial includes 165 children and adults aged 1 to 50. Researchers will compare the drug against a sham procedure …
Phase 3 • Sponsor: OHB Pediatrics Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene-Edited stem cells may let doctors use stronger chemo against brain cancer
Disease control Recruiting nowThis study tests a new approach for people with a recently removed glioblastoma (a fast-growing brain tumor). Doctors take some of the patient's own blood stem cells, add a protective gene (P140K MGMT) to them, and return them to the patient. This allows the use of higher doses o…
Phase 2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a Centuries-Old poison become a new weapon against a blood disorder?
Disease control Recruiting nowThis early-stage trial is testing whether an oral form of arsenic trioxide can safely help people with low-risk myelodysplastic syndromes (MDS) who have not improved with standard treatments. The study will first find the safest dose, then check how well it works after several cy…
Phase 1 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for heart lining pain: can CardiolRx keep flare-ups away?
Disease control Recruiting nowThis study tests whether the drug CardiolRx can prevent another episode of pericarditis (inflammation around the heart) in people who have had repeated attacks. About 110 adults who have been stable on an IL-1 blocker for at least a year will stop that medication and receive eith…
Phase 3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New weekly shot could help sleep apnea and weight loss
Disease control Recruiting nowThis study tests a once-weekly injection called NNC0487-0111 in 300 adults with overweight or obesity and moderate-to-severe obstructive sleep apnea who use a breathing device. The goal is to see if the drug helps with weight loss and reduces breathing pauses during sleep. Partic…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New injection aims to heal skin ulcers in rare disease
Disease control Recruiting nowThis phase 2 trial tests an injection called SHR-1139 in 10 adults with ulcerative pyoderma gangrenosum, a rare skin condition that causes painful, open sores. The main goal is to see if the drug can completely close the target ulcer within 12 weeks. Researchers will also check f…
Phase 2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a targeted pill boost chemo for tough blood cancer?
Disease control Recruiting nowThis Phase 3 trial tests whether adding the drug venetoclax to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) or a related high-risk condition. About 650 participants aged 18 to 75 will receive either venetoclax or a placebo alongside chemo. …
Phase 3 • Sponsor: University of Ulm • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowThis study tests the long-term safety and effectiveness of an oral drug called zasocitinib (TAK-279) in adults with active psoriatic arthritis, a condition causing joint pain and skin patches. About 1,182 participants who completed a one-year parent study will take either a lower…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new treatment for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to recognize and attack cancer cells…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a gut microbiome transplant boost fertility in PCOS?
Disease control Recruiting nowThis trial investigates whether taking capsules containing freeze-dried fecal matter from healthy donors—known as fecal microbiota transplantation (FMT)—can improve pregnancy outcomes and metabolic health in overweight or obese women with polycystic ovary syndrome (PCOS) who are …
Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for rare gut disease? drug trial launches for APECED enteritis
Disease control Recruiting nowThis phase 2 trial tests a drug called emapalumab in 10 people with APECED, a rare disease where the immune system attacks the body. The drug aims to reduce gut inflammation (enteritis) that causes severe symptoms. Participants receive 7 IV doses over 6 months, and researchers tr…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Heart attack survivors: shorter blood thinner course may be safer and effective
Disease control Recruiting nowThis study involves 8,100 adults who had a heart attack and received a stent. It compares different approved blood-thinning strategies to see which one best prevents another heart attack, stroke, or death while also reducing serious bleeding. Participants will either receive a sh…
Phase 4 • Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New radioactive drug targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, 225Ac-ETN029, in 116 adults with advanced DLL3-positive cancers like small cell lung cancer or neuroendocrine tumors. The main goal is to check safety and find the right dose, while also seeing if the drug can shrink tumors. Pa…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a targeted therapy tame rare kidney diseases in daily practice?
Disease control Recruiting nowThis study looks at how well the medication pegcetacoplan works and how safe it is for people with two rare kidney conditions: C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). Researchers will follow about 150 patients who are…
Phase 4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for Still's disease: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new medicine called MAS825 for people with Still's disease, a rare inflammatory condition causing fever, rash, and joint pain. About 20 children and adults with active disease will receive the drug to see if it safely controls symptoms. The goal is to improve d…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug called SAR448501 (DR-0201) in 62 adults with lupus or rheumatoid arthritis. The drug is a bispecific antibody designed to target the immune system. The main goal is to check safety and find the right dose, not yet to prove it works. Partici…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis pain in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether the experimental drug zasocitinib (TAK-279) can reduce joint swelling and pain in people with active psoriatic arthritis. About 600 adults will receive either the drug or a placebo for up to 60 weeks. The main goal is to see if more people on the …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug trial aims to control arthritis in kids
Disease control Recruiting nowThis study is testing a drug called secukinumab, given as an IV infusion, in 20 children aged 2 to 17 with juvenile psoriatic arthritis. The main goals are to see how the drug moves through the body and to check its safety over up to 6 years. This is an early-stage trial, so it f…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Stent graft showdown: which device best tames aortic aneurysms?
Disease control Recruiting nowThe JAGUAR trial compares two approaches to endovascular aneurysm repair (EVAR) in adults with abdominal aortic aneurysms. Participants are randomly assigned to receive either the Alto Abdominal Stent Graft System or another FDA-approved stent graft. Researchers track complicatio…
Sponsor: Endologix • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a new drug ease the dryness, pain, and fatigue of Sjögren's disease?
Disease control Recruiting nowThis phase 2 trial is testing whether an experimental drug called DDY391 can reduce disease activity and improve symptoms like dryness, pain, and fatigue in people with Sjögren's disease. About 344 participants will receive either DDY391 at one of three dose levels or a placebo f…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to tackle diabetes by targeting stress hormone
Disease control Recruiting nowThis phase 2 trial tests clofutriben, a drug that lowers cortisol, in 1500 adults with hard-to-control type 2 diabetes and signs of high cortisol. Participants receive either clofutriben or a placebo daily for 24 weeks. The study measures changes in blood sugar and cortisol level…
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Phone-Based cholesterol coaching after heart attack shows promise
Disease control Recruiting nowThis study tests whether a proactive, pharmacist-led telephone program can help people who have had a heart attack reach safer cholesterol levels. Participants receive pharmacist calls, repeat blood tests, and medication adjustments based on national guidelines. The goal is to se…
Sponsor: University of Alberta • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nanoparticles boost radiation against tough brain tumors
Disease control Recruiting nowThis study tests whether adding AGuIX gadolinium-based nanoparticles to standard brain radiation can better control brain metastases that are at high risk of coming back. About 134 adults with certain cancers (like melanoma, lung, breast, or colorectal) that have spread to the br…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a steroid Add-On make cushing syndrome treatment safer?
Disease control Recruiting nowResearchers are testing a block-and-replace strategy for people with endogenous Cushing syndrome, a condition where the body makes too much cortisol. Participants receive osilodrostat, a drug that lowers cortisol production, along with a replacement glucocorticoid called methylpr…
Sponsor: University of Michigan • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for heart inflammation sufferers: experimental drug VTX2735 enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called VTX2735 in 50 adults with recurrent pericarditis, a condition where the heart's lining becomes inflamed and painful. The goal is to see if the drug is safe and can reduce pain and inflammation. Participants receive different doses over…
Phase 2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody GEN3018 enters first human tests for tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has come back or stopped responding to treatment. The main goal is to check safety and find the right dose. Up to 78 parti…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders
Disease control Recruiting nowThis early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected ar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Weight-Loss drug added to arthritis therapy shows promise in new trial
Disease control Recruiting nowThis study looks at whether adding tirzepatide (a weight-loss drug) to standard ixekizumab treatment helps adults with active psoriatic arthritis who are overweight or obese. About 200 participants will receive both medications for up to 12 months. The goal is to see if this comb…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New study targets rare Virus-Driven inflammatory syndrome
Disease control Recruiting nowThis study looks at a newly recognized disease called KSHV Inflammatory Cytokine Syndrome (KICS), caused by a virus that can also lead to certain cancers. Researchers aim to learn more about the disease and test experimental treatments, including antiviral and chemotherapy drugs,…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New weekly shot aims to treat sleep apnea and obesity together
Disease control Recruiting nowThis phase 3 trial tests a weekly injection called eloralintide in 800 adults with moderate-to-severe obstructive sleep apnea who are also overweight or have obesity. The study looks at whether the drug can improve sleep apnea symptoms and help with weight loss. Participants are …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a wrist sensor cut the dose of ICU muscle relaxants?
Disease control Recruiting nowThis trial tests whether a monitor that measures muscle response can guide the dose of the muscle relaxant atracurium in intensive care unit patients who need a continuous drip for more than 48 hours. Researchers will compare a group whose dose is adjusted using the monitor to a …
Sponsor: Fu Jen Catholic University Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a blood filter strip away toxins in septic shock?
Disease control Recruiting nowThis trial tests whether a special filter called oXiris, used during continuous blood purification, can lower endotoxin levels in adults with septic shock and acute kidney injury. Septic shock is a life-threatening condition where infection causes severe organ failure. The filter…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill could shrink spleen and lymph nodes in rare ALPS disease
Disease control Recruiting nowThis study tests a drug called soquelitinib in 15 people aged 16 and older with autoimmune lymphoproliferative syndrome (ALPS). The goal is to see if the drug can shrink an enlarged spleen or lymph nodes and improve low blood cell counts. Participants take the pill twice daily fo…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New stem cell transplant trial offers hope for rare blood diseases
Disease control Recruiting nowThis study tests a stem cell transplant using blood stem cells from a half-matched family donor (haploidentical) for people with severe aplastic anemia, related MDS, or PNH. Participants receive chemotherapy and a single radiation dose before the transplant, plus a drug to preven…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for stiff lungs? drug trial targets scarring from autoimmune disease
Disease control Recruiting nowThis phase 3 trial tests whether belimumab (Benlysta) can stabilize or improve lung function in adults with interstitial lung disease caused by connective tissue diseases like rheumatoid arthritis or lupus. About 440 participants will receive either belimumab injections or a plac…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a Drug-Coated balloon beat a stent for tough heart attacks?
Disease control Recruiting nowThis study looks back at medical records of heart attack patients with a large clot in a coronary artery. It compares two ways to reopen the blocked artery during emergency angioplasty: a drug-coated balloon that delivers medication and is then removed, versus a drug-eluting sten…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame rare childhood leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, trametinib and azacitidine, for children newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get just these two drugs, while higher-risk patients also receive standard chemotherapy. Th…
Phase 1/2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Oxygen dilemma: which level saves preterm brains?
Disease control Recruiting nowThis study compares using 30% versus 60% oxygen when resuscitating extremely preterm babies (born before 29 weeks). The goal is to see which oxygen level leads to better survival and fewer long-term developmental problems like cerebral palsy or vision/hearing loss. About 1,200 ba…
Sponsor: University of Alberta • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Triple drug cocktail targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—ASTX727, venetoclax, and gilteritinib—for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome that has a FLT3 mutation. The drugs work in different ways to stop cancer cells from growing. The trial aims to f…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Diabetes drug shows promise for dangerous low sodium condition
Disease control Recruiting nowThis study tests whether the diabetes drug empagliflozin (Jardiance) can safely raise low sodium levels in people with certain conditions like SIADH, liver failure, or kidney failure. About 172 adults with chronic low sodium will receive either the drug or a placebo for up to 30 …
Phase 4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo aims to control rare blood cancer in High-Risk patients
Disease control Recruiting nowThis study tests a combination of two drugs, azacitidine and enasidenib, in people with a high-risk blood cancer called myelodysplastic syndrome (MDS) that has a specific genetic change (IDH2 mutation). The goal is to see if the drugs can stop cancer growth and improve outcomes. …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Killer virus turned against childhood brain cancer
Disease control Recruiting nowThis early-stage trial tests whether a specially engineered herpes virus (G207) is safe to inject directly into the brain tumors of children whose cancer has returned. Up to 24 children aged 3 to 21 will receive the virus, and some will also get a small dose of radiation to help …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for tough cancers: experimental drug IMGS-001 enters human trials
Disease control Recruiting nowThis early-stage study tests an experimental drug called IMGS-001 in about 105 people with advanced solid tumors that have come back or not improved after standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. The study has two parts: first, t…
Phase 1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Supercharged immune cells take on resistant blood cancers
Disease control Recruiting nowThis study tests a new type of immune cell therapy for people with myeloid cancers (like AML or MDS) that have come back or not responded to treatment. The cells are taken from donated cord blood, engineered to better recognize and attack cancer cells, and given after chemotherap…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a shot and a vaccine free people with HIV from daily pills? early trial aims to find out.
Disease control Recruiting nowThis early-stage study tests whether giving two powerful antibodies along with a therapeutic HIV vaccine can help people with HIV control the virus after they stop their daily antiretroviral therapy. The trial enrolls 48 adults in Thailand who started HIV treatment very soon afte…
Phase 1 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to tame rare blood disorder flares
Disease control Recruiting nowThis study tests a drug called depemokimab in adults with hypereosinophilic syndrome (HES), a rare condition where too many eosinophils (a type of white blood cell) cause organ damage. The trial includes 123 people whose HES is not well controlled despite standard therapy. Partic…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New weekly shot could replace IV drips for nerve disease
Disease control Recruiting nowThis study tests whether a weekly under-the-skin antibody treatment (XEMBIFY) provides similar blood levels as a standard IV infusion (Gamunex-C) given every 3 weeks in people with CIDP, a chronic nerve disorder. About 40 adults who are stable on IVIG will first receive Gamunex-C…
Phase 3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a new implant regrow your esophagus?
Disease control Recruiting nowThis study tests a new implant designed to help regrow a damaged section of the esophagus in up to 10 adults. The implant uses a special scaffold combined with the patient's own stem cells. The goal is to see if it is safe and can create a new, living esophageal tube. Participant…
Phase 1 • Sponsor: Harvard Apparatus Regenerative Technology, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Tailored sleep apnea therapy shows promise for down syndrome
Disease control Recruiting nowThis study tests whether matching sleep apnea treatment to the specific cause in each person with Down syndrome works better than a one-size-fits-all approach. 200 children and adults will receive either a combination of two drugs (ato-oxy) or oxygen therapy based on their indivi…
Phase 4 • Sponsor: University of Arizona • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to tame rare kidney diseases
Disease control Recruiting nowThis Phase 2 study tests a new drug called ADX-038, alone or with another drug (telitacicept), in 30 Chinese adults with kidney diseases caused by an overactive complement system (IgA nephropathy, C3G, or IC-MPGN). The goal is to see if the treatment is safe and can help control …
Phase 2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New study tests ilaris to tame rare inflammatory disease
Disease control Recruiting nowThis study looks at how well and how safely the drug Ilaris (canakinumab) works for people with Schnitzler's syndrome, a rare condition that causes hives, fever, joint pain, and fatigue. About 5 participants will receive the drug and be monitored for up to 48 weeks. The goal is t…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Diet and exercise boost muscle health in older adults, study finds
Disease control Recruiting nowThis study looks at whether a 12-week structured diet and exercise plan can help adults aged 50 and older with obesity and insulin resistance lose fat and improve muscle function. Participants will receive all meals and exercise three times a week under supervision. The goal is t…
Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene-Editing shot aims to fix rare lung and liver disease
Disease control Recruiting nowThis early-stage trial tests a new gene-editing medicine called TSRA-196 in 72 adults with a severe form of alpha-1 antitrypsin deficiency (the PiZZ genotype) who have lung or liver problems. The treatment is given by IV infusion and aims to raise levels of a protective protein. …
Phase 1/2 • Sponsor: Tessera Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for rare cancer: oral pill targets early mesothelioma in High-Risk patients
Disease control Recruiting nowThis study tests an oral medication (decitabine/cedazuridine) in people with BAP1 gene mutations who have early-stage mesothelioma that is not yet causing symptoms. The goal is to see if the drug can stop the cancer from growing or shrink it. About 9 participants will receive tre…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for rare MDS: targeted drug ivosidenib takes on standard therapy
Disease control Recruiting nowThis study is for people with a rare form of myelodysplastic syndromes (MDS) that has a specific genetic change called IDH1 mutation. Participants have not had prior treatment with certain drugs. They will be randomly assigned to receive either ivosidenib (a daily pill) or azacit…
Phase 3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental cell shot aims to boost brain repair in kids with rare metabolic diseases
Disease control Recruiting nowThis early-stage trial tests whether adding special cells (DUOC-01) into the spinal fluid is safe for children with inherited metabolic diseases that damage the brain. Participants are ages 1 week to 21 years and are already receiving a standard umbilical cord blood transplant. T…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Genetic roadmap guides new hope for tough leukemia
Disease control Recruiting nowThis study screens people with acute myeloid leukemia (AML) for specific genetic markers to assign them to a treatment sub-study with a targeted drug or combination. It aims to improve response rates by personalizing therapy based on each person's cancer profile. The trial enroll…
Phase 2/3 • Sponsor: Beat AML, LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for kids with psoriatic arthritis: apremilast trial begins
Disease control Recruiting nowThis Phase 3 study tests whether the drug apremilast (Otezla) can safely reduce joint inflammation and pain in children aged 5 to 17 with active juvenile psoriatic arthritis. About 60 participants will receive either apremilast or a placebo pill for 16 weeks. The main goal is to …
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could vitamin d ease sarcoidosis? new trial investigates
Disease control Recruiting nowThis study looks at whether vitamin D supplements can help people with sarcoidosis who have low vitamin D levels. Researchers will give some participants vitamin D2 and others a placebo, then measure changes in lung function and quality of life. The goal is to see if correcting v…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug DYNE-101 aims to ease muscle symptoms in DM1
Disease control Recruiting nowThis Phase 3 trial tests whether DYNE-101 can improve muscle function and daily life in 150 adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo by IV every few weeks for 48 weeks. The study measures how quickly people can stand from a ch…
Phase 3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New siRNA drug aims to tame kidney disease
Disease control Recruiting nowThis Phase 2 study is testing a new drug called ADX-038 in 45 adults with complement-mediated kidney diseases, such as IgA nephropathy and C3G. The drug is an siRNA that targets the complement system, which is overactive in these conditions. Researchers are checking if it is safe…
Phase 2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy trial hopes to tackle rare Autism-Linked condition
Disease control Recruiting nowThis early-stage trial tests a single dose of JAG201 gene therapy, given directly into the brain fluid, for people with SHANK3 haploinsufficiency (Phelan-McDermid syndrome), a rare genetic condition causing developmental delays and autism-like symptoms. The study includes childre…
Phase 1/2 • Sponsor: Jaguar Gene Therapy, LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Weekly shot could replace daily growth hormone for kids
Disease control Recruiting nowThis phase 3 trial compares a once-weekly growth hormone injection (lonapegsomatropin) to a daily one (somatropin) in 186 prepubertal children with growth failure due to Turner syndrome, SHOX deficiency, being small for gestational age, or idiopathic short stature. The goal is to…
Phase 3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to standard chemotherapy before a stem cell transplant can help prevent cancer from returning in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 participants aged 12 to 6…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug hopes to heal painful skin ulcers in rare disease
Disease control Recruiting nowThis study tests whether spesolimab, given as an infusion, can help close skin ulcers in adults with pyoderma gangrenosum, a rare inflammatory skin condition. About 90 participants will receive either spesolimab or a placebo, along with corticosteroids. The trial lasts about 1.5 …
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat kidney tumors
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of three drugs—bevacizumab, erlotinib, and atezolizumab—can safely shrink or stabilize advanced kidney cancer in people with hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary renal cell cancer. The dr…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug DSB2455 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called DSB2455 in adults with advanced cancers (breast, ovarian, prostate, pancreatic, or brain metastases) that have a specific DNA repair problem. The main goals are to check safety and see if the drug shrinks tumors. About 180 participan…
Phase 1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New trial aims to find safer chemo for stem cell transplants in leukemia patients
Disease control Recruiting nowThis study tests two chemotherapy drugs, treosulfan and melphalan, given before a stem cell transplant in 220 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to see which drug works better at helping patients survive longer with fewer side …
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Antioxidant cocktail may ease motor deficits in rett syndrome — a trial investigates
Disease control Recruiting nowThis pilot study tests whether an antioxidant cocktail called Rett-T can improve motor function in children and adolescents with Rett syndrome, a rare genetic disorder that affects movement and coordination. Participants, aged 2 to 21 and at least partially able to walk, will rec…
Phase 2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a common steroid save lives in severe lung failure?
Disease control Recruiting nowThis study tests whether the steroid dexamethasone, when added to standard care, can lower the chance of death within 90 days for people with a serious lung condition called ARDS caused by sepsis. About 1,474 adults on breathing machines will take part. The goal is to see if this…
Phase 3 • Sponsor: Southeast University, China • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Two-Drug combo shrink BRCA-Linked breast tumors?
Disease control Recruiting nowThis phase 1 trial tests whether adding the experimental antibody axatilimab to the standard drug olaparib is safe and tolerable for people with HER2-negative breast cancer that has spread and is linked to BRCA1, BRCA2, or PALB2 gene changes. Researchers will enroll about 20 part…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to cut transfusions for MDS patients
Disease control Recruiting nowThis study tests a drug called TAK-226 (Elritercept) in 27 Japanese adults with lower-risk myelodysplastic syndromes (MDS) who need regular blood transfusions. The goal is to see if the drug can help them go without transfusions for at least 8 weeks. Participants will receive inj…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a night of sleep pills ease breathing in sleep apnea?
Disease control Recruiting nowThis trial tests whether a combination of two sleep medications, eszopiclone and lemborexant, can help people who have both obstructive sleep apnea and insomnia. The idea is that these drugs may raise the brain's threshold for waking up, allowing more stable breathing during slee…
Phase 2 • Sponsor: Flinders University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for rare nerve tumor disorder: Multi-Drug trial launches
Disease control Recruiting nowThis study tests several experimental drugs in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves. The goal is to see if these drugs can shrink tumors and control the disease. About 109 participants will receive one of three dr…
Phase 2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug could help ER patients with severe infection shock
Disease control Recruiting nowThis pilot study tests whether giving angiotensin II early in the emergency department can help stabilize blood pressure in patients with septic shock. Twenty adults who need a standard drug called norepinephrine will receive angiotensin II as an add-on. The main goal is to see i…
Phase 4 • Sponsor: Brett A Faine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new drug called TQH3906 for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 156 adults will receive either TQH3906, a placebo, or an existing drug (tofacitinib) for 12 weeks. The main goal is to see if TQH3906 impr…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard medications (cyclophosphamide and tacrolimus) can prevent severe graft-versus-host disease (GVHD) in people receiving stem cell transplants for blood cancers like leukemia. About 124 adults will receive the drug com…
Phase 2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a diabetes pill calm obesity's hidden fire?
Disease control Recruiting nowThis study tests whether empagliflozin, a drug used for diabetes, can reduce chronic inflammation in people with obesity and metabolic syndrome. Researchers will measure immune cells and blood vessel function in 74 adults. The goal is to find a new way to lower heart disease risk…
Phase 1/2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Asthma drug may ease brain fog in gulf war illness
Disease control Recruiting nowThis trial tests whether montelukast, an asthma drug, can improve cognitive and mood problems in veterans with Gulf War Illness. The drug may reduce brain inflammation, which is thought to contribute to symptoms. Researchers will give montelukast or a placebo to 80 veterans and m…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug combo aims to tame stubborn psoriatic arthritis
Disease control Recruiting nowThis study tests whether adding deucravacitinib to standard therapy helps adults with psoriatic arthritis that is not well controlled. About 128 participants will receive the combination and be monitored for 48 weeks. The goal is to reduce skin and joint symptoms and improve qual…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called NT-175 for people with advanced solid tumors (like lung, colon, or breast cancer) that have a specific mutation (TP53 R175H) and a certain immune marker (HLA-A*02:01). NT-175 is made from a patient's own immune cells, which are …
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental antibody targets childhood cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a drug called codrituzumab in children and young adults (ages 1 to 21) whose solid tumors have come back or not responded to treatment and carry a specific protein called GPC3. The main goal is to find a safe dose and see how the body handles the drug…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowThis study tests a drug called risankizumab in children with juvenile psoriatic arthritis, a condition causing joint pain and swelling. About 40 kids will receive either risankizumab or the standard drug adalimumab for 24 weeks, with responders continuing for up to 2 years. The g…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Dialysis patients may straighten up with In-Chair exercise
Disease control Recruiting nowThis trial investigates whether a 12-week supervised exercise program, done during regular hemodialysis sessions, can improve postural problems like hunched back and forward head posture in adults with end-stage renal disease. Participants will be randomly assigned to either the …
Sponsor: Pardis Specialized Wellness Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can olive oil and walnuts shield the brain from stroke and memory loss?
Disease control Recruiting nowThis trial tests whether a Mediterranean diet, enriched with extra virgin olive oil or walnuts, can lower the chance of stroke and slow cognitive decline in people with cerebral amyloid angiopathy (CAA) or CADASIL, two conditions that affect blood vessels in the brain. Participan…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a diabetes drug restore ovulation in PCOS?
Disease control Recruiting nowThis trial tests whether semaglutide, a drug used for diabetes and weight loss, can help restore ovulation in girls and women aged 12 to 35 with polycystic ovary syndrome (PCOS) and obesity. Participants receive semaglutide for 10 months, with doses increased over time. Researche…
Phase 3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a skin lotion tame the symptoms of a rare genetic disease?
Disease control Recruiting nowThis trial tests whether QRX003, a lotion applied to the skin, can reduce the redness, scaling, and itch caused by Netherton syndrome, a rare genetic condition. Participants apply the lotion twice daily for 3 months and visit the clinic every 4 to 6 weeks for checkups. The study …
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a daily pill help kids with rare liver disease avoid transplant?
Disease control Recruiting nowThis study follows 30 people with Alagille syndrome who are taking odevixibat (Bylvay) in their daily lives. The goal is to see if the drug helps them avoid serious surgeries like liver transplant or bile duct repair over the long term. Researchers will also track weight, height,…
Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Beef vs. broccoli: can a Meat-Heavy diet beat the USDA's best?
Disease control Recruiting nowThis study is testing whether a healthy diet centered around beef can reduce inflammation and improve metabolic health better than a standard U.S.-style diet based on USDA guidelines. Researchers will enroll 56 adults with metabolic syndrome or pre-diabetes and assign them to one…
Sponsor: National Cattlemen's Beef Association, a contractor to the Beef Checkoff • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New study aims to pinpoint optimal timing of vasopressin in septic shock
Disease control Recruiting nowThis study tests whether giving the drug vasopressin earlier or later during septic shock leads to better outcomes. Researchers will use a computer alert system to randomly assign 300 ICU patients to early or standard timing. The goal is to see if the timing can be reliably contr…
Phase 4 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New device aims to save legs from clot emergencies
Disease control Recruiting nowThis study is testing a device called the Indigo Aspiration System to remove blood clots from leg arteries in people with acute limb ischemia, a condition where a clot suddenly blocks blood flow. About 300 participants will undergo a procedure where the device sucks out the clot.…
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Dissolvable magnesium stent could revolutionize heart disease treatment
Disease control Recruiting nowThis study tests a new device called Freesolve, a temporary magnesium scaffold that props open blocked heart arteries and then dissolves over time. About 1,859 people with up to two new blockages will receive either this scaffold or a standard permanent stent. The goal is to see …
Sponsor: Teleflex • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New study tracks Real-World safety of odevixibat in rare liver disease
Disease control Recruiting nowThis study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.
Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a lotion calm the severe skin symptoms of netherton syndrome?
Disease control Recruiting nowThis trial tests whether QRX003 lotion, applied to the skin, can safely reduce the severity of Netherton syndrome, a rare genetic condition causing red, scaly skin and intense itching. Researchers will enroll about 20 people aged 14 and older who have the condition. Participants …
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New registry tracks Odevixibat's Long-Term impact on rare liver disease
Disease control Recruiting nowThis registry will follow 10 people with progressive familial intrahepatic cholestasis (PFIC) in South Korea who are taking odevixibat (Bylvay). The goal is to see how safe and effective the drug is over the long term in real-world use. Researchers will track side effects and how…
Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New registry tracks Real-World use of PFIC drug odevixibat
Disease control Recruiting nowThis registry will follow 20 people in China with progressive familial intrahepatic cholestasis (PFIC) who are taking odevixibat (Bylvay) as part of their normal care. The goal is to see how safe the drug is over the long term and how well it controls symptoms like severe itching…
Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can tailored breathing support and early muscle relaxants boost survival in ARDS?
Disease control Recruiting nowThis trial tests two strategies for people with moderate-to-severe acute respiratory distress syndrome (ARDS) who need a breathing machine. First, researchers compare a personalized approach to setting airway pressure based on how much lung is recruitable against standard low or …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can CBD calm the brain in fragile x syndrome?
Disease control Recruiting nowThis phase 2 trial tests whether a daily oral CBD solution can reduce anxiety and disruptive behavior in people with Fragile X syndrome, a genetic condition that often causes intellectual disability and autism-like symptoms. Researchers will give 40 participants either CBD or a p…
Phase 2 • Sponsor: Université de Sherbrooke • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a pill calm the skin symptoms of sarcoidosis?
Disease control Recruiting nowThis trial investigates whether an oral medication called brepocitinib can safely reduce skin lesions in adults with cutaneous sarcoidosis, a condition where inflammation causes bumps and rashes on the skin. Participants will receive either brepocitinib or a placebo to compare ef…
Phase 2/3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a targeted pill keep leukemia from returning after transplant?
Disease control Recruiting nowThis phase II trial is testing whether the drug ivosidenib, taken as a pill, can help prevent relapse in people with acute myeloid leukemia (AML) or myelodysplastic neoplasia (MDS) who have an IDH1 mutation and have recently undergone a stem cell transplant. Participants will sta…
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a simple leg raise guide sepsis fluid treatment?
Disease control Recruiting nowThis pilot trial explores whether a non-invasive cardiac output monitor (NICOM) can help guide fluid resuscitation in emergency department patients with sepsis and low blood pressure. Participants receive standard care, and some also undergo a one-time NICOM assessment that inclu…
Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Steak solution? lean beef may tame blood sugar in teens with PCOS
Disease control Recruiting nowThis pilot study tests whether a 12-week diet that includes at least one daily serving of lean beef, as part of a healthy meal plan, can improve blood sugar control in adolescent girls with PCOS. Participants will receive nutrition counseling and free beef, and researchers will m…
Sponsor: Texas A&M University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a home air filter help your heart?
Disease control Recruiting nowThis trial tests whether using portable HEPA air cleaners at home can reduce exposure to fine air pollution particles and, in turn, lower systolic blood pressure in people with metabolic syndrome. Participants in Qatar will use either a real HEPA filter or a sham filter for four …
Sponsor: Weill Cornell Medical College in Qatar • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A new protocol after heart attacks could slash risk of repeat events
Disease control Recruiting nowThis trial tests whether starting a comprehensive, guideline-based treatment plan immediately after a heart attack can reduce the chance of another heart attack, stroke, or death. The plan targets key risk factors like high cholesterol, high blood pressure, and diabetes using a c…
Sponsor: Zuyderland Medisch Centrum • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can advanced imaging reveal hidden swallowing muscle damage in IBM?
Diagnosis Recruiting nowResearchers at Johns Hopkins University are studying whether neuromuscular ultrasound and MRI can serve as reliable markers of swallowing muscle problems in people with inclusion body myositis (IBM). The study compares imaging and clinical findings in 30 participants, including p…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Acne may signal hidden hormonal disorder in young women
Diagnosis Recruiting nowResearchers at Sohag University Hospital want to know how many women with acne also have polyendocrine metabolic ovarian syndrome, a hormonal and metabolic condition. The study enrolls 90 women aged 15 to 49 who have been diagnosed with acne. Doctors will check each participant f…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a simpler, faster ECG match the gold standard?
Diagnosis Recruiting nowThis trial tests whether a 4-electrode tablet-based ECG (DigitalCardio) can record heart activity as quickly and clearly as the standard 10-electrode ECG. About 50 cardiology patients will undergo both methods in random order. Researchers will measure recording time and compare t…
Sponsor: Clinique Bizet • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
New imaging agent could sharpen liver cancer detection
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 68Ga-GPC3 that targets a protein found on liver cancer cells. About 40 adults with suspected or confirmed hepatocellular carcinoma will receive both this new tracer and a standard tracer (18F-FDG) for PET/CT scans. Researchers will…
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI on your phone: the future of heart attack detection in the field?
Diagnosis Recruiting nowParamedics and other prehospital providers often interpret ECGs under time pressure without expert backup. Missing a blocked coronary artery delays life-saving treatment, while false alarms send patients for unnecessary procedures. This trial randomizes 144 prehospital providers …
Sponsor: École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New screening tool aims to catch hidden arthritis in psoriasis patients
Diagnosis Recruiting nowThis Canadian study tests whether adding two questions about morning stiffness and lower back pain to a standard screening tool (PEST) can help dermatologists identify psoriatic arthritis earlier in people with moderate-to-severe plaque psoriasis. About 502 adults who are candida…
Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Can AI predict your lifespan from a short video?
Diagnosis Recruiting nowResearchers are building AI models that score standard physical and cognitive screening tests from video and audio, and that predict results a person did not obtain. The study enrolls adults 18 and older and follows them for life, linking records to a long-term aging study to che…
Sponsor: Longevity Metrics, Inc. • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Two proteins could give african clinics an early warning for dangerous pregnancy complication
Diagnosis Recruiting nowPreeclampsia is a serious high blood pressure condition that can develop during pregnancy and is a leading cause of death for mothers and babies in Africa. Doctors struggle to predict which women with high blood pressure will become severely ill because current tests are not accu…
Sponsor: Africa Clinical Research Network (ACRN) • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New scan could reveal hidden heart attack triggers
Diagnosis Recruiting nowThis pilot study tests whether a special PET scan using a tracer called Florbetaben can detect inflamed plaque in arteries of people who recently had a heart attack, stroke, or mini-stroke. The goal is to see if this imaging method can identify unstable plaques that are likely to…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
A sharper eye for cancer: new PET tracer targets hidden tumors
Diagnosis Recruiting nowResearchers are testing whether a radioactive tracer called 68Ga/18F-PSMA/PSFA can improve PET/CT scans for finding tumors in people with PSMA-related cancers, including prostate and liver cancer. The study will enroll 500 adults with suspected, newly diagnosed, or previously tre…
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Ambulance blood test could save thousands from unnecessary hospital trips
Diagnosis Recruiting nowThis study looks at whether a simple blood test done in the ambulance can safely rule out a heart attack in people with chest pain. Many patients are taken to the hospital even though they are not having a heart attack. The test uses a portable device to measure a heart protein c…
Sponsor: Central Denmark Region • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Can a simple blood test catch Cushing's earlier?
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose Cushing's syndrome, a condition caused by too much cortisol. Researchers will test the accuracy of the desmopressin stimulation test in 140 people aged 18-70 who have or may have Cushing's, plus healthy volunteers. Participants will…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
A glowing dye could expose hidden heart scarring
Diagnosis Recruiting nowThis study tests whether a new radioactive dye, 68Ga-FAPI, can spot active scarring in the heart muscle using PET-MR scans. Researchers will scan about 290 people with various heart muscle conditions, such as heart failure with preserved ejection fraction, hypertrophic cardiomyop…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
Could a home sleep test unlock better dementia care?
Diagnosis Recruiting nowThis trial asks whether a home sleep apnea test can be a better first step than an overnight lab study for diagnosing obstructive sleep apnea in people with dementia or mild cognitive impairment. Sleep apnea is common in these conditions and can worsen thinking problems, but many…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Could a Cancer-Killing pill stop colon cancer before it starts?
Prevention Recruiting nowThis early-phase study tests the safety of a drug called ONC201 (dordaviprone) in 36 adults at high risk for colorectal cancer due to familial adenomatous polyposis (FAP) or a history of many polyps. The drug aims to kill precancerous cells without harming normal ones. Researcher…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Stent or pills? trial tests best way to stop strokes from narrowed neck arteries
Prevention Recruiting nowThe VISTA trial compares two approaches for people who have had a stroke or mini-stroke caused by severe narrowing of an artery in the neck that supplies the back of the brain. Participants are randomly assigned to receive either a drug-eluting stent plus blood thinners or blood …
Sponsor: Xuanwu Hospital, Beijing • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Jail-Based program aims to cut HIV risk after release
Prevention Recruiting nowThis study tests a program in the Dallas County Jail that identifies people at high risk for HIV and offers them testing and education about PrEP, a daily pill that prevents HIV. A patient navigator helps interested individuals connect with PrEP providers after they are released.…
Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Inhaled DNA-buster may shield trauma patients from lung failure
Prevention Recruiting nowThis trial tests whether giving an inhaled medication called dornase alfa to severely injured patients on breathing machines can lower their risk of developing acute respiratory distress syndrome (ARDS), a serious lung condition. The drug is thought to break down DNA fragments re…
Phase 3 • Sponsor: University Hospital, Strasbourg, France • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Recruiting nowThis Phase 3 trial tests whether fenfluramine (Fintepla) can reduce behavioral and emotional symptoms in people with Rett syndrome. About 200 participants will receive either the drug or a placebo for 14 weeks. The study measures changes in behavior, sleep, and overall condition …
Phase 3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Counseling plus exercise may beat exercise alone for TOS pain
Symptom relief Recruiting nowThis study tests whether adding motivational interviewing (a type of counseling) to a home exercise program can improve pain and arm function in people with thoracic outlet syndrome (TOS). Seventy adults with TOS will be randomly assigned to either exercise alone or exercise plus…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Headband may ease withdrawal after cushing surgery
Symptom relief Recruiting nowThis study looks at how people recover from Cushing syndrome after surgery. Researchers want to understand what affects recovery and whether using a MUSE biofeedback headband can help ease withdrawal symptoms. The study will include 700 adults who are planning to have curative su…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New shot could ease IBS-D symptoms in major trial
Symptom relief Recruiting nowThis Phase 2 study tests whether brenipatide, given as an injection under the skin, can safely reduce abdominal pain and improve stool consistency in adults with diarrhea-predominant irritable bowel syndrome (IBS-D). About 531 participants will receive either the drug or a placeb…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a tiny electric zapper beat pills for IBS pain?
Symptom relief Recruiting nowThis study compares two treatments for abdominal pain in people with irritable bowel syndrome with constipation (IBS-C): a home-use device that delivers mild electrical stimulation (TEA) and the drug escitalopram (Lexapro). About 160 participants will be randomly assigned to one …
Phase 2/3 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug calm the storm of opioid withdrawal?
Symptom relief Recruiting nowResearchers are testing an experimental drug called tezampanel to see if it is safe and can ease opioid withdrawal symptoms in adults with opioid use disorder. The trial enrolls 40 people who are seeking treatment and have recent opioid use. Participants stay in a research center…
Phase 1 • Sponsor: Proniras Corporation • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New shot for stubborn constipation pain enters Mid-Stage trial
Symptom relief Recruiting nowThis study tests an injected drug called brenipatide in 342 adults with irritable bowel syndrome with constipation (IBS-C). Participants will receive either the drug or a placebo for about 35 weeks. The goal is to see if brenipatide safely reduces abdominal pain and improves bowe…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
App-Based mind therapy tested for Kids' tummy troubles
Symptom relief Recruiting nowThis study tests whether a mobile app that plays guided imagery sessions can help reduce chronic abdominal pain in children aged 7 to 12. Participants listen to 10-15 minute audio sessions five days a week for eight weeks, alongside their usual care. The goal is to see if this ap…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New sedation cocktail may protect elderly hearts during ICU breathing support
Symptom relief Recruiting nowThis study compares two sedation methods for elderly ICU patients (65+) who need a breathing tube. One group gets a mix of propofol and ketamine, the other gets propofol alone. The goal is to see which causes fewer dangerous drops in blood pressure. The trial involves 41 particip…
Phase 3 • Sponsor: Helwan University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a 20-Minute playlist calm a heart attack Patient's nerves?
Symptom relief Recruiting nowAcute coronary syndrome, which includes heart attacks, often triggers intense anxiety during the rush to hospital. Researchers are testing whether playing music for 20 minutes in the ambulance, on top of usual care, lowers anxiety and pain more than usual care alone. The trial en…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A simple breathing pattern may ease fibromyalgia symptoms — a trial puts it to the test
Symptom relief Recruiting nowFibromyalgia causes widespread pain, sleep problems, and fatigue. This trial tests whether a structured breathing technique called box breathing — inhaling, holding, exhaling, and pausing for 4 seconds each — can improve sleep quality, pain, and comfort. Sixty adults with fibromy…
Sponsor: Artvin Coruh University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to find safer way to help preemies breathe
Symptom relief Recruiting nowThis study compares two methods of giving surfactant, a medicine that helps premature babies breathe. One method uses a thin tube, the other uses a small airway device. The goal is to see which method causes fewer breathing problems and complications in infants born at 29 weeks o…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple mouthpiece silence snoring?
Symptom relief Recruiting nowResearchers at the University of Alberta are testing whether a passive myofunctional appliance can treat snoring and mild obstructive sleep apnea. The study enrolls 40 adults who snore or have mild sleep apnea. Participants use either the passive appliance or a standard oral appl…
Phase 1 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can light therapy shrink tonsils and ease Kids' sleep apnea?
Symptom relief Recruiting nowResearchers test whether non-invasive light therapy, called photobiomodulation, can reduce tonsil size and improve sleep apnea in children. The study enrolls 64 children with enlarged tonsils and sleep apnea symptoms. Participants receive either active or sham light therapy to th…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a Therapist's hands ease fibromyalgia pain?
Symptom relief Recruiting nowResearchers are testing whether Reiki therapy reduces pain and the overall impact of fibromyalgia in women. Eighty-four women with a confirmed diagnosis will receive either real Reiki or a sham session with no hand placement, once a week for four weeks. The trial measures pain in…
Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tame flushing and diarrhea in rare cancer syndrome
Symptom relief Recruiting nowThis Phase 3 trial tests whether the experimental drug paltusotine can reduce flushing and diarrhea in adults with carcinoid syndrome caused by neuroendocrine tumors. About 141 participants will receive either paltusotine or a placebo daily for 12 weeks. The study measures how mu…
Phase 3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
CBD trial aims to ease sanfilippo syndrome symptoms
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD) can safely improve behavior, mood, sleep, and daily function in people with Sanfilippo syndrome, a rare genetic disorder. Thirty-five participants will receive either CBD or a placebo, then switch after a break. Caregivers will report on…
Phase 2/3 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Ancient herbal mix put to the test against fibromyalgia pain
Symptom relief Recruiting nowThis trial tests whether Yangyin Roujin Formula, a Chinese herbal blend, can reduce pain and improve quality of life in people with fibromyalgia. Sixty adults with fibromyalgia will receive either the herbal formula or a placebo for 12 weeks. Researchers will also collect blood, …
Sponsor: Juan Jiao • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Zapping the vagus nerve: a new hope for fibromyalgia pain?
Symptom relief Recruiting nowResearchers at Massachusetts General Hospital are testing whether non-invasive vagus nerve stimulation can reduce pain and related symptoms in people with fibromyalgia. The study enrolls 60 adults aged 18 to 80 who have had fibromyalgia for at least three months and report modera…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Recruiting nowThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase 2/3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Desert plant tested against Clozapine's weighty side effects
Symptom relief Recruiting nowPeople with treatment-resistant schizophrenia often take clozapine, a drug that can cause serious weight gain and metabolic problems. This pilot study tests whether a daily infusion made from the leaves of the Nitraria retusa plant can reduce those side effects. Thirty patients w…
Sponsor: Faculty of Medicine, Sousse • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New eyeglass attachment could soothe dry eyes in just two hours
Symptom relief Recruiting nowThis study tests a disposable silicone device that clips onto eyeglasses to trap moisture around the eyes. Thirty-five adults with mild to moderate dry eye will wear it for two hours. Researchers will measure tear film stability, tear volume, and symptom changes before and after …
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Could a common plant compound lower blood pressure?
Symptom relief Recruiting nowThis study tests whether quercetin, a natural supplement found in foods like onions and apples, can improve blood pressure and body fat in healthy adults. Researchers will give 40 participants either quercetin or a placebo for a set period. The goal is to see if this simple dieta…
Sponsor: University of Central Lancashire • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a common plant compound help rare telomere disease?
Symptom relief Recruiting nowThis pilot study tests whether quercetin, a natural antioxidant found in many plants, is safe for people with Dyskeratosis congenita or telomere biology disorders. Twelve participants will take quercetin for 24 weeks while researchers monitor side effects and how well people stic…
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
A shot to straighten a smile: botulinum toxin tested in kids with facial asymmetry
Symptom relief Recruiting nowThis trial tests whether botulinum toxin type A injections can improve lower-lip asymmetry in children with hemifacial microsomia, a condition where the lower lip moves unevenly during smiling or speaking. The study enrolls children under 18 with this condition and a crooked-mout…
Sponsor: Peking Union Medical College • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a bone drug ease CRPS pain? large trial underway
Symptom relief Recruiting nowThis phase 3 trial tests whether the drug neridronate, given as four IV infusions over 10 days, can reduce pain and other symptoms of complex regional pain syndrome type 1 (CRPS-1). About 270 adults with CRPS in one limb will receive either the drug or a placebo. The main goal is…
Phase 3 • Sponsor: Ambros Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Drinking water and breathing exercises could be new weapon against sleep apnea
Symptom relief Recruiting nowThis study tests whether simple exercises (like drinking water and breathing in a certain way) can improve sleep quality in 60 U.S. service members with obstructive sleep apnea. Some participants have also had a traumatic brain injury. The goal is to see if these exercises reduce…
Phase 1/2 • Sponsor: Uniformed Services University of the Health Sciences • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Brain retraining trial aims to ease chronic fatigue and long COVID symptoms
Symptom relief Recruiting nowThis study is testing a mind-body program called DNRS for people with ME/CFS (chronic fatigue syndrome) who may also have Long COVID. The program uses brain retraining to help calm overactive nerves and improve symptoms like fatigue, pain, and mood. Researchers will track quality…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can tailored acupuncture help untangle PCOS?
Symptom relief Recruiting nowResearchers are testing whether a personalized acupuncture program combined with lifestyle coaching can improve insulin resistance in women with polycystic ovary syndrome (PCOS). The trial enrolls 210 women aged 18 to 40 with a BMI of 25 to 40. Participants receive acupuncture se…
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Fish or puppets: which distraction works best for needle-phobic kids?
Symptom relief Recruiting nowThis trial tests whether two simple distractions — watching a betta fish or playing with a hand puppet — can lower pain, fear, and anxiety in children aged 5 to 7 during a blood draw. One group will use the fish, another the puppet, and a third will receive standard care. Researc…
Phase 1 • Sponsor: Igdir University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Precision needling targets neck muscles to soothe head pain
Symptom relief Recruiting nowThis study looks at whether a single session of ultrasound-guided dry needling—inserting thin needles into tight neck muscles—can safely reduce headache symptoms. About 50 adults who have had headaches in the last 6 months and have tender neck muscles will participate. The goal i…
Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Could a common numbing drug cut opioid needs in sickle cell emergencies?
Symptom relief Recruiting nowThis study tests whether adding lidocaine, a numbing medicine, to standard pain treatment can lower the amount of strong opioids needed during severe sickle cell pain crises. About 104 adults with sickle cell disease who are in the intensive care unit for a pain crisis will take …
Phase 3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New monthly shot could ease Sjögren's dry mouth
Symptom relief Recruiting nowThis phase 3 study tests whether ianalumab, given as a monthly injection, can reduce dry mouth and other symptoms in people with Sjögren's disease who have a high symptom burden. About 570 adults will receive either the drug or a placebo for 52 weeks. The main goal is to see if t…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Sound waves vs. chronic pain: a new test for CRPS after wrist fracture
Symptom relief Recruiting nowThis trial tests whether extracorporeal shock wave therapy (ESWT), which delivers sound waves to painful areas, can ease symptoms of complex regional pain syndrome type I (CRPS-I) that sometimes follows a wrist fracture. Sixty adults with CRPS-I will receive standard rehabilitati…
Sponsor: Dilek ün oguzhanasilturk • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple tape ease nerve pain and restore grip?
Symptom relief Recruiting nowThis trial tests whether a single application of Kinesio Taping can quickly reduce symptoms and improve grip strength and hand dexterity in adults with thoracic outlet syndrome, a condition where nerves or blood vessels are compressed in the shoulder area. Participants are random…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New fibromyalgia drug AXS-14 enters final testing phase
Symptom relief Recruiting nowThis Phase 3 study tests whether AXS-14 (esreboxetine) can help manage fibromyalgia symptoms like pain and fatigue. About 620 adults with fibromyalgia will take the drug or a placebo daily. The study uses a 'randomized withdrawal' design to see how long the drug's effects last.
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New stimulation pattern could ease tough back pain
Symptom relief Recruiting nowThis study is testing a new way to use an already-approved spinal cord stimulator to treat chronic, hard-to-manage back and leg pain. The device sends mild electrical pulses to the spine, and the new setting (called TVP-SCS) varies the timing of those pulses. Researchers will enr…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New pill aims to take the edge off quitting weed
Symptom relief Recruiting nowThis study tests a new medication called PP-01 to help adults with cannabis use disorder manage withdrawal symptoms when they stop using cannabis. About 420 participants will receive PP-01, an existing drug (nabilone), or a placebo daily for 34 days, with a one-week hospital stay…
Phase 3 • Sponsor: PleoPharma, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New combo therapy aims to ease fibromyalgia pain
Symptom relief Recruiting nowThis study compares taking pregabalin alone versus pregabalin plus venlafaxine for fibromyalgia, a condition causing widespread pain and fatigue. Researchers want to see if the combination provides better pain relief without more side effects. The study will enroll 750 adults wit…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New group therapy aims to tame meltdowns in Prader-Willi teens
Symptom relief Recruiting nowThis study tests a group program to help teens (ages 13-17.5) with Prader-Willi Syndrome and their families learn practical ways to handle irritability, meltdowns, and anxiety. Ten participants will attend weekly 90-minute sessions. The goal is to see if the program improves emot…
Sponsor: Children's Mercy Hospital Kansas City • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could piano practice sharpen the brains of children with FASD?
Symptom relief Recruiting nowThis trial tests whether daily music training—either piano practice or listening to music—can improve behavior and thinking in children with fetal alcohol spectrum disorder (FASD). Each child will do both activities for 12 weeks each, in a random order, with tests before and afte…
Sponsor: The Mind Research Network • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a massive data registry crack the code of Parkinson's and related brain diseases?
Knowledge-focused Recruiting nowResearchers are building a large database of cognitive, behavioral, lifestyle, and genetic information from people with neurodegenerative diseases such as Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. The goal is to find biomarkers that help do…
Sponsor: Vincent Mok • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch major study to unravel hormone disorders
Knowledge-focused Recruiting nowThis study enrolls adults with known or suspected endocrine (hormone gland) disorders, such as diabetes or thyroid disease, to help researchers learn more about these conditions. Participants will undergo medical exams, blood and imaging tests, and possibly genetic testing. The m…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
NIH launches deep dive into gulf war illness mystery
Knowledge-focused Recruiting nowThis study aims to understand Gulf War Illness (GWI), a condition affecting up to 210,000 veterans with symptoms like fatigue, pain, and memory problems. Researchers will compare 85 Gulf War veterans—some with GWI and some without—through extensive tests including blood draws, sc…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans reveal hidden thinking problems in anemia patients
Knowledge-focused Recruiting nowThis study uses a non-invasive brain imaging technique called fNIRS to see how anemia affects thinking and memory. Researchers will measure brain activity in 323 adults with different types of anemia and compare it to cognitive test scores. The goal is to identify which brain reg…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks drug levels in breast milk for nursing moms
Knowledge-focused Recruiting nowThis study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not …
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scan brains to unravel why effort hurts in chronic fatigue
Knowledge-focused Recruiting nowThis study uses functional MRI to see how the brain processes unpleasant sensations like pain and physical effort in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy volunteers. Researchers will apply mild heat and ask participants to sq…
Early phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
The heart rhythm threat hiding in heart attack wards
Knowledge-focused Recruiting nowPeople admitted for acute coronary syndrome, which includes heart attacks and unstable angina, face a higher risk of dangerous heart rhythms such as sustained ventricular tachycardia and ventricular fibrillation. Hospitals monitor these patients, but the exact rate of these rhyth…
Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Massive study aims to unlock secrets of parathyroid diseases
Knowledge-focused Recruiting nowThis study follows up to 3,000 people who have, are at risk for, or are related to someone with a parathyroid disorder. Researchers will collect medical records, questionnaires, and samples like blood and saliva to learn what causes these conditions and how they change over time.…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
2,000 volunteers to help unlock secrets of metabolic syndrome and prediabetes
Knowledge-focused Recruiting nowThis study will follow 2,000 adults with metabolic syndrome or prediabetes over time to understand how these conditions progress and lead to complications. Researchers will track health records, nutrition, and physical function to find key factors that affect long-term outcomes. …
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Why some days hurt more: charting Fibromyalgia's daily swings
Knowledge-focused Recruiting nowFibromyalgia causes widespread pain, fatigue, and trouble with daily activities, and these symptoms can shift from day to day even when their average level stays the same. Researchers at Mardin Artuklu University are studying 150 adults with fibromyalgia to see whether daily chan…
Sponsor: Mardin Artuklu University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists hunt for genes behind rare eye conditions
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of a group of eye conditions called MAC (microphthalmia, anophthalmia, and uveal coloboma), which can lead to vision loss or blindness. Researchers will collect DNA samples from 600 people—both those with MAC and their close relatives…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch major study to unravel salivary gland mysteries
Knowledge-focused Recruiting nowThis study aims to learn more about diseases that affect the salivary glands, which produce saliva. Researchers will collect medical data, blood, saliva, and tissue samples from people with these conditions, their relatives, and healthy volunteers. The goal is to better understan…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists track Sjogren's disease to unlock its secrets
Knowledge-focused Recruiting nowThis study follows 300 people with Sjogren's disease (or symptoms) over time to learn how the condition starts and progresses. Participants undergo exams, saliva and tear tests, and questionnaires during several visits. No treatment is given; the goal is to gather data and sample…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Global registry aims to map the full course of Charcot-Marie-Tooth disease
Knowledge-focused Recruiting nowResearchers are building a global registry to collect patient-reported surveys, genetic test results, and medical records from people with Charcot-Marie-Tooth disease and related inherited neuropathies. The study is open to children and adults with a confirmed or suspected diagno…
Sponsor: Hereditary Neuropathy Foundation • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
Knowledge-focused Recruiting nowThis study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understan…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study seeks to uncover links between ALS and dementia
Knowledge-focused Recruiting nowThis study screens 360 adults with neurodegenerative disorders like ALS, frontotemporal dementia, and progressive supranuclear palsy. Researchers will use medical history, physical exams, memory tests, movement analysis, MRI scans, and other tests to find common features and diff…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study aims to better measure pain in NF1 patients
Knowledge-focused Recruiting nowThis study works to improve questionnaires that measure pain, daily activities, and physical function for people with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas. Participants aged 5 and older will give feedback on existing surveys through group discussions or…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to map brain changes in kids with rare genetic disorders
Knowledge-focused Recruiting nowThis study aims to understand how the brain develops in children with Williams syndrome or 7q11.23 duplication syndrome, compared to healthy children. Researchers will use MRI scans and cognitive tests to track changes over time. The goal is to learn how these genetic variations …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into why skin tumors grow in rare disease
Knowledge-focused Recruiting nowThis study looks at why people with tuberous sclerosis, a rare genetic condition, develop non-cancerous skin tumors. Researchers will examine up to 400 adults, perform skin exams, and take small tissue samples (biopsies) from tumors. The goal is to identify the cells and genetic …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a blood enzyme reveal who will survive deadly shock?
Knowledge-focused Recruiting nowVasoplegic shock is a life-threatening drop in blood pressure that can lead to organ failure. Doctors at University Medical Centre Maribor are studying patients whose blood pressure stays too low despite standard drugs. They measure renin, an enzyme tied to blood pressure regulat…
Sponsor: University Medical Centre Maribor • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive heart study seeks 5,000 volunteers to uncover hidden risks
Knowledge-focused Recruiting nowThis study aims to learn more about heart and blood vessel diseases by observing people who have them or are at risk. Researchers will collect samples and perform tests like imaging and stress tests on up to 5,000 participants, including healthy volunteers and relatives of affect…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare family condition to uncover hidden clues about blood disorder
Knowledge-focused Recruiting nowThis study follows about 50 members of a family with a rare inherited condition called familial hypereosinophilia, where high levels of a type of white blood cell can damage the heart and nerves. Researchers will track participants over many years with yearly checkups, blood test…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into skin bugs to unlock eczema secrets
Knowledge-focused Recruiting nowThis study looks at the tiny organisms living on our skin—like bacteria and fungi—and how they might differ in people with eczema (atopic dermatitis). Researchers will collect skin samples from healthy volunteers and patients aged 2 to 40 with moderate to severe eczema, as well a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowThis study is for people with certain autoinflammatory diseases (like NOMID, DIRA, CANDLE, SAVI, and others) and their healthy relatives. Researchers want to learn more about what causes these diseases and how they affect the body over time. Participants will have medical tests a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
20,000 volunteers needed to decode immune disease genetics
Knowledge-focused Recruiting nowThis study will analyze DNA from up to 20,000 people, including those with immune disorders and their relatives, to find genetic variants linked to conditions like atopy, autoimmunity, and primary immunodeficiency. Researchers will also study how best to return genetic results to…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists probe immune System's role in chronic disease
Knowledge-focused Recruiting nowThis study looks at how the body's innate immune system responds to certain environmental exposures by measuring inflammation markers in blood. Researchers will collect blood samples from up to 725 healthy volunteers aged 18-45 to analyze how specific genes and proteins react. Th…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
The hidden breath: how a mismatch between patient and machine may shape ARDS recovery
Knowledge-focused Recruiting nowResearchers at Hospital Civil de Guadalajara are observing mechanically ventilated patients with acute respiratory distress syndrome (ARDS) to measure how often a breathing mismatch called reverse trigger occurs. They monitor patients continuously with esophageal manometry from t…
Sponsor: Hospital Civil de Guadalajara • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can your genes predict eye damage from a common arthritis drug?
Knowledge-focused Recruiting nowThis study looks at whether certain genes make some people more likely to develop eye damage from the drug Plaquenil, which is used for autoimmune diseases like lupus and rheumatoid arthritis. Researchers will compare people who have had eye damage from Plaquenil with those who h…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cancer tissue bank opens to fuel research
Knowledge-focused Recruiting nowThis study collects tissue and fluid samples from up to 5,000 cancer patients to help researchers learn more about cancer and develop new tests and treatments. Samples are taken from routine procedures or from extra biopsies done just for research. The goal is to build a resource…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek clues to rare cancer syndrome in 5,000-Person study
Knowledge-focused Recruiting nowThis study aims to learn more about Li-Fraumeni syndrome (LFS), a genetic condition that raises the risk of several cancers. Researchers will study up to 5,000 people with LFS or related cancer histories to find new genes, understand how the TP53 gene works, and identify factors …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Girls' period patterns under the microscope: a quest to decode healthy puberty
Knowledge-focused Recruiting nowThis study follows healthy girls ages 8-14 and teens with irregular periods to learn how their menstrual cycles become regular after their first period. Researchers also include girls at risk for PCOS and compare them to women with and without PCOS. The goal is to understand norm…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
The question after preventive mastectomy: would women do it again?
Knowledge-focused Recruiting nowResearchers at an Italian hospital are asking women who carry BRCA1/2 gene variants and chose risk-reducing mastectomy to describe their experience in an online survey. The survey covers why they chose surgery, which procedures and reconstructions they had, complications, sensati…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of food allergies
Knowledge-focused Recruiting nowThis study looks at the causes and effects of food allergies and related conditions like eczema and eosinophilic esophagitis. Researchers will collect blood, skin, and genetic samples from up to 1,800 people over many years. The goal is to find biomarkers and pathways that explai…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare cancer syndrome under the microscope: what families need to know
Knowledge-focused Recruiting nowThis study follows people with a rare genetic condition called DICER1 syndrome, which raises the risk of certain childhood cancers like pleuropulmonary blastoma. Researchers will collect medical histories, genetic samples, and tissue from up to 1,500 participants and their relati…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye scans as a window to the body: study probes retinal imaging across diseases
Knowledge-focused Recruiting nowResearchers at the University of Miami are studying whether advanced eye imaging devices can reveal useful information about the eye in health and disease. The study has two parts: one observes the eyes of healthy people and people with conditions such as multiple sclerosis, dry …
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch Long-Term study to unravel mysterious liver disease
Knowledge-focused Recruiting nowThis study is observing 400 people aged 12 and older who have noncirrhotic portal hypertension (NCPH) or are at risk for it. NCPH is a liver condition that increases blood pressure in the liver's blood vessels without causing cirrhosis, and often has no early symptoms. Researcher…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for gene behind rare kidney cancer syndrome
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of hereditary leiomyomatosis renal cell cancer (HLRCC), a condition that can lead to painful skin bumps, uterine fibroids, and kidney tumors. Researchers will study people with known or suspected HLRCC and their family members to iden…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Sickle cell study aims to uncover disease patterns
Knowledge-focused Recruiting nowThis study follows up to 3,500 people with sickle cell disease to learn more about how the condition progresses and what complications arise. Participants receive their usual medical care outside the hospital and visit the clinic for check-ups and research tests. No experimental …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Banking blood and bone marrow to decode plasma cell disorders
Knowledge-focused Recruiting nowResearchers at Peking University First Hospital are building a prospective cohort of 2,000 people with plasma cell disorders, including multiple myeloma, amyloidosis, and related conditions. Participants give blood, bone marrow, and urine samples before and after treatment, and t…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare immune disease to unlock its secrets
Knowledge-focused Recruiting nowThis study follows people with autoimmune lymphoproliferative syndrome (ALPS) and their relatives over many years. Researchers will collect blood and tissue samples, track symptoms, and study genetics to better understand why the immune system attacks the body. The goal is to lea…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into the roots of a mysterious lung disease
Knowledge-focused Recruiting nowThis study aims to understand how lymphangioleiomyomatosis (LAM) damages the lungs at the cellular and genetic level. Researchers will follow up to 2,000 participants, including women with LAM and healthy volunteers, using advanced imaging and lab tests. The goal is to find the p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare gene study aims to unlock kidney cancer risks
Knowledge-focused Recruiting nowThis study looks at a rare inherited condition called Birt-Hogg-Dube (BHD) syndrome, which raises the risk of kidney cancer. Researchers will collect blood, saliva, and tissue samples from up to 950 participants to find the genes involved and understand how kidney tumors grow. Th…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek clues on white blood cell behavior in allergies and parasites
Knowledge-focused Recruiting nowThis study aims to understand how and why eosinophils (a type of white blood cell) become active in conditions like allergies, asthma, and parasitic infections. Researchers will observe up to 800 people aged 1 to 100 with high eosinophil levels. No experimental treatments are giv…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch major study to unravel rare bone disease
Knowledge-focused Recruiting nowThis study follows up to 500 people with polyostotic fibrous dysplasia or McCune-Albright syndrome to learn how these conditions change over time. Researchers will collect medical data and tissue samples to better understand the disease. The goal is to improve future diagnosis an…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
China launches massive kidney registry to map nephrotic syndrome
Knowledge-focused Recruiting nowResearchers at Sun Yat-sen University are building a registry of people with nephrotic syndrome across hospitals in China. The study aims to enroll 5,000 patients regardless of the underlying cause. By recording baseline and follow-up information, the team will track kidney funct…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists launch Decade-Long quest to unravel rare stroke disorder
Knowledge-focused Recruiting nowThis study follows 155 adults with CADASIL, a genetic condition that narrows small blood vessels and raises the risk of strokes and dementia, over nine years. Researchers will use brain scans, blood tests, and other exams to track how the disease changes blood vessels and thinkin…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists hunt for hidden subgroups in sudden respiratory failure
Knowledge-focused Recruiting nowResearchers at Evangelismos Hospital are studying adults who arrive in the emergency department with sudden acute hypoxemic respiratory failure, a condition where the blood oxygen drops dangerously low. The team collects clinical, imaging, physiological, and biological data early…
Sponsor: Evangelismos Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Diabetes study aims to uncover hidden links between diet and physical decline
Knowledge-focused Recruiting nowThis observational study will follow 2000 adults with type 2 diabetes to see how their eating habits, body composition, and grip strength change over time. Researchers hope to identify patterns that could help improve care. Participants must be 18 or older and able to complete ba…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can a special suit improve balance for people with brain and nerve disorders?
Knowledge-focused Recruiting nowThis study is collecting information from 200 people with cerebral palsy, multiple sclerosis, stroke, fibromyalgia, or similar nerve disorders to see how the EXOPULSE Suit affects their balance and risk of falling over time. Participants will be followed routinely, and researcher…
Sponsor: Otto Bock Healthcare Products GmbH • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Heart rhythm gene hunt: 2,000 patients join biobank
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2,000 people with or without heart rhythm problems. Researchers will analyze the samples to find genetic differences linked to arrhythmias. The goal is to better understand the causes of these conditions, not to test a new treatme…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Biobank aims to unlock the mysteries of calciphylaxis
Knowledge-focused Recruiting nowCalciphylaxis is a rare disorder where calcium builds up in small blood vessels in the skin, causing painful lesions. Researchers at Massachusetts General Hospital are building a biobank and patient registry to collect samples and health information from up to 300 adults with the…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can a smartwatch track how kids recover from cancer surgery?
Knowledge-focused Recruiting nowThis study is testing whether smartwatches and blood tests can measure how well children recover after surgery to remove a solid tumor. About 40 children and their caregivers will wear smartwatches and answer questionnaires before surgery and for up to a year after. Researchers w…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Egypt launches major study to track rare genetic disorder NF1
Knowledge-focused Recruiting nowThis study is a disease registry that will collect information from 200 people in Egypt who have neurofibromatosis type 1 (NF1), a genetic condition that causes tumors to grow on nerves. The goal is to understand how the disease progresses over time, what treatments patients rece…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Telehealth program aims to improve end-of-life conversations for older cancer patients
Knowledge-focused Recruiting nowThis study tests a telehealth program that helps older adults (60+) with blood cancers like leukemia or MDS talk to their doctors about their care wishes. The program also helps them fill out advance directive forms. Researchers want to see if it improves communication and reduce…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Scientists track rare gene variant to unlock blood disorder mysteries
Knowledge-focused Recruiting nowThis study follows people of all ages who have or may have a RUNX1 gene variant, which can cause bleeding problems and increase the risk of blood cancers. Researchers will collect medical history, blood samples, and bone marrow over many years to understand how the condition deve…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Could a simple questionnaire unmask Fibromyalgia's hidden emotional toll?
Knowledge-focused Recruiting nowThis study evaluates a questionnaire called the Emotional Allodynia Questionnaire (AEQ), which measures how people with fibromyalgia react emotionally to everyday social cues. Researchers want to see if the tool can reliably identify fibromyalgia and tell it apart from other type…
Sponsor: University of Bari • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Laser imaging may uncover secret triggers of lung disease
Knowledge-focused Recruiting nowThis study explores whether a technique called LIBS, which maps chemical elements in lung tissue, can help doctors identify possible environmental or workplace causes of chronic lung diseases. Researchers will analyze stored biopsy samples from 70 adult patients using LIBS and an…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Blood cancer registry tracks thousands to map disease course
Knowledge-focused Recruiting nowResearchers are building a registry to collect long-term health information from adults with myelodysplastic syndromes and therapy-related acute myeloid leukemia. The study gathers details on blood counts, bone marrow tests, genetic changes, and treatments. By following these pat…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Could your DNA hold the key to preventing hearing loss?
Knowledge-focused Recruiting nowThis study aims to understand why people with Turner syndrome often lose their hearing. Researchers will look at genetic and epigenetic markers in 150 adults aged 18-60. Participants will have hearing, balance, blood, and imaging tests. The goal is to find new ways to treat or de…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
HIV pain puzzle: are natural painkillers to blame?
Knowledge-focused Recruiting nowThis study looks at whether people with HIV have chronic pain because their bodies don't make enough natural painkillers (opioid peptides). Researchers will test pain sensitivity in 200 adults (with and without HIV) using heat, touch, and pressure. The goal is to understand the c…
Sponsor: Florida International University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Could your genes raise your melanoma risk? new study seeks answers
Knowledge-focused Recruiting nowThis study aims to understand how genetics and environmental factors contribute to melanoma, a serious skin cancer. Researchers will enroll up to 3,000 people with a personal or family history of melanoma or related conditions. Participants will fill out questionnaires, provide b…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists hunt for lung disease genes in 3,500 volunteers
Knowledge-focused Recruiting nowThis study looks at how genes play a role in lung diseases like cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will examine DNA from up to 3,500 people with and without lung disease to find genetic differences. The goal is to better understand what causes these cond…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists launch global effort to unravel mysteries of rare lymphatic diseases
Knowledge-focused Recruiting nowThis study is creating a registry of up to 1,000 people with rare lymphatic system disorders. Researchers will collect information from medical records and yearly surveys to understand how these diseases progress, what treatments are used, and how they affect quality of life. The…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
500-Patient study aims to unravel mysteries of rare immune diseases
Knowledge-focused Recruiting nowThis study follows 500 children and adults with rare genetic disorders called type I interferonopathies, which cause severe inflammation and neurological problems. Researchers will track how the disease progresses over time and look for biological markers to improve diagnosis and…
Sponsor: Imagine Institute • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Gene test may predict painkiller side effects in children
Knowledge-focused Recruiting nowThis study looks at whether a child's genes can predict how they will respond to painkillers after spine fusion surgery. Researchers will test 300 children aged 10 to 21 for specific gene variants linked to pain relief and side effects like nausea and breathing problems. The goal…
Sponsor: Senthil Sadhasivam • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists investigate rare overgrowth disorder proteus syndrome
Knowledge-focused Recruiting nowThis study aims to understand the genetic and biological causes of Proteus syndrome, a rare condition causing abnormal growth of bones, skin, and other tissues. Researchers will follow up to 1,500 participants over time, using medical exams, imaging, and blood tests to track how …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Researchers launch study to unravel mysteries of rare immune disorder sHLH
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop secondary hemophagocytic lymphohistiocytosis (sHLH), a serious immune condition causing fevers and organ damage. Researchers will follow 300 participants for up to 3 years, collecting blood samples and medical data to identify…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can better training help providers spot fetal alcohol spectrum disorders sooner?
Knowledge-focused Recruiting nowResearchers at the University of Rochester are testing a program called FMF Connect Pro that trains mental health providers to screen for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders, and support caregivers through a companion app. The study compares two t…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
800 patients, 3 years: mapping the mystery of rare headache attacks
Knowledge-focused Recruiting nowResearchers at six Italian headache centers are following about 800 adults with trigeminal autonomic cephalalgias, a group of rare headaches that includes cluster headache, paroxysmal hemicrania, SUNCT, SUNA, and hemicrania continua. The study observes routine care rather than as…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Ambulance risk score could speed heart attack care
Knowledge-focused Recruiting nowThis trial tests whether using a risk score and a rapid blood test in the ambulance can help decide where to take patients with chest pain. About 1,048 adults at intermediate or high risk for a heart attack will be randomly assigned to either this new triage method or usual care.…
Sponsor: Cyril Camaro • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Could a new drug calm the gut and stop IBS pain?
Knowledge-focused Recruiting nowThis study looks at whether a new drug called UCB8600 can stop mast cells in the gut from overreacting, which may cause pain in people with irritable bowel syndrome (IBS). Researchers will take gut tissue from 60 people (some with IBS, some healthy) and treat it with UCB8600 in t…
Sponsor: Guy Boeckxstaens • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Kids' voices in surgery: new study aims to measure what really matters to young patients
Knowledge-focused Recruiting nowThis study wants to improve how we measure children's recovery and experience after surgery and anesthesia. Researchers will translate and test a recovery scale for Danish children aged 4-12, and also develop a new questionnaire that lets children describe their own hospital expe…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tests if education can reduce heart risks after spinal cord injury
Knowledge-focused Recruiting nowThis study aims to see if a specially designed education module helps people with spinal cord injury (SCI) learn about their increased risk for heart disease, obesity, and metabolic problems. Researchers will enroll 250 adults with SCI and measure changes in knowledge, body weigh…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists launch deep dive into rare bleeding and lung disease
Knowledge-focused Recruiting nowThis study aims to learn more about Hermansky-Pudlak Syndrome (HPS), a rare inherited disease that causes light skin/eye color, bleeding problems, and often deadly lung scarring. Researchers will follow 600 people with HPS and their family members to track how the disease progres…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists seek genetic clues to mysterious fever diseases
Knowledge-focused Recruiting nowThis study aims to learn more about the genetics and natural history of autoinflammatory diseases, which cause repeated fevers and inflammation. Researchers will study up to 5,000 people, including patients, their relatives, and healthy volunteers. Participants provide blood and …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Why do Women's hearts fail differently? scientists launch massive study
Knowledge-focused Recruiting nowThis study aims to understand why heart disease develops differently in women compared to men. Researchers will measure inflammation markers and hormone levels in 6,000 women with chest pain. They hope to uncover how female sex hormones and inflammation interact to influence hear…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood protein clues may predict chemo success in older cancer patients
Knowledge-focused Recruiting nowThis study looks at 60 adults with acute myeloid leukemia or related blood cancers who are receiving a gentler type of chemotherapy. Researchers will measure certain proteins in the blood to see if they can predict how well the treatment works. The goal is to better understand wh…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Could pollution and sleep habits be messing with your hormones? new study investigates.
Knowledge-focused Recruiting nowThis study looks at how things in your environment—like pollution, chemicals, diet, and sleep—might affect your hormones and reproductive health. Researchers will follow 300 people aged 8 and older who have conditions like low or high hormone levels, early or late puberty, or inf…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Do silicone breast implants trigger lasting Whole-Body symptoms? large study tracks 3,000 women for five years
Knowledge-focused Recruiting nowResearchers are following 3,000 women who plan to have breast surgery, comparing those who receive silicone implants with those who have breast lifts or reductions without implants. The study measures fatigue, pain, thinking, mood, and other systemic symptoms before surgery and f…
Sponsor: Research Inc • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Head posture linked to fibromyalgia pain in new study
Knowledge-focused Recruiting nowThis study looks at whether forward head posture (a common issue) is linked to worse fibromyalgia symptoms. Researchers will measure the angle of the neck in 134 adults with fibromyalgia and compare it to their symptom severity using a questionnaire. The goal is to better underst…
Sponsor: Ankara Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Could a quick CPAP boost help preterm babies breathe better?
Knowledge-focused Recruiting nowThis study tests whether briefly increasing the air pressure from a CPAP machine before giving surfactant therapy helps preterm babies' lungs work better. Surfactant is a natural substance that helps immature lungs stay open, and it's often given through a thin tube. The trial wi…
Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New study aims to catch mesothelioma early in High-Risk families
Knowledge-focused Recruiting nowThis study follows 300 adults aged 30 and older who have or may have a BAP1 gene mutation, which raises the risk for mesothelioma and other cancers. Researchers will use advanced CT scans, blood tests, and minimally invasive camera procedures to look for early signs of cancer. Pa…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Brain tumor DNA test could match kids to smarter treatments
Knowledge-focused Recruiting nowThis study uses genetic testing of brain tumors from children, adolescents, and young adults (ages 1 to 39) with newly diagnosed high-grade glioma, including DIPG. The goal is to identify specific genetic changes in each tumor and then see if patients can join a treatment trial t…
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One million volunteers join quest to decode aging
Knowledge-focused Recruiting nowThis observational study will enroll up to one million adults to understand how health, environment, and lifestyle affect aging and disease. Researchers will link participants' clinical data with information from public records, such as pollution and social factors, to create a d…
Sponsor: Longevity Metrics, Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One million volunteers join quest to decode aging
Knowledge-focused Recruiting nowThis study will follow 1,000,000 adults aged 18 and older for the rest of their lives. Researchers will collect health measurements and track who develops diseases, becomes frail, or dies. The goal is to find which tests best predict how well people age, so doctors can one day of…
Sponsor: Longevity Metrics, Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of pituitary and hypothalamic tumors in children. Researchers will collect blood and tumor samples from up to 2,000 participants to analyze DNA and look for inherited patterns. The study also trains doctors and tests new MRI technique…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Heart risk under the knife: new study tracks anesthesia dangers in rare cardiac condition
Knowledge-focused Recruiting nowThis observational study will follow 200 adults with Brugada Syndrome who need anesthesia for surgery or other procedures. Researchers want to see how often dangerous heart rhythms occur during and up to 30 days after anesthesia. They will also check if certain anesthetic drugs o…
Sponsor: Hospital Clinic of Barcelona • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can early markers predict how atypical Parkinson's diseases progress?
Knowledge-focused Recruiting nowThis observational study follows 500 people with atypical parkinsonian syndromes, including multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration. Researchers track motor and non-motor symptoms and imaging changes every …
Sponsor: Second Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Massive study tests Droid-Assisted health screenings for rural communities
Knowledge-focused Recruiting nowThis study aims to find the best way to deliver preventive health screenings to people in underserved and rural areas. It will compare different methods, such as interactive health reports, mobile screening units, and even droid-assisted screenings, to see which improves health e…
Sponsor: William Brandenburg, MD • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists hunt for thyroid cancer genes in families
Knowledge-focused Recruiting nowThis study looks at families where non-medullary thyroid cancer runs in the family. Researchers want to learn how the disease develops, find genes that might increase risk, and figure out the best way to screen for it early. Participants will have exams, imaging, and blood tests,…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Do obese children with autism face different heart risks?
Knowledge-focused Recruiting nowThis study looks at whether obese children with autism spectrum disorder differ from those without autism in fitness and heart health. Researchers will review medical records of 200 children aged 6 to 18, including step test results, handgrip strength, body measurements, and bloo…
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Scientists launch massive tumor repository to unlock cancer secrets
Knowledge-focused Recruiting nowThis study collects extra blood, urine, and tumor samples from children and adults with certain cancers to build a large tissue repository. Researchers will analyze these samples to learn more about the genetic and molecular makeup of these tumors. The goal is to support future s…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Magnetocardiography device could spot heart attacks faster
Knowledge-focused Recruiting nowThis study is testing a new bedside device called CardiAQ MCG that measures the heart's magnetic fields to detect blocked arteries (ischemia). Researchers will enroll 150 adults scheduled for heart catheterization to see if the device can accurately predict heart attack status. T…
Sponsor: SB Technology, Inc. • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a gene biobank unlock better cancer screening for Li-Fraumeni families?
Knowledge-focused Recruiting nowThis study creates a database and biobank for people with Li-Fraumeni syndrome or related TP53 gene changes, conditions that raise the lifetime risk of cancer to as high as 90%. Researchers will collect clinical data, blood samples, and tumor tissue from up to 300 participants to…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
A nationwide effort to map a rare blood Cancer's toll
Knowledge-focused Recruiting nowResearchers in Italy are building a large registry of adults newly diagnosed with myelodysplastic syndromes, a group of blood cancers where the bone marrow does not make enough healthy blood cells. The study will collect data on up to 10,000 people to measure how many new cases o…
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Scientists hunt for biomarkers to unlock DM1 treatments
Knowledge-focused Recruiting nowThis study follows 1,000 adults with myotonic dystrophy type 1 (DM1) over time to measure how the disease progresses. Researchers will track walking speed, hand muscle relaxation, grip strength, heart and lung function, and daily activity. The goal is to establish reliable biomar…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a global patient registry unlock the secrets of a rare breathing disorder?
Knowledge-focused Recruiting nowResearchers are building an international registry to collect health information from people with congenital central hypoventilation syndrome (CCHS), a rare condition that affects breathing control. The study asks patients with a confirmed PHOX2B gene mutation to fill out surveys…
Sponsor: Ilya Khaytin • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
At-Home swab could spot uterine cancer in lynch syndrome patients
Knowledge-focused Recruiting nowThis study explores whether people with Lynch syndrome can use a self-collected vaginal swab at home to detect early signs of uterine cancer. Researchers will enroll 30 participants who will collect samples and answer surveys. The main goal is to see if this approach is practical…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Lying flat or upright? study tests best position for ARDS breathing
Knowledge-focused Recruiting nowThis study looks at how tilting the body (trunk inclination) changes lung mechanics in 40 adults with moderate to severe ARDS who are on ventilators. Researchers will measure lung pressures and use electrical imaging to see how different positions and ventilator settings affect l…
Sponsor: Zhongda Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study aims to unravel the mystery of PCOS in women with type 1 diabetes
Knowledge-focused Recruiting nowThis study investigates why women with type 1 diabetes (T1D) frequently develop polycystic ovary syndrome (PCOS), a condition of high androgen levels. Researchers will compare five groups of 12 participants each, including women with T1D and PCOS, women with T1D alone, men with T…
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Tailoring ventilators to each Patient's lungs: a new hope for ARDS?
Knowledge-focused Recruiting nowThis study looks at how to adjust breathing machine settings for people with moderate-to-severe ARDS, a serious lung condition. Researchers will use a special imaging technique to see how air and blood flow match up in the lungs. The goal is to find the best settings for each pat…
Sponsor: Zhongda Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a 45-Minute iPad test unlock how CCHS affects the brain?
Knowledge-focused Recruiting nowThis study measures thinking, memory, and attention in people with congenital central hypoventilation syndrome (CCHS), a rare condition that can reduce oxygen to the brain. Participants complete a 45-minute app-based cognitive assessment on an iPad, and parents or adult participa…
Sponsor: Ilya Khaytin • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a worldwide patient registry unlock better treatments for angelman syndrome?
Knowledge-focused Recruiting nowThis study builds a global online registry to collect long-term health information from children and adults with Angelman Syndrome. Parents and caregivers report on diagnosis, symptoms, and daily functioning over time. The goal is to better understand the condition's natural cour…
Sponsor: Foundation for Angelman Syndrome Therapeutics, Australia • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study hopes to spot cancer early in NF1 patients
Knowledge-focused Recruiting nowThis study is for people aged 3 and older with neurofibromatosis type 1 (NF1), a genetic condition that often causes noncancerous nerve tumors. About half of people with NF1 get these tumors, and sometimes they turn cancerous. Researchers want to test a new method to predict whic…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a national registry crack the code of a rare childhood disease?
Knowledge-focused Recruiting nowThis study aims to create a national registry in Egypt for children diagnosed with hemophagocytic lymphohistiocytosis (HLH), a rare and serious immune disorder. Researchers will collect data from hospitals across the country to build a detailed map of how the disease presents in …
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a new eye scanner match the gold standard for cataract surgery?
Knowledge-focused Recruiting nowThis study compares measurements from two biometers—devices that use light to measure the eye's internal structures—to see if they agree. The measurements are important for calculating the correct lens power before cataract surgery. The study includes people with healthy eyes, ke…
Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Ventilator pressure showdown: which setting saves lungs best?
Knowledge-focused Recruiting nowThis study looks at how different levels of positive end-expiratory pressure (PEEP) on a ventilator affect the diaphragm and lungs in ICU patients with respiratory failure. Twenty-five adults on pressure support ventilation will each receive low, medium, and high PEEP for short p…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
AI hunts for early clues to Parkinson's and Alzheimer's progression
Knowledge-focused Recruiting nowThis study follows 600 people with neurodegenerative diseases such as Parkinson's, Alzheimer's, and related conditions over 1 to 10 years. Researchers collect data from routine clinical exams, brain imaging, movement analysis, and blood tests. They use statistical tools and artif…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Scientists hunt for hidden cancer clues in families
Knowledge-focused Recruiting nowThis study aims to learn how genes and the environment contribute to rare tumors and cancer risk in individuals and families. Researchers will collect medical histories, genetic samples, and health data from up to 500 participants of all ages. No treatment is given; the goal is t…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Brain scans reveal effects of pausing Weight-Loss drug
Knowledge-focused Recruiting nowThis study will follow 40 adults aged 18-70 who currently take tirzepatide, a medication for blood sugar and appetite control. Researchers will temporarily stop the drug for 3-4 weeks and then restart it for 6-8 weeks, using brain scans, questionnaires, and stool samples to track…
Sponsor: The University of Texas at Dallas • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can we predict lung failure in children by measuring their breathing effort?
Knowledge-focused Recruiting nowThis study investigates whether measuring the physical effort of breathing in children with acute respiratory distress syndrome (ARDS) can predict how the disease will progress. Researchers will use advanced, non-invasive monitoring tools to track breathing drive, effort, and lun…
Sponsor: Universidad Nacional Andres Bello • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists launch major study to unravel mysteries of rare immune diseases
Knowledge-focused Recruiting nowThis study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity. Researchers will observe up to 500 patients over time using blood tests, imaging, and other exams. The goal is to find better ways to diagnos…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Massive study aims to decode cancer genes for better family counseling
Knowledge-focused Recruiting nowThis study looks at genetic changes in families to figure out which ones truly increase cancer risk. Researchers will analyze DNA from 11,000 people, including those with certain gene variants and their relatives. The goal is to improve genetic counseling and help doctors decide …
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New study to reveal hidden pancreatic issues in alagille syndrome patients after transplant
Knowledge-focused Recruiting nowThis study aims to find out how often exocrine pancreatic insufficiency (EPI) occurs in people with Alagille syndrome who have had a liver transplant. About 30 participants aged 7 to 50 will eat a high-fat diet and collect stool samples for lab testing. The results will help doct…
Sponsor: Digestive Care, Inc. • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Could a nickel allergy explain your Child's stomach pain?
Knowledge-focused Recruiting nowThis study looks at children with functional gut disorders, like stomach pain or irritable bowel syndrome, to see how many are also allergic to nickel or certain plant proteins called LTPs. Researchers will test for these allergies and also check in the lab whether a supplement c…
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
NF2 patients wanted for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people with neurofibromatosis type 2 (NF2) for up to 10 years to learn how the disease progresses. Participants will have yearly exams, MRI scans, hearing tests, and blood draws. The goal is to understand tumor growth, hearing loss, and speech or swallowing…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a blood bank unlock the genetics of brain disease?
Knowledge-focused Recruiting nowResearchers at the University of Pennsylvania are building a large repository of blood, DNA, and family history data from people with age-related brain diseases like Alzheimer's, Parkinson's, and ALS, as well as their family members. The goal is to support studies into the geneti…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists seek hidden causes of chronic lung infections
Knowledge-focused Recruiting nowThis study follows 900 people with bronchiectasis—a condition where airways are damaged and prone to infection—to learn why they get sick repeatedly. Researchers will collect medical history, lung function tests, and blood, urine, and sputum samples from patients and their family…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists launch deep dive into mysterious inflammatory diseases
Knowledge-focused Recruiting nowThis study aims to understand the causes and progression of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) by observing up to 2,000 participants over time. Researchers will collect medical history, blood samples, and genetic data to identify …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can money problems delay trauma recovery? a new study investigates
Knowledge-focused Recruiting nowThis study follows 185 adults in the Netherlands who are hospitalized with serious trauma injuries. Researchers will ask them to fill out short questionnaires about their quality of life, pain, fatigue, and daily functioning at several points over a year. The goal is to see wheth…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists dig into immune signals to unlock psoriasis mystery
Knowledge-focused Recruiting nowThis study looks at 40 adults with psoriasis—some with joint pain (psoriatic arthritis) and some without—to compare immune signals in their blood and skin. Researchers want to understand why some people develop joint problems. Participants give blood and skin samples for lab anal…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can brain scans and genes predict CADASIL's course?
Knowledge-focused Recruiting nowThis study looks at 100 adults with CADASIL, a genetic condition that affects small blood vessels in the brain and can lead to strokes and thinking problems. Researchers will collect genetic data, symptoms, and brain MRI images to see how these factors relate. The goal is to bett…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Registry aims to unlock secrets of rare brain tumor in NF1 patients
Knowledge-focused Recruiting nowThis study creates a registry of medical records, scans, and surveys from adults with neurofibromatosis type 1 (NF1) who also have a glioma brain tumor. Researchers will track diagnosis, treatments, and quality of life over time to better understand the disease. The goal is to im…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare genetic condition in kids
Knowledge-focused Recruiting nowThis study is creating a registry for children with PTEN Hamartoma Tumor Syndrome (PHTS), a rare genetic condition that increases cancer risk. Researchers will follow 100 participants for 3 years to link genetic changes with health outcomes. The goal is to develop better monitori…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
A sip of food dye may expose a hidden gut leak linked to ICU survival
Knowledge-focused Recruiting nowThis study tests whether a simple oral food dye can measure intestinal permeability in intensive care patients with organ failure. Researchers will give patients a small dose of dye and track how much appears in the blood, then compare that with survival at 90 days. The goal is t…
Sponsor: Direction Centrale du Service de Santé des Armées • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists launch major study to uncover secrets of kidney autoimmunity
Knowledge-focused Recruiting nowThis study follows up to 2000 people with immune-related kidney diseases, such as nephrotic syndrome and lupus nephritis. Researchers will collect medical history, lab tests, and blood or urine samples to better understand these conditions. The goal is to learn more about causes …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Blood oxygen dips may reveal who stays on CPAP
Knowledge-focused Recruiting nowThis study follows 200 adults with newly diagnosed obstructive sleep apnea who are starting CPAP therapy. Researchers measure biomarkers from the initial sleep study, including hypoxic burden, pulse wave amplitude drops, and heart rate variability. They then check whether these m…
Sponsor: Clinique du Millenaire • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can a national biobank network end the diagnostic odyssey for rare diseases?
Knowledge-focused Recruiting nowThis study aims to create a network of biobanks across Italy that collect and store biological samples and health data from people with rare diseases and their families. The goal is to standardize how samples are collected and shared, so researchers can access high-quality materi…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can we predict sudden cardiac arrest in heart disease patients?
Knowledge-focused Recruiting nowThis observational study aims to uncover clinical and genetic risk factors for sudden cardiac arrest and death in patients with coronary artery disease (CAD). Researchers will follow about 4,000 participants who have been diagnosed with CAD, collecting data from surveys, ECG reco…
Sponsor: Tampere Heart Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Can 30,000 patients reveal Parkinson's hidden patterns?
Knowledge-focused Recruiting nowThis study follows a large group of people with Parkinson's disease and related conditions in France to map how the disease unfolds over time. Researchers collect detailed information on symptoms, treatments, and genetic samples at regular visits. The goal is to identify distinct…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
A fingertip test that could reveal hidden danger in sepsis
Knowledge-focused Recruiting nowThis study looks at whether a simple bedside check called capillary refill time (pressing on a fingernail to see how fast color returns) can be combined with a blood test to spot a hidden problem in septic shock. Sometimes blood flow to organs seems normal, but tissues are still …
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC